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Abbreviations
bR bacteriorhodopsin from Halobium salinarum
SRII sensory rhodopsin II from Natronomonas pharaonis 
hR halorhodopsin from Natronomonas pharaonis 
ESR rhodopsin from Exiguobacterium sibiricum
CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
DMPC L-α-1,2-dimyristoylphosphatidylcholine
DDM n-dodecyl-β-D-maltopyranoside
Sarkosyl sodium N-lauroylsarcosinate
SDS sodium dodecyl sulfate
MP membrane protein
GPCR G-protein coupled receptor
MISTIC Membrane-Integrating Sequence for Translation Integral membrane protein 
Constructs
Lys Thermostabilized T4 lysozyme
MO  monoglycerol monooleoyl, monoolein
NTR non translating region
PCR polymerase chain reaction
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 1  Introduction
Membrane proteins (MPs) are major functional components of cell membrane. They implement
function  of  signal  transduction,  carry  out  passive  and  active  transport  across  membrane,  and
mediate  intercellular  communications.  Membrane  proteins  constitute  about  one  third  of  human
genome and are targets for more than 50-60% of modern drugs [1]. Availability of the structures of
MPs with atomic resolution is crucial not only for drug design, but also for basic science. However,
despite great interest and importance of MPs, their structures make up just about 1% of all high
resolution structures deposited in Protein Data Bank [2-4].
Throughout the years X-ray crystallography became a method of choice to determine a high
resolution 3D structure of MPs, since it allows determination of atomic coordinates for small and
large protein molecules. However, its application has two general bottlenecks dramatically slowing
down the MP studies: protein production and crystallization.
Generally,  homologous  expression  of  MPs is  at  very low level,  making  the  purification  of
material  from  natural  source  virtually  impossible.  Unfortunately,  the  yield  of  heterologous
overexpression is quite often poor. Purification of the functional MP is not a straightforward process
requiring multiple  steps.  Despite  the loss of  material  on each step can be acceptable,  the total
protein losses throughout the whole solubilization and purification process make a considerable part
of total expressed protein. The final yield of pure functional MP is low in many cases, thus limiting
further studies, especially structural studies. 
However, even if the protein material is available in large quantities, the determination of high
resolution  MP structure  using  X-ray  crystallography is  not  facile,  while  this  method  demands
crystals.  Unfortunately,  MPs  are  often  difficult  to  crystallize  due  to  the  inherent  instability  of
solubilized MPs in detergent  and steric  hindrances caused by detergent  micelles.  The available
methods  of  MP crystallization  are  far  from what  is  required.  Despite  recently  new  promising
approaches to crystallization of MP were developed [5-7], the determination of the MP structure at
atomic resolution is still a great challenge.
In this work we are mostly focused on the issues of MP production and crystallization. The
major  object  under  study was bacteriorhodopsin from  Halobium salinarum (bR), a  light-driven
pump that provides proton vectorial  transport  across the cell  membrane of archaea  [8,  9].  This
protein is a striking example of difficulties that scientists encounter handling MPs. The case of bR
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illustrates to the full extent the fails of functional heterologous expression of MPs and problems of
MP crystallization.
Bacteriorhodopsin  consists  of  7  transmembrane  α-helices  with  retinal  molecule  bound
covalently to the Lys 216 residue  [10].  As one of  the simplest  proteins  involved in  a key and
universal step of energy production in living cells, bR is of great interest for bioenergetics. Due to
the high level of homologous expression, ease of purification from the natural source [11], and high
thermal and chemical stability [12] this protein has become the most studied MP being a model for
expression, folding, and crystallization experiments. 
Despite availibility from natural source and appearance of first crystals in 1980 [13], the high
resolution 3D structure of bR was first obtained in 1996  [6], when a new in meso crystallization
concept  was introduced. In meso approach is based on the use of three-dimensional amphiphilic
bilayer  arrays  forming  interconnected  bilayers  pervaded by aqueous  channels  as  crystallization
medium. In more  native  lipid-based environment  MP remains  stable  for  a  longer  time,  and its
crystallization is not restrained by the bulky detergent micelle. This new approach allowed scientists
to obtain atomic resolution structures of bR [6, 14] that significantly improved understanding of the
vectorial  proton transfer mechanism  [15]. However,  there are still  a controversies regarding the
structures  of  bR  photocycle  intermediates  obtained  by  different  groups  [16]  requiring  new
structural studies of the protein.
For the investigation of bR photocycle and determination of the atomic structures of photocycle
intermediates an availability of different bR mutants is essential. The bR and its mutants are also
highly demanded in the applied studies regarding possible bR applications in bioelectronics, optics,
biophotonics, etc  [17, 18]. But homologous production of bR and its mutants in halobacteria is
laborious,  time-,  and  resource-consuming.  Therefore,  the  more  efficient  system  for  functional
expression of bR would be of wide interest. 
The functional expression of bR in E. coli  would be the most simple, robust, and inexpensive
system [19], and the efforts to reach this goal last already almost 30 years [20]. First studies have
shown a low level of wild type bR expression in  E. coli because of severe degradation of newly
synthesized protein [20]. Application of exogenous N-terminal tags allowed to stabilize the protein,
prevent its degradation, and increase the yield of modified bacterioopsin up to 17 mg of protein per
liter of culture [20, 21]. Further progress was related to the use of the fusion proteins that boosted
the expression level up to 100-200 mg/l [22-24]. However, the mentioned systems did not provide
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functional bR expression: the protein had to be first undergone unfolding followed by refolding.
Such behavior of bR is all the more surprising, as the expression of a number of closely related
retinal proteins, namely sensory rhodopsin I and II from H. salinarum [25, 26], halorhodopsin and
sensory rhodopsin II from N. pharaonis [27], bacteriorhodopsin from Exiguobacterium sibiricum
[28],  deltarhodopsin  from  Haloterrigena  turkmenica  [29],  bacteriorhodopsins  and  sensory
rhodopsins from Haloarcula marismortui [30], and others, was shown to be functional in  E. coli.
Solving this puzzle would shed some light on the obstacles found in heterologous MP expression in
E. coli.
Why the other retinal proteins do express functionally in E. coli and bR does not? What is the
difference between bR and, for instance, SRII that allows functional expression of SRII in E. coli?
In  the  present  study  we  have  addressed  this  problem  applying  the  protein  complementarity
approach. We constructed chimeric proteins between bR and complementary protein SRII, the only
retinal protein expressed functionally in  E. coli [27, 31] for which the high resolution 3D crystal
structure was available to the moment we have started this study [32, 33]. This approach allowed us
to localize quickly the reason for the lack of bR expression in E. coli. We suggest that this approach
may have a general application. 
The major problem of bR low expression could be caused by the unfavorable mRNA structure
downstream of ribosome binding site or by presence of positively charged amino acids on the N-
terminus of bR. The removal of the positive charge on the N-terminus of bR improved the yield of
the protein up to 7 times comparing to native gene. Two silent mutations that destabilize the stem
impeding the transcription of the bR gene gave 50-fold expression gain comparing to native gene.
In addition, improving of expression conditions led to better incorporation of the newly synthesized
protein into E. coli membrane resulting in considerable amount of the properly folded bR. We have
developed the protocol for purification of the functional bR in non-denaturing conditions with the
yield  of  2.4±1.3  mg/L  providing  the  protein  most  closely  resembling  bR  from  native  purple
membranes. Using developed protocol the V49A, D85N, and D96N mutants of bR were readily
produced. 
One of the major tasks of the present work was to obtain the bR-Lys fusion protein that can
allow to resolve the controversies on bR structural studies. In 2007 the first high resolution structure
of GPCR was published [34]. The one of the main features that made crystallization of the protein
possible was the use of GPCR-Lys FP. Lysozyme reduced conformational heterogeneity stabilizing
the protein and provided crystal contacts facilitating nucleation. In next few years several other
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GPCR structures were published where Lys was used as a crystallization tag [35-38]. We suppose
that bR would be a good starting model for investigation if the utilization of Lys as crystallization
tags is general. As GPCRs have the same structural topology as bR, we suppose that crystallization
of bR-Lys fusion protein have high chances for success. As in meso grown crystals of bR are prone
to severe twinning the crystallization of bR-Lys fusion may produce twinning-free crystals of bR in
another  space  group.  Such  crystals  would  facilitate  the  determination  of  the  precise  atomic
structures of bR and its intermediates without bias caused by twinning. The other very important
point is to check what is the influence of Lys as a crystallization tag on the structure of crystallized
protein. The structure of bR ground state is well-described by several groups thus providing a good
model for comparison of structure with tag and without it.
Realization of such goal requires a crystallization of the bR-Lys fusion protein demanding high
yield expression system and effective crystallization approaches. Here, bR can serve as a guiding
reference,  as  the  approaches  for  the  expression  and  crystallization  of  this  protein  have  been
developing throughout several decades.
In membranes of halobacteria bR forms the 2D crystalline lattice called purple membranes.
Purple membranes consist of 25% of lipids and 75% of bR. The reported X-ray structures of bR
were solved using protein preparations from purple membranes  [5-7]. High resolution structures
show that bR trimers are surrounded by the native lipid belt shielding the hydrophobic area of the
protein  [14]. Despite multiple protocols of  E. coli expression there have not been reports about
successful 3D crystallization of the heterologously expressed bR. The 2D crystals of bR expressed
in E. coli were obtained from protein reconstituted into native H. salinarum lipids [39]. Taking into
account the participation of the native lipids in the formation of the lattice of 2D and 3D bR crystals
there were speculations about the influence of  H. salinarum native lipids on the crystallization of
bR. Are native lipids required for bR crystallization or they can be avoided?
Another important point is the use of detergents. Since the in meso grown crystals of bR were
obtained from purple membranes solubilized in OG, the use of other detergents might impair the
ability of bR to form crystals. In addition, there is a concept that for MP solubilization the long
chain detergents are good as they stabilize the protein,  while for crystallization the short  chain
detergents are better as they do not provide a steric conflicts and increase the curvature of lipid
bilayers. The detergent exchange is very long and can be harmful for protein protein. Unfortunately,
the role of detergent in the process of  in meso crystallization is not well studied. Does OG form
specific contacts to stabilize in meso grown bR crystals? Can we use the mixtures of detergents to
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eliminate the step of detergent exchange? This and relevant questions are still open.
Thus, the detailed investigation of the influence of lipid/detergent environment on the in meso
crystallization of bR is required. In the present study to establish the role of detergent in  in meso
crystallization we carried out the crystallization of the bR from H. salinarum purple membranes in
three mixtures of detergents. The crystals appeared in all mixtures. Using the crystals grown in OG-
MEGA10 mixtures the structure of bR ground state was solved at 1.45  Å resolution. This high
resolution structure (along with the others solved by my colleagues) have proved that detergent
molecules are not necessary important for the formation of contacts between protein molecules in
the crystals, and that the mixtures of detergents can be also used in in meso crystallization. Thus, we
have shown that detergent influences on the  in meso crystallization not via providing a specific
crystal contacts but by altering the physical properties of the lipid matrix. Moreover, the wild type
bR and its mutants expressed in E. coli were also crystallized in meso. The crystals had the same
hexagonal shape as crystals grown from purple membranes and diffracted up to 2.4  Å resolution
when  tested  using  synchrotron  radiation,  thus  giving  the  first  diffracting  3D  crystals  of  bR
expressed in E. coli. This way we have proved the quality of the obtained protein material. On the
other  hand,  the  well  diffracting  crystals  obtained  from  the  probes  where  the  lipids  from  H.
salinarum were not present confirm that native lipids are not required for the in meso crystallization
of bR.
Thus, the goals of the present study were:
1. Development of  E. coli based expression system that will enable functional expression of
bacteriorhodopsin  and  its  mutants  with  significantly  high  yield  for  the  subsequent
crystallographic studies of bacteriorhodopsin and its  photocycle intermediates as well  as
industrial  use.  For  the  obtained  protein  non-denaturing  purification  protocol  should  be
elaborated allowing the  production  of  bacteriorhodopsin and its  mutants  with the  purity
sufficient for crystallization and other downstream applications. 
2. Expression in and purification of the functional fusion protein between bacteriorhodopsin
and lysozyme for crystallographic studies. 
3. Investigation of the influence of the detergents and their mixtures, as well as native lipids on
in meso crystallization of bR. The main practical objective was to clarify if it is possible a)
to avoid the use of H. salinarum native lipids; and b) to employ the mixtures of detergents to
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avoid  the  complete  detergent  exchange,  which  is  usually  recommended  by  standard
protocols of crystallization.
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 2  Literature review
 2.1  Membrane proteins.
Every cell is surrounded by biological membrane that acts as barrier between the inner space of
the cell and external environment. Biomembrane essentially consists of lipid bilayer with embedded
membrane proteins (MPs) realizing the functions attributed to biomembranes. Membrane proteins
fulfill  the interactions of cell  with the outside medium and,  thus,  implement  function of signal
sensing,  carry  out  passive  and  active  transport  across  membrane,  are  responsible  for  cell-cell
recognition and intercellular junctions as well as for some very important energetic processes in
cell. The importance of MP studies can be illustrated by the fact that MPs are targets for more than
50% of modern medical drugs [1].
For clear understanding of MP functions the structure of the MP at atomic resolution is required.
High  resolution  structures  of  MPs  are  prerequisite  for  computer  based  drug  design  as  well.
However, in practice, solving the MP structure at high resolution was proved to be difficult being a
great challenge in modern structural biology. Despite MPs constitute about one third of human
genome, their structures make up just about 1% of all high resolution structures deposited in Protein
Data Bank  [2, 4]: from more than 92 000 of the total structures the MP structures comprise only
~1200 (statistic is available at http://blanco.biomol.uci.edu/mpstruc/). The count of the unique MPs
is only ~400 (Fig. 1). Such lag between soluble and membrane protein structures is explained by the
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Figure  1:  The  amount  of  unique  MP structures  in  Protein  Data  Bank.  From
http://blanco.biomol.uci.edu/mpstruc/.
amphiphilic nature of the MPs that allow them to settle in membrane but give a rise to problems
when handle them outside of native lipid environment.
In spite of great variety of methods to obtain information about protein structure, throughout the
years X-ray crystallography became a method of choice to determine a high resolution 3D structure
of  MPs,  since  it  allows  determination  of  atomic  coordinates  for  comparatively  large  protein
molecules. But this method has two general bottlenecks dramatically slowing down progress in the
field: MP production and MP crystallization.
The first thing one will encounter trying to work with MPs is the availability of the purified
protein material.  Generally,  in  normal  conditions  MPs present  in  cell  at  very low level,  so the
purification of the material from natural source in most cases is virtually impossible. In such case
heterologous  overexpression  is  required,  however,  its  yield  is  often  poor.  Moreover,  the
requirements [40] of MPs to the specific lipids from their native organisms can limit the folding of
MPs during heterologous overexpression. Then, due to their amphiphilic nature MPs have to be
transferred to solution (solubilized) before purification. Outside of their native lipid environment
MPs are significantly less stable than in membrane. Organic solvents convert MPs to nonfunctional
state and, thus, should be avoided. The selection of proper surfactant (detergent) and optimization of
solubilization conditions are still a matter of trials and errors in looking for a compromise between
the  amount  of  total  protein  recovered  and  the  fraction  of  functional  protein  in  preparations.
Additionally,  the  use  of  detergents  considerably  decrease  the  efficiency of  protein  purification
methods mostly designed for water soluble proteins. Thus, purification of functional MP is not a
straightforward  process  and  requires  multiple  steps  leading  to  the  protein  losses.  Taking  into
account that typical concentrations of MP required for crystallization is over 10 mg/ml, the final
yield  of  pure  functional  MP limits  its  further  studies  in  many  cases.  Even  utilization  of  the
nanovolume in meso crystallization [41] requires at least 1 mg of the purified protein for extensive
screening of crystallization conditions. Such amount of purified material is not readily available for
a lot of the MPs, particularly for the pharmaceutically important human MPs.
Yet still if the protein is expressed and functionally purified with high yield, the solving of MP
structure is not a low-duty affair. Because X-ray crystallography demands crystals. However, if for
soluble proteins crystallization techniques are well developed and successfully applied in practice,
crystallization of  MPs is  still  a  great  challenge.  The problems in  crystallization  originate  from
amphiphilic nature of MPs. Detergent micelle is a poor substitution of the native membrane, for this
reason  solubilized  MP is  inherently  unstable.  Even  extremely  stable  in  purple  membranes  bR
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solubilized in OG quickly denatures under light illumination [42]. Growth of MP crystal can take up
to 2 months and during all  this  time the protein should remain properly folded and functional.
Crystallization of MPs by detergent can be also hampered by steric hindrances caused by detergent
micelles. When MP is solubilized, detergent molecules form a belt covering the hydrophobic areas
of MP but at the same time decreasing the possible area of protein-protein interactions. Recently
several new promising approaches to crystallization of MPs were developed [5-7]. They employ as
a  crystallization  media  a  special  lipid  environment  that  is  closer  to  the  native  membrane  than
detergent  micelle.  Nevertheless,  available  methods  of  MP crystallization  are  far  from what  is
required and solving of MP structure at atomic resolution is still a challenge. Bacteriorhodopsin
from H. salinarum (bR) being the most studied MP to date is an illustrative example of state of art
in MP research.
 2.2  Bacteriorhodopsin.
2.2.1.General overview.
Bacteriorhodopsin from H. salinarum (bR) is a light-driven pump that provides proton vectorial
transport across the cell membrane of the archaea [8, 43]. It consists of 7 transmembrane α-hilices
with retinal molecule (vitamin A derivative) bound covalently to the Lys 216 residue via protonated
Schiff base [10]. Amino acid sequence of bR as well as nucleotide sequence of bR native gene are
known (Fig. 2)  [45, 46]. In nature bR is expressed by H. salinarum, archea that can be found in
highly  saline  lakes  or  salt  preserved  food.  The  halobacterium  cells  can  grow  aerobically  or
anaerobically, but under low oxygen concentration and intense light they overexpress bR that forms
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Figure 2: Schematic representation of bR primary and secondary structure. Modified from [44].
purple membranes. Being the natural 2D crystals of bR with P3 symmetry [47] purple membranes
can occupy up to 50% of the surface area of halobacteria. Bacteriorhodopsin comprises 75% of
mass of purple membrane being the only protein in it [48]. Purple membranes can be easily isolated
by several centrifugations [11] and the yield of homogeneous bR can reach 30 mg per liter of H.
salinarum culture. In purple membrane bR is stable in wide range of pH (2-10) and temperatures
(up to 100°C) [49]. Such eminent features of bR allowed it to become not only the model of protein
transfer across membrane, but the general model of MP. Many new approaches to MPs (concerning
expression, solubilization, crystallization) were first tried on bR and then applied to other proteins.
As a result bR to date is the most studied MP.
Besides the great significance for science, bR have the important practical applications. There
are dozens of patents (quickly reviewed in [50]) and proposed applications of bR. This protein was
used to construct prototypical devices of fourier-transform holographic associative processors and
3D volume data  storage  [17,  18] and  photosensors  [51].  Application  of  bR in  constructing  of
artificial retinas [52, 53]  seems to be natural. Also, bR was proposed to use as a molecular switch
[54] in nanobiotechnology. This protein also was used in construction of solar cells [55]. Thus, the
studies of bR will find a use not only in pure, but also in applied science.
2.2.2. Photocycle of bR.
After absorption of photon initial storage of light energy in bR occurs by the isomerisation of
retinal  molecule.  From  this  excited  state  the  sequence  of  reversible  conformational  changes
(photocycle) occurs in bR and results in the effective transfer of proton across membrane. In such a
way the light energy is converted into the electrochemical gradient across the membrane of archea.
Afterwards, this energy can be used by ATP synthase to produce ATP. Thus, archea is one of the
simplest systems performing according to the chemiosmotic theory of energy coupling proposed by
P. Mitchell in 1961 [56]. Moreover, the other proton pumps, for example cytochrome c oxidase or
ATP syntase, contain proton translocation mechanism that can have a universal features in nature.
Simplicity of bR that realize a direct transfer of protons across membrane attracted attention of
scientific community to the details of its photocycle that was in focus of MP research over a period
of two decades.
The details of photocycle taking place in bR after absorption of quantum of light by retinal are
illustrated on  Fig. 3. To date thanks to the huge efforts of different groups all over the world the
huge  volume  of  information  about  bR  photocycle  was  obtained  using  different  techniques:
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mutational studies, UV-Vis spectroscopy, FTIR, NMR, electron, neutron, and X-ray diffraction. All
this data can not be cited here, but they were carefully reviewed in numerous articles.
As of today the general steps of proton transfer by bR are considered to be as follows. The
photocycle starts from isomerisation of retinal after photon absorption from all-trans to 13-cis state
to form a K intermediate state within several picoseconds (13-cis 15-anti in some studies). The
resulting  steric  clash  induces  the  cascade  of  thermal  structural  rearrangements
K↔L↔M1↔M2↔N↔O↔bR resulting in the transfer of bR back to the ground state coupled with
effective proton transfer across membrane. 
The formation of blue-shifted L-state occurs in the time scale of μs and governs subsequent
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Figure 3: Photocycle of bR. A. Schematic representation of the proton transfer steps in the bR
photocycle, overlaid on the ground state model (ribbon representation in green, showing helices A
to G).  Strategic  residues that  participate in  the proton transfer (Asp96, Asp85,  Arg82,  Glu194,
Glu204), and retinal bound to Lys216, are highlighted. The primary proton transfer (1) is from the
Schiff base to Asp85. A proton is released to the extracellular medium (2) by the proton release
group, thought to be Glu194 and Glu204. The Schiff base is subsequently reprotonated from Asp96
(3) which is then reprotonated from the cytoplasmic medium (4). The final proton transfer step (5)
from Asp85  via  Arg82  to  the  proton  release  group  restores  the  ground  state.  B. The  retinal
chromophore is covalently bound to Lys216 via a protonated Schiff base. Following absorption of a
photon the all-trans retinal is isomerized to the 13-cis configuration. C. The spectral intermediates,
their absorption maxima, and their lifetimes at room temperature are shown. From [57].
protonation of Asp85. Main structural changes characterizing the L-state consist in the approaching
of Asp85 to the protonated Schiff  base combined with movement of C-helix,  reorganization of
retinal N-H bond of retinal, and changes in retinal binding pocket. During the transition from K-
state to L the pKa of Asp85 grows significantly allowing it to accept the proton from Schiff base.
The primiry transfer of proton from Schiff base to Asp85 occurs during transition to M1-state and
takes around 40 μs. In the M-state itself two different spectrally silent states are distinguished: early
M-state  (M1-state)  and  late  M-state  (M2-state).  The  main  changes  in  M1-state  occur  in  the
extracellular part of bR, where water molecule W402 is disordered thus breaking the bond between
Schiff base and Asp85. Along with that retinal adopts a relaxed 13-cis conformation. By this means
the pKa of Asp85 increases considerably and its protonation from Shiff base is not longer possible.
Asp82 in this state is oriented to the extracellular side of bR that promote a proton release from,
probably, Glu194 and Glu204. The transition from M1-state to M2-state takes around 350 μs. The
main structural changes affect the cytoplasmic part of bR, where occur considerable shifts of F and
G helices formed a hydrophobic plug. This plug prevented the back diffusion of protons through the
membrane. The shifts of F and G helices form an opening towards towards cytoplasm, which is
filled with several water molecules. Establishing of such formation decrease the pKa of Asp96 and
facilitate the subsequent reprotonation of the Schiff base. Thus, simultaneous increase of Asp85 pKa
and decrease of Asp96 pKa form so called protonation switch. Some authors also claim that there is
additional M2'-state - late intermediate when the proton release occurs, but the general changes in
the M-state are considered to be similar by all groups.
During  the  transition  from M2-state  to  N-state  the  reprotonation  of  Shiff  base  from Asp96
occurs. In O-state the Asp96 was reprotonated from the from cytoplasmic surface and the retinal
molecule spontaneously reisomerised from 13-cis to all-trans. Then, water molecule W402 reorders
in  its  position  having  the  hydrogen  bond  with  the  protonated  Schiff  base  that  facilitate  the
reordering of Asp82 and Asp85. Finally,  the proton release group is  protonated from Asp85 to
complete the photocycle.
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Despite  the  general  mechanism of  the  proton transfer  by bR is  known,  there  are  dramatic
controversies in fine details and some steps of the photocycle are still not clarified. For example,
there is no structure of O-state of bR. The O-like structure of D85S mutant can not be accounted as
a reliable source of information, because of considerable disturbance of the tertiary structure of bR
which  are  not  reported  by  other  methods.  Another  important  controversy  is  the  scale  of
conformational  changes  in  bR  in  M-state.  While  electron  and  neutron  diffraction  report  the
conformational changes up to 3.5 Å for F helix of bR, X-ray crystallography observed only 0.7 Å
shift  of  the  F  helix.  It  is  supposed  that  the  crystal  contacts  in  3D  crystal  of  bR restrain  the
conformational changes and, thus, do not reveal the real rearrangements of bR.
However, the most contradictory situation appeared to emerge around L-state structure. This is
one of the most important states as it precedes the primary proton transfer from Schiff base to
Asp85. However, there are several structures of L-state of bR that conflict with each other [16]. One
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Figure  4: Schematic overview of the large conformational changes during the bR photocycle
according to [57]. In the ground state of bR the protonated Schiff base nitrogen (blue) is H-bonded
to Wat402 (black), which has a hydrogen bond to Asp85. A local flex of helix C in L-state (indicated
by red arrow) allows Asp85 to approach the Schiff base enabling a proton transfer to Aps85. The
reorientation of Arg82 towards the extracellular medium facilitates this bend of helix C, increases
the pKa of Asp85, and governs the proton release to the extracellular medium. In M 2 an outward
shift  of  the  cytoplasmic  part  of  helix  F  (indicated  by  red  arrow)  exposes  key  groups  to  the
cytoplasmic medium allowing ordering of the water molecules (black) along the cytoplasmic half of
the  proton  translocation  channel.  These  structural  changes  allow  the  Schiff  base  to  be
reprotonated  from Asp96,  and  then  Asp96  to  be  reprotonated  from the  cytoplasm.  Structural
relaxation recovers the original ground state. For emphasis, helix C is colored red and helix F is
colored yellow.
group was able to achieve the resolution of 2.1 Å [58, 59] using in meso grown crystals. The main
structural changes in L-state are: 1) the shift of N-H bond of Schiff base to the cytoplasmic side of
the protein; 2) disordering of the water molecule W402; 3) Asp85 approaches the Schiff base; 4) C
helix is distorted to facilitate the approach of Asp85 to Schiff  base.  The proton transfer occurs
directly from Schiff base to Asp85. Another group was able to produce the structure at  1.53 Å
resolution using in cubo grown crystals [60, 61]. The main structural changes described are: 1) there
is no considerable conformational changes in bR helices; 2) retinal is in exited distorted state; 3) the
water molecule W402 is ordered and H-bonded to the Schiff base. In this model the proton transfer
occures from Schiff base to Asp85 via water W402. The third model of L-state of bR  [62] was
solved at  2.4  Å resolution  using  the  P622-symmetry crystals  obtained  by vesicles  fusion.  The
features of this model are: 1) the shift of N-H bond of Schiff base to the cytoplasmic side of the
protein; 2) the side chain of Leu93 is distorted providing a space to the water molecule W402 that is
ordered and has a hydrogen bond to Schiff base. In this model the proton is transferred from Schiff
base occurs via OH-group of Trp89. Thus, there are three different models of the L-state - the key
intermediate  to  understanding  the  mechanism of  proton  transfer.  Thus,  further  crystallographic
studies of bR are required to understand the vital details of protein translocation by bR. For this
purpose we should improve the established protocols for crystallization. Also, for the obtaining the
structures of bR intermediate states we will require the fast and efficient system to produce different
mutants of bR. In next chapters the current approaches to expression and crystallization of bR will
be reviewed.
 2.3  Crystallization of membrane proteins.
The first structure of MP was solved by H. Michel in 1984 [63]. Since that time several new
approaches were introduced and to date there are four main approaches to crystallization of MPs.
They are 1) in surfo crystallization; 2) in cubo crystallization; 3) crystallization by vesicle fusion; 4)
bicelle  crystallization.  The  first,  in  surfo method  was  introduce  for  soluble  proteins  and  then
adapted to MPs. The other methods were introduced especially for MPs and use lipids as a matrix
for crystallization. 
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The first  MPs were crystallized  using  in  surfo approach.  In  essence,  it  is  the  conventional
method  to  crystallize  water  soluble  proteins  (either  sitting  drop  or  hanging  drop)  adapted  for
crystallization  of  MPs  directly  from  detergent  (surfactant)  solutions.  Crystallization  trials  are
organized  as  shown in  Fig. 5.  The  concentrated  solution  of  the  protein  solubilized  in  required
detergent is placed on crystallization bridge. The bridge itself is located in reservoir  filled with
highly concentrated saline buffer. The system is sealed. During the equilibration of water activities
in the protein drop and in the matrix solution water evaporates from the drop and the sample is
concentrated. By that means the conditions in the sample can favor crystal nucleation and in such a
case  crystals  can  grow in  the  protein  probe.  This  approach  is  a  direct  extension  of  the  same
methodology to the MPs and, thus, can utilize the vast range of technical advances in this area:
there are automated crystallization dispensers, precipitant solutions, and crystallization additives.
The purified protein samples also do not require any additional manipulations. These factors explain
the popularity of this approach: to date most of the MP structures were solved using in surfo grown
crystals.
However, despite the apparent facility and considerable advantages of this method, there are
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Figure 5: A. Illustration of the in surfo sitting drop method. The drop of the protein concentrated
protein solution is placed into the reservoir with highly concentrated saline buffer. Then the system
is sealed and during equilibration in the system crystallization of the membrane protein is possible.
The picture is modified from [64]. B. The membrane protein crystal types according to Michel [65].
In  type  I  crystals  the  protein  molecules  are  organized  in  parallel  layers  and  contact  between
proteins  is  established  by  in-plane  hydrophobic  surfaces,  while  in  type  II  crystals  the  protein
molecules interact by polar domains. The membrane proteins are presented as a cylinders with
hydrophobic (grey) and polar (red) regions. The molecules of lipids are shown in yellow, detergent
molecules - in green.
considerable  disadvantages  of  the  in  surfo approach.  One  of  the  main  drawbacks  is  that
crystallization occurs directly from protein solubilized in detergents. Detergent micelle is not a good
substitute  for  the native  lipid membrane.  Solubilized MPs outside of  native membrane tend to
denature or aggregate. Another problem is associated with the presence of detergent molecules in
the crystal. The in surfo grown crystals have type II crystal packing (Fig. 5) [65], where detergent
molecule form a belt around hydrophobic region of MP as it was shown by neutron diffraction [66].
If the detergent micelle is big enough while the polar region is small enough, this micelle can cause
a steric conflict leading to the inability to obtain well ordered crystals by in surfo method. It was
exactly the case with bR. The first in surfo grown crystals were obtained in 1980 by H. Michel [13],
however the diffraction was limited to 8 Å resolution. The polar domain of bR is extremely small,
and it was not possible to obtain highly ordered bR crystals before Landau and Rosenbuch have not
introduced a new method of MP crystallization 16 years later  [6]. Moreover, the  in surfo grown
crystals tend to be of larger size than crystals grown by other methods, however, they are much
sparser, so their diffraction power is lower. Thus, the crystallization of MPs using in surfo approach
seems to be not optimal for crystallization of MPs.
To overcome the limitations of in surfo crystallization method in 1996 Landau and Rosenbuch
introduced  a  novel  in  meso approach for  crystallization  of  MPs  [6].  Appealing  feature  of  this
approach is the use of amphiphilic lipid bilayer as a crystallization media in contrast to traditional
in  surfo method.  The  in  meso approach  is  based  on  the  use  of  lipid  mesophases.  Typically,
monoglycerol  monooleoyl  (C18:1c9;  monoolein,  MO)  is  used  as  a  host  lipid  for  in  meso
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Figure 6: Temperature-composition phase diagram of the monoolein/water system determined
under “conditions of use” in the heating and cooling directions from 20°C. A cartoon representation
of the various phase states is included in which colored zones represent water. Taken from [67].
crystallization,  the temperature-composition phase diagram of MO/water  system is  presented in
Fig. 6. The mechanism of in meso crystallization is still not clearly understood, but proposed to be
as follows. First, the solution of solubilized protein is added to the molten MO and the cubic phase
Pn3m forms spontaneously within several days  [6]. Initiation of crystallization by addition of dry
salt  dramatically  decreases  the  lattice  constant  of  the  phase,  i.e.  shrinks  the  phase  [68].  This
increases the energy of the single protein in curved lipid bilayer, thus favoring crystal nucleation
[69].  The  addition  of  liquid  precipitant,  in  contrast,  leads  to  the  swelling  of  the  phase,  thus
destabilizing it [70] and promoting nucleation. The growth of crystal nucleus induce the transition
of Pn3m cubic phase into Lα lamellar phase  [71] that forms lipid conduit  feeding the growing
crystal from the bulk of cubic phase [72].
The in meso approach was introduced more than a decade ago and is credited with ~10% of all
integral MP structures  [72]. It was considerably developed over this time: the introduction of the
crystallization screen solutions [73], nanovolume dispenser system [41, 74], and MP stability assay
[75] considerably expand the experimental potential of this method, while controlling of  in meso
crystallization  [76] may  provide  the  ample  grounds  for  rationalization  of  crystallization
experiments. These step by step improvements finally led to a great success in structural biology:
G-protein coupled receptor was crystallized for the first time using in meso approach in 2007 [34]. 
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Figure 7: Cartoon representation of the events proposed to take place during the crystallization
of an integral membrane protein from the lipidic  cubic mesophase. The process begins with the
protein  reconstituted  into  the  curved  bilayers of  the  ‘bicontinuous’  cubic  phase  (tan).  Added
‘precipitants’ shift  the equilibrium away from stability in the cubic membrane. This leads to phase
separation wherein protein molecules diffuse from the continuous bilayered reservoir of the cubic
phase by way of a sheet-like or lamellar portal to lock into the lattice of the advancing crystal face
(midsection of figure). Protein (blue-green), bilayer and aqueous channels (dark blue) have been
drawn to scale. The lipid bilayer is 40 Å thick. From [70].
At the same time, the alternative lipid-based crystallization methods were developing. Except in
meso approach  there  are  two  other  methods  that  involve  more  native  lipid  environment  for
crystallization of MPs, namely, vesicles fusion and crystallization from bicelles. Both methods as
well as in meso crystallization of bR give 3D crystals of type I (Fig. 5), where two neighboring MPs
interact in the plane of the layer by hydrophobic contacts.
 In case of vesicles fusion crystallization occurs from natural protein enriched membranes, for
example, purple membranes of bR. The vesicles of 50 nm in size are formed during incubation of
the isolated membranes with small amount of neutral detergent in presence of precipitant at elevated
temperatures. When the vesicle solution is cooled down and concentrated, crystals can be obtained
by sitting drop method [7]. The vesicles fusion method was introduced for of bR [7], but then the
structures of halorhodopsin from Natronomonas pharaonis, archaerhodopsins from Halorubrum sp.
aus,  and deltarhodopsin-3 from  Haloterrigena thermotolerans were obtained using this method.
However, the 3D crystals were obtained in all these cases by utilizing naturally occurring protein
enriched membranes, which are very rare case, therefore, a general applicability of this method is
open to question. 
The second  method,  crystallization  from bicelles,  employs  the  artificial  disc-shaped  bilayer
micelles that are formed in a special mixtures of a lipid and a detergent and called bicelles  [5].
Membrane protein is first incorporated into bicelles at low temperatures (+4°C), and then usual
sitting drop crystallization trials are set with bicelles solution. The crystallization occurs in gel-like
lipid phase, that forms at the elevated temperatures (room temperature or higher) in the probes. The
advantage of crystallization from bicelles is that at low temperatures the crystallization media is
liquid thus facilitating the handling of protein samples and crystals. The method seems to be general
as the list  of proteins  crystallized from bicelles include different  types  of MPs:  bR  [5],  mouse
voltage dependent anion channel  [77],  xanthorhodopsin from  Salinibacter ruber [78],  rhomboid
protease from E. coli [79], and even GPCRs (β1-adrenergic receptor from turkey [80] and human β2-
adrenergic receptor [81]).
As  a  result  of  the  enormous  efforts  in  the  field  of  MP crystallization  the  number  of  MP
structures steadily grows (Fig. 1). However, still the count of the unique MPs is ~400, while only
human  GPCRs  amount  to  800  [82,  83].  Still  there  are  no  structures  of  many  important
therapeutically relevant human proteins, as well as proteins important for our general understanding
of biological processes in living cells. Thus, the available methods of MP crystallization are far
from what is required and recently appeared new promising approaches to crystallization of MPs
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should be developed. The idea to use crystallization tags seems attractive.
It worth noting that the first structure of GPCR [34] was obtained using Lys as crystallization
tag. Later several more GPCR structures were obtained using Lys by the same group [35, 37, 38, 84,
85] as well as by another groups [86-89]. In these cases Lys stabilized inherently flexible GPCRs
and  provided  protein-protein  crystal  contacts  to  produce  crystals.  Crystallization  tags  and,  in
general, expansion of a polar surface of MPs was first employed to crystallize cytochrome c oxidase
[90] in complex with antibody fragment and was addressed in further studies [91, 92]. For soluble
proteins  the  use of  fusion proteins  was  first  apprehended with  concern  on  the  subject  of  their
structural heterogeneity. However, the first high resolution crystal structures allayed these anxieties
[93], and new crystallization tags were proposed  (for example, [94, 95]). In the field of MPs the use
of crystallization tags was first proposed in 1994  [96], then  cytochrome(b562), flavodoxin,  Lys,
beta-lactamase, and heat  shock ATPase domain  were examined as crystallization tags  [97],  but
without considerable success. Then aspartyl transcarbamylase was fused to bR [98] to try this water
soluble protein as a crystallization tag, but the fusion protein appeared to be prone to aggregation
and resisted crystallization trials. Thus, the idea of crystallization tags for MPs was neglected for a
while and drawn considerable attention only after crystallization of human β2-adrenergic receptor
using Lys [34]. Though, the versatility of Lys for crystallization of MPs in general, despite massive
crystallization of GPCRs, is still questionable because to date only GPCRs were crystallized using
this crystallization tag. Accordingly, we are addressing this problem fusing Lys to bR. The choice of
bR as a model protein has a considerable advantage due to the previous studies of this protein: as
bR one of  the  most  studied  MPs,  the enormous volume of  information  concerning expression,
purification, crystallization, and functioning is available. Particularly important is that the structure
of bR ground state is known, and thus comparison of the structures of bR crystallized with and
without crystallization tag can help to establish the influence of crystallization tag on the structure
of MP: is the structure native or disturbed by crystallization tag? On the other hand, there is a lot of
uncertainty in the details of bR photocycle. There is a certain probability that bR-Lys fusion protein
will give a crystals in a space group where the twinning is not possible. Thus, the crystallization of
this fusion protein can be useful not only from the perspective of examination of the crystallization
tag idea, but also in a context of investigation of bR itself.
Decided to crystallize the bR-Lys we should first  establish the expression system to obtain
sufficient amount of purified functional homogeneous bR-Lys fusion protein. Here, the information
considering expression of wild type bR can come in handy. The most popular system for functional
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expression of bR is by far the homologous expression in halobacteria. For example, in  [99] the
authors achieved in the transformants the yield of bR equal to yield from wild type strains, and the
expression of bR mutants was established in the system. Employing an analogous homologous H.
salinarum system along with the expression of wild type gene established the expression of fusion
proteins  [100].  Particularly,  the bR-aspartyl  transcarbamylase fusion  protein  was expressed  and
purified in this system [98]. The yield of functional fusion protein in non-denaturing contitions was
7 mg per liter of culture, and the protein formed purple membranes. However, our experiments
(chapter 3.1) have shown that in case of Lys fusion the protein do not form purple membranes. In
addition, the cells were not colored indicating that the high expression yield of functional fusion
protein was not achieved. Therefore, we had to reconsider the choice of expression system for bR-
Lys fusion protein.  The functional expression in  E. coli  would be the most simple,  robust, and
inexpensive system [19]. The efforts to reach the expression of bR in E. coli last already almost 30
years.
 2.4  The expression of bR in E. coli.
2.4.1.The use of exogenous N-terminal sequences to stabilize bR.
The first paper addressed the bR expression in  E. coli appeared in 1987  [101]. As bR gene
contains 13 amino acid long signal peptide that is very different from E. coli signal sequences and is
unlikely removed by E. coli signal peptidase, the  H. salinarum leader peptide was substituted for
the signal peptide of  E. coli outer membrane lipoprotein with additional amino acid sequences of
three different  lengths  coming from lipoprotein.  Resulting fusion protein amino acid sequences
were inserted into pIN plasmid under control of lac repressor. The yield of expression of bR fusion
proteins in E. coli was estimated as 0.05% of total protein (or, according to our estimations, 0.4 mg
per liter of culture). The expression of bR was deleterious for cell growth depending on the  N-
terminal amino acid sequence. The level of bR mRNA was comparable with the level of bR mRNA
found in H. salinarum. Taking into account the N-terminal degradation of the expressed protein and
its  low half  life  times  in  vivo (15-40  minutes)  the  authors  explained  the  low yield  of  protein
expression by extensive degradation of newly synthesized bR in cells. Nevertheless, the protein was
solubilized by Triton X-100 from membranes and purified using immunoaffinity column of bR
monoclonal antibody and preparative SDS-PAGE. Denaturated protein was refolded using standard
DMPC/CHAPS protocol to the extent of 55%. The proton pumping activity of bR was shown.
In the subsequent  paper  [20] the bR gene (with one additional  N-terminal methionine) was
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introduced  into  pJP plasmid  containing  T5  promoter  under  control  or  without  control  of  lac
repressor. Despite the high level of transcription of the gene, expression of the protein was not
detected. The variation of promoter, ribosome binding site as well as the spacing between Shine-
Dalgarno sequence and the initiation codon had no effect on expression level of bR. Then, the
codons of first six amino acids in bR gene were altered to introduce the codons preferred by E. coli.
In case of controlled expression these changes had no effect on the bR yield, while uncontrolled
expression led to the significant yield of bR. It is worth noting that the authors did not relate the
changes of the first bR codons with the changes of mRNA secondary structure, but rather attended
to the primary nucleotide sequence. The difference between controlled and uncontrolled expression
was attributed to the palindromic sequence of  lac operator in mRNA structure that could form a
hairpin  loop structure  and have  a  negative influence on the  ribosome-binding site  immediately
downstream. However, the uncontrolled expression of bR gene was extremely deleterious to the
cells  and  led  to  the  severe  plasmid  instability.  The  authors  had  to  use  expression  system,  PL
promoter  controlled  by  temperature  sensitive  repressor.  When  the  expression  of  bR  gene  was
induced by temperature shift to 42°C, bR made 8-10% of newly synthesized protein. However, due
to intensive degradation of the synthesized bR (half-life time was estimated as 8-10 minutes) only
30-40% of bR was stable and recoverable. Thus, the expression yield of bR was estimated as 0.5%
of total  protein (or,  according to  our estimations,  4  mg per  liter  of culture).  Importantly,  there
appeared to  be two phases in the turn over  of bR, an early rapid degradation and then a long
refractory phase where bR is rather stable. The protein was stabilized by the entire signal peptides
of  E. coli outer membrane protein A and  β-lactamase, but the signal sequences were not cleaved
providing  21-  and  23  amino  acids  long  N-terminally  extended  bR.  The  synthetic  bR  gene
facilitating DNA manipulations gave the same bR yield as the gene with altered codons [102]. The
protein was purified in several steps  [103]. First, bR was extracted from E. coli membranes into
chloroform/methanol-based solvent system. Then the protein was either purified using preparative
SDS-PAGE  or  delipidated.  Delipidation  was  achieved  either  by  extraction  of  lipids  using
chloroform/methanol  mixture  or  by  gel  filtration  in   chloroform/methanol-based  solvent.  The
delipidated samples were purified using either hydroxylapatite or ion exchange chromatography in
organic solvent. The protein transfer from organic solvents to SDS by phase separation followed by
renaturation of the samples using DMPC/CHAPS standard approach. The efficiency of purification
was 70-80%. The purity of the nonfunctional  preparations  was estimated as 90-99%, while the
regeneration  efficiency  was  55-80%.  Interestingly,  the  renaturation  efficiency  of  bR  from  H.
salinarum decreased from 95% to 85-90% when the protein was subjected to identical procedures
(i.e. exposed to organic solvents and etc.). The proton pumping activity and light adaptation of bR
- 26 -
were shown.  Thus,  using  the  described expression  and purification  system for  the first  time it
became possible to obtain the milligram quantities of sufficiently pure functional bR for structural
studies.
In order to establish the functional expression of bR in E. coli the same authors investigated the
insertion of expressed in  E. coli bR into membrane  in vivo modifying the  N-terminal amino acid
sequence [104]. The T7 RNA polymerase system under control of lac operator was used. The bR
was expressed with one of the following modifications of  N-terminus: an additional methionine,
additional  signal  sequence  of  E.  coli lipoprotein,  additional  signal  sequence  of  E.  coli outer
membrane protein,  or  native  bR gene with additional  13 amino acid  long  H. salinarum signal
sequence. The degradation of the protein was estimated to be 80% for native signal sequence, 70%
for protein with additional methionine, 20% in case of E. coli signal peptides. The expressed protein
was located in both outer and cytoplasmic membranes. The H. salinarum signal sequence was not
processed, and only 1-2% of both bR with and without  H. salinarum signal sequence bounded
retinal. The cleavage of lipoprotein and outer membrane protein was partial, 15% and 50% of total
protein synthesized, respectively. The protein in the outer membrane was not processed at all, while
in inner membrane the protein was processed to higher extent. Unprocessed protein did not bind
retinal, but the fractions of the processed protein that bound retinal was 20% for both proteins. The
authors suggested the presence of two differently folded states of bR, one of them binds retinal,
while the other do not.
A new expression system [21] employed the stabilization of bR protein with N-terminal amino
acid sequence. Nucleotide sequence encoding 13 heterologous residues derived partially from  β-
galactosidase were added to the N-terminus of bR under control of wild-type lac promoter, and the
resulting fusion protein was expressed in  E. coli. The protein expression was deleterious for cell
growth.  The  half-life  time  of  expressed  bR  was  26  minutes.  The  protein  was  found  in  cell
membrane,  inner  membrane  contained  82%  of  the  synthesized  protein.  The  protein  was
heterogeneous  due  to  the  modifications  of  the  N-terminus.  The  expression  level  of  bR  was
estimated as 5.8% of total cell protein or 17.6 mg per liter of cells.
The expressed bR was first solubilized in 2% SDS and then purified by multiple passes runs of
high performance size exclusion chromatography  [105]. Then the protein was renaturated using
standard  DMPC/CHAPS(O)  approach  followed  by  another  size  exclusion  chromatography  to
remove residual SDS, lipids, and retinal. In order to remove unfolded bR and change detergent to
nonylglucoside  the  dye-ligand  affinity  chromatography  was  performed.  The  efficiency  of
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purification was ~50%, the functionality of purified protein was supposed to be 100%. The proton
pumping activity was shown. The described system was used to produce several mutants of bR.
Finally, despite  N-terminal heterogeneity of produced bR, using the purified protein reconstituted
into  H. salinarum native lipids  the 2D crystals  of bR were obtained in P3 symmetry.  At room
temperature the electron diffraction to a resolution exceeding 3.0 Å was observed and the projection
difference Fourier maps were obtained for wild type protein and D96N mutant  [39]. The same
system was used to express bR-aspartyl transcarbamylase fusion protein  [98], however the better
yield and formation of purple membranes  in vivo in  H. salinurum prompted the authors to use
halobacterial expression system.
Thus, the first progress in the expression of bR in E. coli was attributed to the stabilization of
bR  N-terminus  with  exogenous  peptides  to  prevent  degradation  of  the  protein.  This  approach
allowed to obtain the bR expression yields up to 18 mg per liter of culture. However, the functional
expression of bR was not achieved, and the protein purification was carried out under denaturing
conditions. As the result, the purified bR was heterogeneous and contained additional amino acids
on the N-terminus.
In 1999 one more important work concerning expression of bR appeared [27]. The C-terminally
His-tagged gene of mature bR was inserted into pET vector employing T7 RNA polymerase system
under control of lac operator. The His-tagged bR was expressed in E. coli at 37°C. The protein was
solubilized in DM from membranes isolated by ultracentrifugation and purified using metal affinity
chromatography.  Investigation  of  photocycle  kinetics  of  the  purified  protein  reconstituted  into
native H. salinarum lipids showed that the last stages of photocycle of bR expressed in E. coli are
retarded comparing to homologously expressed bR. The total yield of the protein was estimated as
0.084 mg per liter of culture. The purity of the preparations was maximum 30% judging from UV-
Vis spectrum. The important point is that the expression was carried out with retinal added and
purification was performed under nondenaturing conditions. In next study [29] bR was used as a
reference for expression of  Haloterrigena turkmenica deltarhodopsin in the similar system as in
[27]. It was mentioned that when cells are cultivated with addition of retinal they are not colored,
however when the isolated membrane were solubilized in DDM, the suspension became purple. But
this phenomenon was neither described in details nor examined in followed publications.
 In addition, besides the modifications of bR gene by the short peptides used for expression of
bR gene in  E.  coli,  the  utilization  of  fusion proteins  to  boost  the  expression  yield  of  bR was
examined as well.
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2.4.2.The use of fusion proteins for expression of bR.
Besides  the  use  of  short  N-terminal  peptide  derived  from  β-galactosidase  to  prevent  the
degradation of bR, the 1-47 and 601-1008 amino acid fragment of  β-galactosidase was used as a
fusion protein for expression of bR [24]. The synthetic bR gene was appended to this fragment via
short linker containing IgA protease cleavage site. The gene of the fusion protein was clone into
pLZ plasmid downstream the wild type  lac promoter/operator  region and expressed in  E. coli.
Induction of expression did not have any adverse effect on the cell growth, as the fusion protein was
expressed as inclusion bodies. Simple washing of the cell lysate allowed to obtain 150-200 mg of
insoluble fusion protein per liter of cell culture. Then the protein was cleaved by IgA protease in
heterogeneous phase, and the bR was selectively extracted to the organic solvent. Next, the protein
transfer  to  SDS  aqueous  solution  followed  by  the  renaturation  of  bR  in
phosphatidylcholine/CHAPS micelles. The proton pumping activity was demonstrated. Finally, the
anion exchange resin was used to change the detergent to OG. The total yield of purified bR was
30-50 mg per liter of culture, however, the efficiency of retinalization was only 25%. The protein
was not purified thereafter leading to the low quality preparations. 
In the next study [22], the bR was fused to E. coli maltose binding protein without periplasmatic
localization signal to target the resulting fusion protein to inclusion bodies. The synthetic bR gene
with appended nucleotide sequence encoding 1D4 purification tag was inserted downstream the
MalE gene of E. coli. The resulting maltose binding protein-bR fusion protein was expressed in E.
coli under control of tac promoter. The expressed fusion protein was stable and accumulated in cells
as  inclusion bodies  yielding  170 mg of  protein  per  liter  of  culture.  The inclusion  bodies  were
isolated from cell lizate, washed and solubilized in 8M urea which was removed by dialysis. At this
stage the purified fusion protein was in aggregated state, however it did not precipitate. The fusion
protein contained Fxa cleavage site between maltose binding protein and bR and was cleaved by
trypsin in presence of SDS. The proteolytic products were separated using gel filtration. Then, bR
was refolded using standard DMPC/CHAPS approach followed by further purification on either ion
exchanger  or 1D4 immunoaffinity column.  Finally,  the dye-ligand affinity chromatography was
performed  to  remove  unfolded  protein.  Dark  adaptation  and  photocycle  of  the  protein  were
demonstrated. The final yield of the functional bR was assessed as 6-10 mg per liter of culture (the
purification efficiency ~10-15%) with 100% of protein being functional. Using isoelectric focusing
the purified bR was shown to contain two different protein species. The purified protein contained
additional six N-terminal amino acids as well as optional nine amino acid long 1D4 purification tag
- 29 -
on the C-terminus. Keeping in mind the idea of crystallization tags the authors purified functional
maltose binding protein-bR fusion protein. However, no further information concerning this matter
was published.
Recently, a new fusion protein, MISTIC (Membrane-Integrating Sequence for Translation of IM
protein Constructs), was used for expression of bR in  E. coli [23]. The  His-tagged MISTIC-bR
fusion protein was inserted into pET plasmid with T7 RNA polymerase system under control of lac
operator. The fusion protein was expressed in E. coli at 18°C and was found in membranes. It was
solubilized in Sarkosyl from membranes isolated by ultracentrifugation. MISTIC-bR fusion protein
was purified from crude membrane extract using metal affinity chromatography. Then the fusion
protein  was  cleaved  on-column at  thrombin  cleavage  site  between MISTIC and bR.  Detergent
exchange from Sarkosyl to SDS was achieved on column by subsequent washes containing required
detergent.  Eluted  from  column  bR  was  refolded  using  standard  DMPC/CHAPS  approach.  To
remove the residual lipids and retinal and exchange detergent to nonylglucoside the second run of
metal affinity chromatography was used. Proton pumping activity was demonstrated for the purified
protein.  The protein contains additional  N-terminal  amino acids (at  least,  Gly-Ser derived from
thrombin cleavage site) and C-terminal His-tag. The authors claim the yield of functional purified
protein to be 120 mg of purified functional bR per liter  of culture with 100% of protein being
functional.
2.4.3.Expression of another retinal proteins in E. coli.
Thus, despite that the different approaches were proposed for expression of bR in E. coli, the
high yield functional expression of bR in E. coli was not achieved. The problem in expression of bR
is even more surprising taking into account that there are many reports describing the functional
expression  of  another  retinal  proteins  in  E.  coli.  Namely,  sensory rhodopsin  I  and  II  from  H.
salinarum [25,  26],  halorhodopsin  and  sensory  rhodopsin  II  from  N.  pharaonis [27],
bacteriorhodopsin  from  Exiguobacterium  sibiricum [28],  deltarhodopsin  from  Haloterrigena
turkmenica [29], bacteriorhodopsins and sensory rhodopsins from Haloarcula marismortui [30], as
well as two microbial  rhodopsins from  Haloquadratum walsbyi [106] and  two rhodopsins from
Krokinobacter eikastus (the first, KR1, being a prototypical proton pump, while the second, KR2,
pumps sodium ions outward,  [107]) were expressed in  E. coli with the yield more than 1 mg per
liter of culture. The proteins were folded  in vivo, when cell cultures were grown in presence of
retinal. In addition, in these cases the reasonable extent of purification was acheived under  non-
denaturing conditions by single step of metal affinity chromatography. So, why the other retinal
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proteins do express functionally in E. coli and bR does not? Thus, one of the main objectives of the
present study is to give the answer for this question.
2.4.4.The role of lipid/detergent environment in crystallization in meso.
The change of expression system from homologous H. salinarum to heterologous E. coli as well
as  the  respective  change  of  purification  protocol  can  affect  not  only  expression,  but  also
crystallization. At first, the problem of detergent influence on the process of in meso crystallization
appears. A lot of residual detergent derived from solubilization appears in crystallization probes.
Large quantities of detergent were shown to destabilize lipid cubic phase [108]. The detergent was
not observed in in meso grown crystals of bR by MALDI mass spectrometry [109]. However, the in
meso grown crystals of bR were obtained using the protein solubilized from purple membranes in
OG, but not in other detergents. Is OG use is crucial for successful crystallization of bR or one can
use other detergents in in meso crystallization. Or mixture of detergents? Is the type of the detergent
important or, maybe, its concentration? Does detergent have any influence on crystallization process
at all?
Another even more important question is the influence of native lipids in crystallization of bR.
Understanding that native lipids are important for expression, crystallization, and function of MPs
steadily grows [40, 110]. The native lipids from H. salinarum were shown to play an important role
in formation of purple membranes and in meso grown crystals of bR [109, 111, 112]. In addition,
the  only available  crystals  of  bR expressed  in  E.  coli (2D crystallization)  were  obtained  from
protein reconstituted into native H. salinarum lipids [39]. As the lipid composition of H. salinarum
membranes is very different from lipid composition of  E. coli membranes, bR or bR-Lys fusion
protein expressed in  E. coli and devoid of native  H. salinarum native lipids can appear to be not
crystallizable.  Therefore,  the  question concerning the influence  of  native  lipids  on the  in  meso
crystallization should be examined. 
 2.5  Conclusions.
The  main  purpose  of  the  project  is  the  X-ray crystallography studies  of  bR to  clarify  the
appeared controversies in the mechanism of proton pumping. Such study requires sufficient amount
of pure functional protein and new approaches to crystallization of the protein. We suggested that
the  functional  expression  of  bR in  E.  coli  would  be  the  most  simple,  robust,  and inexpensive
approach satisfying these conditions. However, despite that the different protocols were proposed
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for expression of bR in  E. coli,  the high yield functional  expression of  bR in  E. coli was  not
achieved. The existing protocols for crystallization of bR are well developed, but twinning of the
bR crystals obtained by in meso approach and insufficient ordering of crystals obtained by vesicle
fusion  do  not  allow  to  elucidate  the  mechanism  of  proton  pumping  by  bR.  Utilization  of
crystallization  tags  seems  to  be  a  promising  approach  to  produce  in  meso highly  ordered
nontwinned bR crystals with Lys being one of the emerging candidates on the role of fusion protein.
We proposed to  use  the  E.  coli system developed for  functional  expression  of  bR to  produce
functional bR-Lys fusion protein. Crystallizing bR and bR-Lys fusion protein one should also pay
attention to the influence of lipid/detergent environment on the process of in meso crystallization. In
spite of importance of this matter for success of crystallization, the role of lipid and detergent in
crystallization in meso was not carefully explored. Thus, the main objectives of this study, namely,
establishing of E. coli-based system for functional expression of bR and bR-Lys fusion protein and
subsequent  crystallization  of  these  proteins  as  well  as  investigation  of  the  influence  of
lipid/detergent environment on in meso crystallization, are relevant for structural studies of bR.
Moreover, bR is a model MP. Therefore, findings concerning development of the E. coli system
for functional expression of bR can be useful for expression of other MP targets in  E. coli.  In
addition, currently the versatility of crystallization tag approach was not examined as well as the
influence  of  crystallization  tags  on  structure  and  function  of  a  crystallized  protein.  Since  the
structure of bR ground state is well established, expression and crystallization of bR-Lys fusion
protein will allow to compare the structures of bR crystallized with and without crystallization tag
and thus estimate a structural changes imposed by crystallization tag. Crystallization of bR without
native H. salinarum lipids will allow to investigate the influence of native lipids on structure and
function  of  MP.  Thus,  solving  of  the  main  problems  formulated  above  will  provide  important
information concerning expression and crystallization of  MPs in general  and thus  facilitate  the
progress in the field of structural studies of MPs.
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 3  Results and discussion
 3.1  H. salinarum expression
To explore the generality of crystallization tag idea using bR as a model MP and obtain in
another space group crystals of bR that may be twinning free and, therefore, may help to obtain
precise  atomic  structure  of  bR one should  first  obtain  the  functional  bR-Lys  fusion  protein  in
amounts sufficient for crystallographic studies.  The  H. salinarum based homologous expression
system is preferable because, in spite of the difficulties of work with archaea, this system [113] can
give the yields of functional bR mutants up to 30 mg per liter of culture (wild type yield, [99]) and
of fusion proteins  [98] up to 7 mg per liter of culture. We used the system of pEF191 Huloferux
volcunii  -  Escherichia  coli shuttle  vector  that  bear  bR  coding  sequence  with  short  flanking
untranslated regions of native bR gene and bR-deficient H. salinarum L33 strain bearing impaired
bR  gene  [99].  Transformation  of  L33  cells  with  pEF191  plasmid  results  in   incorporation  of
recombinant bR gene into homologous bR locus and leads to the production of native bR. We have
introduced Lys coding sequence to the pEF191 shuttle vector at two different positions: between
Met163 and Arg164 of EF-loop and to the C-terminus of bR that gave the bRL and bRLE fusion
proteins, respectively.
The plasmids pEF191bRL and pEF191bRLE containing coding sequences of fusion proteins
between bR and Lys were constructed as described in Material and methods. First colonies appeared
15-20 days after transformation of L33 strain of  H. salinarum with the plasmids. Colonies were
separated and analyzed for the presence of Lys gene.  The cells transformed with pEF191bRLE
plasmid did not show Lys coding sequence in genome. We suppose that this is spontaneous mutants
with mevinoline resistance as it was reported before  [99] and that genetic recombination did not
occur properly in this case. The reason might be the disturbance of structure of bR gene by Lys
insertion on C-terminus of bR. In previous study [114] severe deterioration of expression yield of
wild type bR with C-terminal His-tag was shown in archaea.
Both wild type bR and bR-Lys fusion protein genes were present in the genomic DNA of the
cells transformed with pEF191bRL plasmid. Clones were separated by several passages of cells on
agar  plates  with  antibiotic.  On  the  second  passage  cells  showed  different  morphology:  some
colonies had typical for H. salinarum L33 yellow color while the others appeared to be white. We
suppose that in white colonies the genetic recombination have successfully occurred and bRL gene
incorporated into genome L33 cells.
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The cells transformed with pEF191bRL plasmid were cultivated in liquid media. The culture did
not gain purple color characteristic for the cells that express functional bR on the high level and
form purple membranes. Therefore, we can conclude that insertion of Lys into E-F loop of bR
prevent formation of purple membranes in archaea, and functional expression of the fusion protein,
if present, is on the low level. In previous study [98] aspartyl transcarbamylase fusion was shown to
impair threefold the expression of bR in H. salinarum, however the synthesized protein amounted to
7 mg per liter of culture and purple membranes were formed. Our findings suggest that ability of bR
for functional accommodation of massive insertions is limited. As the high level of functional bR
expression along with formation of  purple  membranes  facilitating  the purification  of  the  target
protein was supposed to be the main advantage of the  H. salinarum expression system  [11], the
absence  of  purple  membrane  formation  make archaea  not  promising  for  expression  of  bR-Lys
fusion proteins.
 3.2  MISTIC constructs.
3.2.1.Expression and purification of MISTIC fusion proteins.
When H. salinarum system have not shown an appropriate expression of bR-Lys fusion protein,
we  have  decided  to  change  expression  system.  One  of  the  most  well-developed,  facile,  and
inexpensive expression systems to date are E. coli based systems [19]. Expression of bR in E. coli
was tried  with  a  limited  success  many times  (see  chapter2.4for  review).  MISTIC (Membrane-
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Figure  8: A. The schematic presentation of the MbRL, MbRLE, and MbRLEs fusion proteins.
MISTIC is shown in pale blue, bR in violet, Lys in pink, and His-tag in yellow. The truncated bR in
construct MbRLEs contains amino acids from 1 to 232. In MbRL construct Lys is inserted between
Met163 and Arg164. B. The plot illustrating the optical density OD600 of E. coli SE1 cells bearing the
gene of fusion protein with functional Lys throughout the culture growth. After overnight incubation
of the culture most of the cells were dead and the cell pellets were soft and mucoid.
Integrating Sequence for Translation of IM protein Constructs) have revealed itself as a promising
fusion protein, as it boosts expression of bR and other MPs to high levels and targets them to the E.
coli membrane [23, 115].
The MISTIC gene was amplified by PCR from PSCodon-MhCx26 obtained previously in our
laboratory and added to the  N-terminus of the bR-Lys fusion proteins. We have constructed three
variants of MISTIC-bR-Lys fusion proteins: MbRL, MbRLE and MbRLEs (Fig. 8). Fusion protein
MbRL contains Lys inserted into E-F loop of bR between residues Met 163 and Arg 164. Fusion
proteins MbRLE and MbRLEs contain Lys appended to the  C-terminus of full-length bR and bR
truncated at Glu 232, respectively. The MISTIC-bR-Lys fusion proteins were inserted into pSCodon
vector, which uses the T7 RNA-polymerase expression system [116] with a separate-component-
stabilization system [117] and contains genes of tRNAs for rare codons of E. coli. 
First experiments showed that, when MISTIC-bR-Lys fusion proteins are expressed in E. coli,
Lys  is  properly folded  and  displays  its  hydrolytic  activity.  The  overnight  grown induced  cells
achieved the OD = 1.0÷1.5 comparing to the OD = 3.0÷5.0 for the cells that harbored control
plasmids without functional Lys gene and were grown under same conditions (Fig.  8). The cell
pellets  were  soft  and  mucoid  indicating  the  destruction  of  the  cellular  membranes  during
cultivation. 
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Figure  9: A. SDS-PAGE analysis illustrating the progress of the purification under denaturing
conditions  of  MISTIC-bR-Lys  fusion  proteins.  The  MbRL purified  in  Sarkosyl  is  presented  as
example. 1 - cell suspension before solubilization; 2 - fraction solubilized in Sarkosyl; 3 - Protein
Ladder;  4 -  Ni-NTA column wash;  5 -  Ni-NTA column eluate.  B. The screen of  detergents for
solubilization of MISTIC-bR-Lys fusion proteins with MbRLEs as example. The lanes 2-7 on SDS-
PAGE are eluates from Ni-NTA column in different detergents. 1 - Protein Ladder; 2 - DM; 3 - DDM;
4 - Sarkosyl; 5 - Fos12; 6 - LDAO; 7 - SDS. Band corresponding to the target protein is indicated.
Overnight culture was harvested by centrifugation, resuspended and lysed using microfluidizer.
The membranes were isolated by ultracentrifugation. The solubilization test included 6 different
detergents:  DM,  DDM,  Sarkosyl,  Fos12,  LDAO  and  SDS.  After  overnight  solubilization  the
suspensions were clarified by centrifugation, diluted, and loaded on Ni-NTA resin. The columns
were washed with buffer containing 20 mM imidazole, and the target proteins were eluted in buffer
containing 200 mM imidazole. The progress of the protein purification is presented on the Fig. 9.
The SDS-PAGE analysis have shown that MISTIC-bR-Lys fusion proteins are not soluble in DM
and DDM, while LDAO, FOS12, and Sarkosyl are the most suitable detergents, as they allow to
solubilize majority of the target protein (Fig. 9). SDS gave the lowest purification yield because the
solubilized protein did not bind to the column. The FOS12, DDM and Sarkosyl were considered as
the best detergents: FOS12 and Sarkosyl provided the best overall yield of purification, while DDM
is compatible  with Fxa protease and,  thus,  do not  require  detergent  exchange.  The SDS-PAGE
analysis  did not reveal  presence of  the target  protein in  column flowthrough and wash for the
selected detergents. The yields for these detergents were about 3 mg (for FOS12 and Sarkosyl) and
0.3 mg (for DDM) of purified protein per liter of culture as quantified by coomassie-stained SDS-
PAGE.
To increase the total yield of the protein we abolished the activity of Lys. The E11F mutation of
lysozyme was previously reported to eliminate its enzymatic activity  [118]. We have introduced
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Figure  10: Expression  of  the  MISTIC-bR-LysE11F  fusion  protein  with  abolished  enzymatic
activity of Lys.  A. The plot illustrating the kinetics of culture growth of  E. coli SE1 cells bearing
fusion protein gene containing Lys with abolished enzymatic activity comparing to the cells bearing
fusion protein gene with functional Lys. After overnight incubation of the culture the cells reached 5-
fold higher OD600 and the cell pellets were hard in contrast to the cells with functional Lys gene. B.
SDS-PAGE  illustrating  the  difference  in  protein  yields  of  MISTIC-bR-Lys  fusion  proteins  with
functional and with nonfunctional Lys. 1 - Protein Ladder; 2 - MbRLEs Ni-NTA column eluate; 3 -
MbRLEsE11F Ni-NTA column eluate.
E11F mutation into Lys coding sequence of MbRLEs with wild type Lys. The E11F mutant was
expressed  and purified  by the  same protocol  as  MbRLEs fusion  protein.  The final  OD of  the
overnight grown cell culture was 4.8 in comparison to the OD 1.2 of the cells contained plasmid
with functional Lys coding sequence (Fig. 10). The cell pellets were solid indicating the inactivation
of the Lys. The introduction of the E11F mutation increased the expression yield threefold from 3 to
10 mg per liter of culture as seen from the Fig. 10.
3.2.2.Cleavage and renaturation of MISTIC fusion proteins.
Cleavage.
The purified MbRL, MbRLE and MbRLEs fusion proteins were concentrated to 0.25 mg/ml and
dialyzed against Factor Xa cleavage buffer with 0.2% DDM, as these detergent and protease are
compatible. After dialysis, 5 μg of each protein was incubated 24 h at 20°C with 2.0, 0.4, 0.08,
0.016  and  0.0032  units  of  protease  in  20  μl  aliquotes.  Results  of  the  cleavage  screening  are
presented on  Fig. 11. Surprisingly, Factor Xa did not show considerable activity at recommended
pH 6.5, but at pH 8.0 the activity of the enzyme was acceptable. For constructs MbRL, MbRLE and
MbRLEs the optimal cleavage was observed at a ratio of 0.4 units per 5 μg of protein. SDS-PAGE
analysis have clearly shown the presence of the cleaved target bR-Lys fusion protein, not cleaved
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Figure 11: SDS-PAGE illustrating the purity of the preparations before cleavage and screening
of conditions for the protease Factor Xa cleavage. A. The eluates after Ni-NTA column were used
to access the purity of the preparations: 1 - MbRL; 2 - MbRLE; 3 - MbRLEs; 4 - MbRLEsE11F. B.
The protease digestion of MbRLEs fusion protein under different conditions: lanes 1 - 6 illustrate
different protease concentrations (units of protease per 5 μg of protein), line 7 - prolonged time of
incubation with optimal concentration (0.4 units per 5 μg of protein) of protease. 1 - Protein Ladder;
2 - 0.0032; 3 - 0.016; 4 - 0.08;5 - 0.4;6 - 2.0; 7 - 40 h incubation of the reaction (instead of 16 h).
The  bands  corresponding  to  the  target  cleaved,  not  cleaved,  and  nonspecific   products  are
indicated.
MISTIC-bR-Lys fusion protein and unknown product of unspecific cleavage, corresponding to the
band  at  22  kDa  on  acrylamide  gel  in  7:1:2  ratio,  respectively  (as  quantified  by  SDS-PAGE
densitometry,  Fig. 11). Prolongation of incubation time with the optimal protease concentration to
the 48, 72 or 96 h led to the complete degradation of the protein (Fig. 11).
Purification of cleavage mixture.
To  separate  the  target  cleaved  product  from  the  impurities  we  used  size-exclusion
chromatography on Superose 6PG column with 180 ml bed volume. The elution profile had a clear
peak at 124.4 ml corresponded to the uncleaved protein, target and unspecific cleavage products as
followed from SDS-PAGE analysis (Fig. 12). Thus, the gel-filtration was proved to be inefficient
for separation of the target fusion protein from impurities.
Ion-exchange  chromatography  could  be  another  useful  method  to  separate  fragments  after
proteolysis.  Despite  relatively low overall  charge of the total  MISTIC-bR-Lys fusion protein at
neutral pH, the protein is strongly polarized. The fusion protein has an isoelectric point (pI) of 6.68,
while pI are 4.57, 5.55, and 9.76 for MISTIC, bR, and Lys, respectively. We used Sepharose High
Performance strong cation exchange column that was supposed to bind Lys positively charged at pH
7.0. The elution profile had two distinct peaks at 23.76 and 28.90 ml as seen on Fig. 13. According
to  SDS-PAGE  analysis,  the  three  proteins  (uncleaved  protein,  target  and  unspecific  cleavage
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Figure 12: Separation of the Factor Xa cleavage products by gel-filtration. Elution profile shows
two distinct peaks. The corresponding fractions were analyzed on SDS-PAGE: 1 - the sample after
proteolysis before gel-filtration; 2 - Protein Ladder; 3 - fraction 23; 4 - fraction 28; 5 - fraction 33; 6 -
fraction 35; 7 - fraction 37; 8 - fraction 40. Fractions are indicated in red on elution profile. Fractions
from 23 to 38 correspond to the first peak, fractions from 39 to 46 correspond to the second peak.
The uncleaved,  unspecific  and target  products  of  proteolysis  are  indicated.  SDS-PAGE clearly
shows that  the target  protein can not  be separated by gel-filtration from the other products of
reaction.
products) bound to the column and were eluted as a single peak what did not allow to separate the
target protein from contaminants.
Renaturation of uncleaved protein.
The  reason  for  the  presence  of  the  different  proteolytic  products  could  be  the  inherent
heterogeneity of  the  fusion  protein  denatured  in  strong  detergents  that  give  a  rise  to  different
accessibility of the cleavage site of protease in different molecules. If we managed to refold the
protein to the functional state first,  then it might become homogeneous and might not give the
unspecific cleavage sites. The most simple and effective system to refold bR is DMPC/CHAPS
bicelles [119].
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Figure  13: Separation of  the Factor  Xa cleavage products on ion-exchange column. Elution
profile shows two distinct peaks. The corresponding fractions were analyzed on SDS-PAGE: 1 - the
sample after proteolysis before column; 2 - column flowthrough; 3 - Protein Ladder; 4 - fraction 12;
5 - fraction 13; 6 - fraction 15; 7 - fraction 16; 8 - fraction 17; 9 - fraction 18; 10 - fraction 19; 11 -
fraction 21; 12 - fraction 22. Fractions are indicated in red on elution profile. Fractions from 12 and
13 correspond to the first  peak,  fractions from 14 to  25 correspond to the second peak.  The
uncleaved, unspecific and target products of proteolysis are indicated. SDS-PAGE clearly shows
that the target protein can not be separated from the other products of reaction by the used ion-
exchanger at chosen conditions.
The MbRLEs fusion protein solubilized in DDM, FOS12, or Sarkosyl was purified as described.
Then samples were concentrated to 0.25 mg/ml and dialyzed overnight with 3 changes of buffer
against  50  mM Na/Na-Pi  pH 6.0  supplied  one of  the  following detergents:  0.2% DDM, 0.2%
FOS12, 0.2% SDS (the protein for this sample was solubilized in Sarkosyl), or 0.5% Sarkosyl.
Then, the equal volume of DMPC/CHAPS bicelles contained 40 μM of all-trans retinal was added
and  samples  were  left  at  room  temperature  with  stirring  for  retinalization.  After  overnight
incubation the samples with DDM, FOS12, and Sarkosyl did not change color indicating that retinal
did not incorporate into bR in those samples. However, SDS sample turned pink demonstrating that
renaturation  of  bR-Lys  fusion protein  was  achieved.  To remove redundant  detergent  and,  thus,
improve the incorporation of the protein into lipids we added to the samples Bio-Beads adsorbent
assuming its capacity as 70 mg of detergent per 1 g of beads. But no visible changes occurred in the
samples. The samples in SDS after retinalization contained pink pellet (Fig. 14), probably being the
liposomes with incorporated properly folded bR fusion protein. We have tried to resolubilize the
pellet in either DDM or FOS12, but 1.5% DDM did not solubilize the protein, while 1% FOS12
denatured the protein leading to the loss of color by MbRLEs fusion protein.
Renaturation of cleaved protein directly from proteolytic mixture.
Failed  to  renature  the  MbRLEs fusion  protein  tried  to  alter  purification  strategy.  First,  we
cleaved this fusion protein and then tried to renature the bRLEs fusion directly in the proteolytic
mixture without separation of the products. However, when the proteolytic mixture was dialyzed
against renaturation buffer, we observed the heavy precipitation of the bR-Lys fusion protein. We
suggest that MISTIC artificially maintained the solubility of the bR-Lys fusion membrane protein,
but when MISTIC was cleaved the fusion protein lost its solubility and precipitated.
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Figure 14: The pink pellet in the
renaturation  sample  of  MbRLEs
denatured  in  SDS.  The
renaturation  was  carried  out
according to standard procedure of
bR renaturation  in  DMPC/CHAPS
vesicules.  After  overnight
incubation the protein was found in
the pink pellet.
Conclusions.
Thus, the resulting fusion protein turned out to be extremely polarized being difficult to handle.
Despite the high yield achieved by use of MISTIC this fusion tag prevents bR-Lys fusion protein
from proper folding in vivo and in vitro. After cleavage of MISTIC unfolded protein seems to loose
immediately its solubility at pH it should be functionally refolded. Moreover, the employment of
the strong detergents to solubilize MISTIC probably led to the inherent heterogeneity of the protein
and unspecific cleavage by Factor Xa protease. The proteolytic products were difficult to separate
aggravating the situation. Therefore, the strategy employed the simultaneous use of two different
fusion tags, MISTIC as expression tag and Lys as crystallization tag, did not pay for itself. Having
all these problems concerning the use of two fusion proteins for expression of bR-Lys fusion protein
we decided to avoid such strategy in the further development of the project.
As native bR gene is notoriously known for its low expression yield in E. coli [20], we intended
first to find out the reason of this phenomenon and develop the expression system that will allow
the functional expression of bR in E. coli with a high yield. Thereafter, utilizing the bR expression
system we might be able to produce functional bR-Lys fusion protein without need for cleavage of
the fusion tags or renaturation of the target protein.
 3.3  Complementary protein approach.
Throughout  the  years  the  functional  bR  expression was  tried  many  times.  Application  of
exogenous  N-terminal  tags  allowed  to  stabilize  the  newly  synthesized  protein  preventing  its
degradation and increasing bR yield [20, 21]. Further progress was related to the use of the fusion
proteins  that  boosted  the  expression  level  [22-24].  However,  despite  the  high  yield  of  the
synthesized bR mentioned systems did not provide functional bR expression: the protein should
have been first undergone unfolding followed by refolding.
Such behavior of bR is all the more surprising, as the expression of a number of closely related
retinal proteins, namely sensory rhodopsin I and II from H. salinarum [25, 26], halorhodopsin and
sensory rhodopsin II from N. pharaonis [27], bacteriorhodopsin from Exiguobacterium sibiricum
[28],  deltarhodopsin  from  Haloterrigena  turkmenica [29],  bacteriorhodopsins  and  sensory
rhodopsins from Haloarcula marismortui [30], and others, was shown to be functional in  E. coli.
Why the bR does not express functionally in E. coli? What is the difference between bR and another
retinal proteins that allows their functional expression in E. coli?
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In present study we have introduced the complementary protein approach that allowed us to
localize  and  solve  the  problem of  bR low expression  yield  in  a  few steps.  Schematically  this
approach is presented on Fig. 15. Given two homologous proteins, the first one, the complimentary
protein, gives the high expression yield in the chosen expression system in contrast to the other,
target protein, one can construct chimeric proteins containing different parts of the proteins. If one
of the constructed proteins has high expression level comparing to the protein under study, it can be
proceeded further. In the second iteration of the problem finding the insert from the complimentary
protein is divided into parts and each part is substituted to the counterpart from the original protein
resulting in the new pair of chimeric proteins. Analyzing the expression yields of these chimeric
proteins one can identify the part impairing expression. In the same manner we can finally reveal
the  underlying  problem that  do  not  allow  the  expression  of  the  target  protein  in  the  selected
organism.
This approach has a limited application requiring the existence of the localizable “point” reason
for a protein expression fail. If the lack of expression is caused by extensive factor influencing the
vast area of the protein (for example, positive charge of the extracellular face of the protein or
commonly encountering rare codons), the complimentary protein approach will not be able to cope
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Figure 15: A general representation
of  the  complementary  protein
approach.  Given  two  homologous
MPs  with  high  (blue)  and  low  (red)
level  expression  in  a  selected
organism, one can construct chimeric
proteins (1st iteration)  comprising the
part  of  target  protein  (the  red  one)
and complementary protein (the blue
one).  Analyzing  expression  yields  of
the  chimeric  proteins  one  can
conclude which part of the protein is
responsible  for  a  heterologous
expression  failure.  In  the  next  step,
one can divide the new insert of the
complementary  protein  to  parts  and
construct  next  pair  chimeric  proteins
(2nd iteration)  to  localize  more
precisely the problem place. Acting in
the  same  manner  one  can  finally
localize  the  problem of  lack  of  high
yield expression of target protein in a
limited  number  of  steps.  Such
approach  allow  one  to  reduce  the
required number of genetic constructs
from 2N point  mutations  to  ~2∙log2N
chimeric  proteins,  where  N  is  the
number of  amino acids in  the target
protein.
with the problem. However,  the closer  is  the resemblance of  the complimentary protein to  the
protein  under  study,  the  higher  should  be  the  probability  of  success.  Additional  rational
considerations related to the target protein and chosen expression system can increase the chances
of progress.
In a favorable case the described approach might lead to the issue finding in 10 steps (~log2N,
where N is the number of amino acids in the target protein) for the protein of a typical size  less
than  1000 amino  acids  accounting  the  finite  set  of  amino  acids  in  the  protein.  Therefore,  the
localization  of  the  expression  problem  can  be  accomplished  by  constructing  only  2×10  =  20
chimeric proteins instead  of 2N mutant proteins (the number of possible single mutations if this
mutations substitute amino acids from target protein for amino acids from complementary protein).
Moreover,  additional  information  and rational  considerations  about  the  protein  structure  or  the
expression  system  used  can  decrease  the  number  of  required  chimeric  proteins.  Even  if  the
described approach failed to perform at certain step, the information obtained on previous iterations
can help to narrow the area of problem search. Thus, we suppose that the complementary protein
approach can have a general application. 
In the present study we addressed the problem of low yield expression of bR in  E. coli using
complementary protein  approach.  Previous  publications,  and  particularly  [104],  concerning  this
problem gave us an idea that the low yield of bR expression and the lack of functional expression
are aroused by the ineffective incorporation of the newly synthesized protein into E. coli membrane.
We  have  applied  the  complementary  protein  approach  to  the  bR  and  used  the  SRII  as  a
complementary protein, since this is the only retinal protein expressed functionally with the high
yield in  E. coli [27, 31] for which the high resolution 3D crystal structure was available to the
moment we have started this study [32, 33].
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 3.4  Functional expression of wild type bR and its mutants in E. coli. 
3.4.1.Amino acid alignment.
In spite of high level of amino acid similarity bR did not show functional expression in E. coli
as  opposed  to  SRII,  hR,  and ESR.  Trying  to  solve  this  riddle  we made  amino  acid  sequence
alignment of bR to the aforementioned homologous retinal proteins shown in  Fig. 16.  Previous
results  indicated  that  the  difficulties  of  bR  expression  in  E.  coli could  be  attributed  to  the
impediment of insertion of newly synthesized bR into E. coli membrane [104].The “positive inside”
rule states that MP topogenesis is controlled by positively charged amino acids [120] that keep the
cytoplasmic parts of the MP in cytoplasm by interactions with negatively charged headgroups of
anionic lipids and withstand both Sec-dependent and independent translocation against membrane
potential [121, 122]. As observed in vitro using lysates and inner membrane vesicles prepared from
E. coli as a model bR inserts co-translationally into  E. coli membrane in Sec-dependent manner
[123] demonstrating that amino acid sequence of the first transmembrane helix and adjacent regions
is particularly important for the insertion of integral MPs into membrane. Therefore, analyzing the
amino acid sequence alignment of bR to the other homologous retinal proteins we attended only to
the region of first transmembrane helix and adjacent amino acids.
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Figure 16: Sequence alignment of HR, ESR, SRII and bR amino acids of helix A with adjacent
regions. This proteins were chosen because the structural data allowing the reliable assigning of
transmembrane  regions  were  available  only  for  these  proteins.  Positively  charged,  negatively
charged and hydrophobic amino acids are marked with blue, red, and green colors, respectively.
Transmembrane domains of the helix A are marked with light grey according to the structural data.
The features, which may effect expression of the protein, were revealed in bR and are underlined. 
In this region we found (Fig. 16) two distinct features of bR that could be a factor limiting the
ability  of  the  helix  to  insert  into  E.  coli membrane  according  to  “positive  inside”  rule.  First,
positively charged Arg7 on the extracellular  N-terminus of bacteriorhodopsin deviates  from the
“positive  inside”  rule.  Second,  bR  has  different  positively  charged  amino  acid  pattern  in  the
cytoplasmic loop A-B, where lysines substitute for arginines in the vicinity of the membrane. Such
a charge distribution on the membrane flanking regions of the first helix could compromise folding
and expression rate of bR.
3.4.2.Expression and purification of chimeric proteins between bR and 
SRII.
To investigate whether the charge distribution in the helix A region influences bR expression
level  in  E.  coli and  the  insertion  of  the  protein  into  bacterial  membrane  we  applied  the
complimentary protein  approach to  bR.  We chose  SRII  as  a  complimentary protein  since  it  is
expressed in E. coli functionally with a high yield [27] and satisfies the “positive inside” (Fig. 16).
In addition, SRII was the only retinal protein expressed in  E. coli for which the high resolution
structure was available. We constructed several chimeric proteins combining counterparts of bR and
SRII as illustrated on Fig. 17. Following the protein complementarity approach, at first we replaced
initial 43 amino acids of bR for the corresponding 36 amino acids of SRII composing chimeric
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Figure  17: Design  of  chimeric
proteins  between  bR  and  SRII.
Parts  of  bR  with  corresponding
amino acid sequence are shown in
purple,  for  SRII  the  color  is
orange. Subscript  in the name of
the  construct  indicates  amino
acids of bR that were replaced by
the  counterparts  from  SRII  and
vice versa. N-terminus, first α-helix
and the beginning of the second α-
helix are shown.
protein SR1-44bR (as described in Materials and methods). Second, to elucidate the influence of
extracellular, transmembrane and cytoplasmic regions independently we constructed in a similar
way the chimeric proteins SR1-10bR, SR28-44bR, and SR1-10,28-44bR, respectively.
The chimeric protein genes were inserted to pSCodon plasmid under control of inducible T7/lac
promoter/operator. The E. coli SE1 cells were transformed with pSCodon plasmid carrying genes of
target chimeric proteins to produce expression strains.
First, SR1-44bR chimeric protein was expressed and purified. The progress of the purification
process is illustrated in Fig. 18. The expression level of the protein was assessed to be 7.0±1.0 mg
of protein per liter of culture from SDS-PAGE and BCA assay using Ni-NTA purified product. The
screening of  the detergents  for  solubilization of  the  chimeric  protein showed (Fig. 18)  that  the
strong  detergents  (FOS-12,  Sarkosyl)  solubilize  the  protein  completely,  but  mild  non-ionic
detergents were not so efficient. DM, DDM can solubilize only up to 40-50% of the protein (DM,
DDM). The protein resisted solubilization in OG. Thus, in the further experiments we purified the
protein under semi-denaturing conditions employing Sarkosyl for solubilization. 
To investigate the influence of the  N-terminus, A-B loop, and first transmembrane region we
expressed simultaneously SR1-44bR, SR1-10bR, SR28-44bR, and SR1-10,28-44bR chimeric proteins.  The
proteins were purified using Ni-NTA resin. Solubilization pellet, Ni-NTA flowthough and wash did
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Figure  18: The purification of  the chimeric  proteins analyzed with  SDS-PAGE and Western
blotting.  A. Western blotting with anti-His-tag antibodies showing the efficiency of purification of
SR1-44bR chimeric protein in different detergents. 1 - DM; 2 - DDM; 3 - OG; 4 - Fos12; 5 - Sarkosyl.
Relying on these data we chose Sarkosyl to solubilize the chimeric proteins as the most effective
detergent. B. Western  blotting with anti-His-tag antibodies (and SDS-PAGE, lane 10) illustrates the
process of the purification of chimeric protein in Sarkosyl (SR1-10bR was taken as an example). 1 -
cytoplasm; 2 - isolated membranes; 3 - solubilization suspension after ultracentrifugation; 4 - Ni-
NTA column flowthrough; 5 - wash A; 6 - wash B; 7 - wash C; 8 - Ni-NTA column eluate; 9 - Protein
Ladder; 10 -  Ni-NTA column eluate (SDS-PAGE). The protein shows the distinct tendency to form
multimers in Sarkosyl, monomer and trimer are indicated.
not contain considerable amount of the target proteins (Fig. 18, panel B, lanes 4-7). The yield and
purity of the proteins were assessed from SDS-PAGE (Fig. 19, panel A, lanes 1-4). The purity of the
Ni-NTA purified chimeric proteins was minimum 90%. The SR1-10bR and SR1-10,28-44bR constructs
showed the same yield as SR1-44bR chimeric protein, while SR28-44bR had expression level nearly as
low as native bR gene (Fig. 19). This data allowed us to localize the problem of bR expression in E.
coli at the N-terminus of the protein.
To evaluate the efficiency of the expression of bR in  E. coli comparing to the other retinal
proteins, which have been shown to express in E. coli with the high yield, we have expressed and
purified chimeric protein SR1-10bR, native bR gene, SRII and ESR. The E. coli BL21 (DE3) cells
were  transformed with  pET27bmod plasmid bearing  SRII  gene  while  E.  coli SE1 cells   were
transformed with pSCodon plasmid bearing ESR, SR1-10bR, or native bR genes. The proteins were
expressed  at  the  same  conditions.  The  ESR  and  SRII  were  purified  under  non-denaturing
conditions, while SR1-10bR and bR were solubilized in NLS and detergent was then exchanged to
SDS according to the protocol described in Materials and methods. Acrylamide gel with the Ni-
NTA eluates loaded is presented in the Fig 19. According to the densitometry of the SDS-PAGE the
yields of the proteins were 21 mg, 14 mg, 8 mg, and 0.15 mg per liter of culture for ESR, SRII,
SR1-10bR, and native bR respectively. Thus, the exchange of the first 10 amino acids of bR to their
counterparts from SRII allowed us to increase ~50-fold the yield of the bR and made its  yield
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Figure 19: The SDS-PAGE analysis of expression of the chimeric proteins and its comparison
with the other retinal proteins. A. Analysis of the Ni-NTA eluates of the chimeric proteins purified in
Sarkosyl. 1 -  SR1-10bR; 2 - SR28-44bR; 3 - SR1-10,28-44bR; 4 - SR1-44bR. The yields of the chimeric
proteins were quantified using BCA protein assay and SDS-PAGE densitometry, the results are
presented as histogram. B. Comparison of the yield of chimeric protein with the yields of the other
retinal proteins. After purification on the Ni-NTA column eluates were loaded on SDS-PAGE and
yields were quantified  using BCA protein assay and SDS-PAGE densitometry,  the results are
presented as histogram. 1 - Protein Ladder; 2 - bR; 3 - SR1-44bR; 4 - SRII; 5 - ESR.
comparable to the yields of the other retinal proteins.
Interestingly,  the  construct  bR1-8SR containing  first  10  amino  acids  of  bR  instead  of  their
counterparts on the N-terminus of SRII yielded 6.0±1.8 mg/l comparing to 18.1±2.8 mg/l for SRII.
In the study [124] the authors accomplished the spectral tuning of SRII by constructing chimeric
proteins between SRII and bR and were able to produce in small amount the functional chimera
comprising A-C helices of bR and D-G helices of SRII expressed in  E. coli. In case of  bR1-8SR
construct we have not obtained functional protein under non-denaturing conditions. We suppose that
the introduction of charged Arg7 from bR into the hydrophobic interface of  helix  A brakes its
hydrophobic interactions with the other helices leading to the destabilization of the SRII structure
and misfolding of the bR1-8SR chimera. Thus, the suppressing influence of the  N-terminus of bR
have been supported by deterioration of functional SRII expression in E. coli when N-terminus of
SRII was replaced with its counterpart from bR.
3.4.3.Functionality of the chimeric proteins and their characterization.
When the chimeric protein was expressed with retinal added to the cell culture and purified
under non-denaturing conditions using DDM, it did not appear to be colored and, thus, functional.
To acquire functionality the protein must be subjected renaturation.  The prevailing protocol for
bacterioopsin retinalization employs the DMPC/CHAPS vesicles and protein solubilized in SDS
[119]. Attempts to renaturate bR directly from Sarkosyl were not successful as well as attempts to
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Figure  20: Expression of bR1-8SR chimeric protein and its comparison to SRII. Both proteins
were purified in two different detergents (DDM and Sarkosyl) on Ni-NTA column. The eluates were
loaded on SDS-PAGE: 1 - Protein Ladder; 2 - bR1-8SR in Sarkosyl; 3 - bR1-8SR in DDM; 4 - SRII in
Sarkosyl; 5 - SRII in DDM. The yields of the protein were quantified using SDS-PAGE densitometry
and BCA protein assay kit,  the results are presented as histogram. The UV-Vis spectra of the
proteins solubilized in DDM were measured. In contrast to SRII, bR1-8SR did not show retinal peak.
renaturate bR in SDS obtained by the exchange of Sarkosyl to SDS using dialysis. However, when
the detergent exchange was carried out directly on the Ni-NTA column, the chimeric protein was
able  to  refold  (Fig. 21).  The  amount  of  functional  protein  was  calculated  from  absorbance
maximum of retinal at 555 nm (Fig. 21) and taking into account the extinction coefficient of bR in
DMPC/CHAPS vesicles to be 55 300 cm-1M-1 [125]. The total protein was estimated from BCA
protein assay. The amount of the functional protein was assessed as 91%. Taking into account that
the purity of the Ni-NTA purified samples was previously determined to be ~90% we concluded
that the chimeric protein was retinalized completely. 
After renaturation the protein samples contained excessive amount lipid/detergent vesicles and
free retinal. These components can impede the spectroscopic and crystallography studies, thus we
should have removed them. For this purpose we used size-exclusion chromatography (SEC). The
renatureted chimeric protein in DMPC/CHAPS mixture was loaded on the Superose6HR column
with bed volume 24 ml and eluted in 50 mM Na/Na-Pi pH 6.0, 0.1% DDM. Protein elution profile
(Fig. 21) had only one distinct peak at 15.1 ml corresponding to the radius of gyration of 4.9 nm (or
170 kDa molecular weight) according to column calibration. The peak was very narrow (0.5 ml,
while for MPs characteristic values are 0.8 ml or wider) but had a clear wing in the area of the
smaller molecular weight.
- 49 -
Figure 21: Renaturation of SR1-10bR chimeric protein and its characterization. A. The renaturated
chimeric protein had a distinct purple color. UV-Vis spectrum showed that sample has strong retinal
absorption peak characteristic to functional bR shifted due to the absorption of the residual free
retinal. B. Analysis of the renaturated protein using gel-filtration. The protein eluted as a monomer
in DMPC/CHAPS bicell. As a reference we used native bR from purple membranes in Amphipol
A8-35.  The  maxima  of  elution  peaks  corresponding  to  the  water-soluble  proteins  (with  their
molecular weights) used for calibration of the column are indicated by arrows.
Relying on this information we concluded that on SEC-column the partial delipidation of the
protein did occur. SDS-PAGE confirmed this finding (Fig. 22). The sample before loading on the
chromatographic column showed the single band and excessive amount of lipid (seen on the gel as a
smeared patch in the range of low molecular weights), whereas the samples collected after the
column showed two different bands. While the low molecular weight band (~22 kDa) corresponds
to the protein in lipid before gel-filtration, the second band (~26 kDa) matches the protein purified
on the Ni-NTA resin. Unfortunately, delipidation of the samples was not complete leading to the
non-homogenous preparations. The fractions pooled we not able to be concentrated to the volume
requiring  for  the  successive  loading  on  the  column turning  into  gel-like  phase.  Moreover,  the
excessive  lipids  resulted  in  the  clogging  of  the  column.  Thus,  this  protocol  did  not  allow the
delipidation of the samples with high efficiency and on the large scale forcing us to try another
approaches.
To achieve  complete  delipidation  we used the  Ni-NTA resin  second time:  the  protein  after
renaturation was loaded in a batch mode to the Ni-NTA column equilibrated with 50 mM Na/Na-Pi
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Figure  22: Delipidation  of  the  SR1-10bR reconstitution mixture.  A. SDS-PAGE illustrating the
delipidation of the reconstitution mixture using gel-filtration. 1 - Protein Ladder; 2 - concentrated
sample before loading on the column; 3 - gel-filtration, fraction 29; 4 -  gel-filtration, fraction 30; 5 -
gel-filtration, fraction 32. B. Normalized SEC elution profiles of SR1-10bR reconstitution mixture. The
samples  were:  concentrated  renaturation  mixture  directly  (blue),  renaturation  mixture  after
delipidation on Ni-NTA column (red), and the second run on gel-filtration column of the sample
delipidated using Ni-NTA (violet). As a reference we used bR from purple membranes in Amphipol
A8-35 (yellow). The maxima of elution peaks corresponding to the water-soluble proteins (with their
molecular weights) used for calibration of the column are indicated by arrows. Fractions collected
are indicated in dark red. C. SDS-PAGE analysis of the delipidation using Ni-NTA and SEC. 1 - gel-
filtration, fractions 26-32; 2 - Ni-NTA column flowthrough; 3 - Ni-NTA column wash; 4 - Ni-NTA
column  eluate;  5  -  gel-filtration  after  Ni-NTA,  fractions  31-32;  6  -  gel-filtration  II  after  Ni-NTA,
fractions 30-33; 7 - Protein Ladder. Protein in lipids corresponds to the band  ~23 kDa, whereas
delipidated protein corresponds to the band 26kDa.
pH 6.0, 0.1% DDM buffer and incubated overnight for the improved binding of the protein to the
column. As NG is known as the detergent that provides the bR photocycle most close to one of bR
in purple membranes, we used this detergent in the elution buffer. Attempts to elute the protein
using low pH (acetic buffer with pH 4.5) were not successful. Further attempts to elute the protein
with imidazole and/or DDM resulted in complete denaturation of the protein. However, combining
DDM with imidazole in elution buffer at pH 6.0 resulted in the successful elution of the protein in
the next preparation. 
After subsequent Ni-NTA column the protein eluates were loaded into SEC-column and eluted
in 50 mM Na/Na-Pi pH 6.0, 0.1% DDM buffer. The elution profile showed only one distinct peak at
15.9 ml corresponding to the radius of gyration of 3.7 nm (or 65 kDa molecular weight) according
to  column calibration  corresponding  to  the  mostly  delipidaded  protein  (Fig. 22).  The  fractions
corresponding to this peak were collected and successive loading of the protein on SEC-column
indicated delipidation of the sample. SDS-PAGE proved this observation showing the most of the
protein in the 27 kDa band corresponding to the delipidated protein (Fig. 22). However, analysis of
the probes taken from the second Ni-NTA column flowthrough and wash as well as lipid pellet
before first gel-filtration indicated that significant part of the protein (at least 30%) was lost during
removal of excessive lipids.
Expression  of  the  chimeric  proteins  between  bR and SRII  showed that  the  complementary
approach is a valuable tool to localize the reason of the expression failure. The exchange of first 10
amino acids of  bR to their  counterparts  from SRII increased the expression level  50-fold.  The
expressed protein can be purified under denaturing conditions using Ni-affinity chromatography to
the purity over 90%. Despite the fact that chimeric protein was not expressed functionally in E. coli
it  could  be  easily  renaturated  with  high  efficiency  using  standard  approach  employing
DMPC/CHAPS vesicle. The high protein purity as well as delipidation of the samples could be
achieved by means of the successive Ni-affinity and size exclusion chromatographies. However,
such approach to the functional purification of the bR is not straightforward and do not give any
significant advantage over the other published methods (see chapter2.4for review).
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 3.5  Identification of the reason of the low level expression of bR in E. 
coli.
3.5.1.Expression of the point mutants R7E and R7Q of bR.
One of the goals of the study was the expression of the native bR in E. coli. Consequently, we
should clarify the reason of the increase in the yield of the chimeric protein SR1-10bR to be able to
produce the protein with amino acid sequence most close to the sequence of native bR. Within the
short  fragment  identified  by protein  complementarity  approach  the  most  probable  amino  acids
impeding expression of bR could be suggested using rational considerations. We supposed that the
reasons of low expression level of bR in E. coli could be the presence of positively charged Arg7 on
the N-terminus side of the helix A of bR or the unfavorable mRNA structure of bR gene near the
ribosome binding site. We investigated this factors separately either by introducing point mutations
that eliminate Arg7 or by optimizing mRNA structure with silent mutations in bR gene.
First,  we  have  replaced  the  Arg7  amino  acid  with  neutral  or  negatively  charged  residues
constructing the point mutants R7Q and R7E, respectively. According to “positive inside” rule [120]
this  residue could impede the insertion of the bR into  E. coli membrane,  thus  diminishing the
protein yield. To explore this hypothesis we expressed and purified the point mutants according to
the  same  protocol  as  chimeric  proteins.  SDS-PAGE  analysis  have  showed  that  there  was  no
considerable losses of protein during purification (Fig. 23). Using BCA Protein Assay and SDS-
PAGE analysis we found the yields of the point mutants to be 0.96±0.20 mg and 0.37±0.10 mg of
protein per liter of culture for the R7Q and R7E mutants, respectively.
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Figure 23: Expression of the point mutants R7Q and R7E, their purification and comparison to
native bR and SR1-10bR chimeric protein.  A. SDS-PAGE illustrating the progress of purification of
R7Q mutant  protein.  1 -  cell  lysate;  2 -  cytoplasm;  3 -  membrane suspension;  4 -  solubilized
fraction; 5 - nonsoluble material; 6 - Ni-NTA column flowthrough; 7 - Ni-NTA column wash; 8 - Ni-
NTA column eluate; 9 - Protein Ladder. B. Corresponding anti-His-tag immunoblot. The lanes 1-8
are the same as on SDS-PAGE.  C. Comparison of  protein yields of  point  mutants of  bR and
reference proteins SR1-10bR and bR. 1 - SR1-10bR; 2 - bR; 3 - R7Q; 4 - R7E.
For comparison, the yield of the SR1-10bR chimeric protein and native bR were 7.0±1.0 mg and
0.14±0.04 mg per liter of culture, respectively. The yield of the point mutants is considerably higher
than that of native bR, on the other hand, it is still significantly lower than for the SR 1-10bR. We can
suggest the simultaneous influence of several factors on the expression of bR in E. coli. It is first
influenced by the “positive inside” rule, since the elimination of Arg7 increases the expression yield
of point mutants 3- and 7-fold. However, the expression gain of SR1-10bR is over the 50 times. Thus,
despite its strong influence it is not only “positive inside” rule that caused the increase of expression
yield of the chimeric protein comparing to wild type bR. We suggested that there is an additional
effect, and the reason of the observed increase in protein yield could be the influence of the mRNA
structure of bR gene downstream the ribosome binding site.
3.5.2.Optimization of bR mRNA.
The stability of mRNA folding downstream the ribosome binding is known to have a strong
impact  on  the  protein  expression  level  [126].  Particularly  illustrative  is  the  study  with  green
fluorescent protein, when the yield of the protein in E. coli varied 250-fold across the synthetic gene
library encoding the same amino acid sequence [127]. The authors have shown that the stability of
mRNA folding near  ribosome binding site  and associated rate  of  translation initiation  play the
predominant role in the defining the expression level of the protein. In the other work [20] it has
been  shown that  the  variation  of  nucleotide  sequence  near  ribosome binding  site  significantly
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Figure 24: The mRNA shapes of the native bR, SRII, chimeric protein SR1-10bR, and optimized
bR gene  for  the  region  (-4,  +47) with  numbering  starting  from ATG start  codon.  This  region
corresponds  to  amino  acids  from Met0  to  Leu15. Free  energies  presented  are  expressed  in
kcal/mol. The values of mRNA free energy for SRII and SR1-10bR are considerably smaller than
those of  native bR gene. mRNA structure optimization of bR by silent mutations have increased
the free energy of the region (-4, +47) by 6.2 kcal/mol.
influences the expression level of bR in E. coli. Our purpose was to examine whether the increase
of the protein yield of chimeric proteins can be explained by the impaired translation initiation due
to possible unfavorable mRNA structure of bR near ribosome binding site.
Using the mRNA structure prediction software  mRNAshapes [128] we have found a putative
stem structure at the start of the bR gene (Fig. 24). As the stem stretches beyond nucleotide 37, we
had to expand the region under consideration to (-4, 47) comparing to previous study [127].  This
region corresponds to amino acids from Met0 to Leu15. The free folding energy of mRNA for the (-
4, 47) region of bR is predicted to be -22.4 kcal/mol, while the corresponding value for SRII, ESR,
and  hR  genes  are  -12.3,  -5.2,  -13.1  kcal/mol indicating  the  decreased  stability  of  the  mRNA
structures at the 5'-terminus near ribosome binding site. The change of first 9 amino acids of bR to
the counterparts of SRII have considerably weakened the interactions between the 6-15 and 33-41
nucleotides and increased the free energy by 13.0  kcal/mol (Fig. 24). And vice versa, the folding
energy of bR1-8SR is -15.5 kcal/mol explaining the lower yield of this chimera. Since the expression
level of the native bR, SRII, SR1-10bR, and bR1-8SR have correlated with the stability of the (-4, 47)
region of mRNA structure, we introduced into wild type bR gene two silent mutations (C9A, G12A
corresponding to amino acids Ala2 and Gln3) that increase the free energy by 6.2  kcal/mol and
significantly reduce the stem stability (Fig. 24).
3.5.3.Expression in E. coli of the mRNA-optimized bR and its 
purification under denaturing conditions.
The mRNA optimized bR gene was inserted into pSCodon plasmid, expressed in  E. coli SE1
cells, and purified under denaturing conditions as described in Materials and methods similar to the
chimeric proteins. SDS-PAGE analysis have showed that there was no protein in the probes from
solubilization  pellet,  column  flowthrough  and  washes,  while  cytoplasm contained  considerable
amount of target protein (Fig. 25). The purity of the preparations was accessed by SDS-PAGE to be
higher than 90%. The protein could be renaturated to functional state in the same fashion as SR1-
10bR with the high efficiency. The expression yield was estimated by SDS-PAGE and BCA protein
assay kit as 7.6±2.9 mg per liter of culture. This yield is essentially the same as the yield of the
chimeric protein SR1-10bR (p = 0.74). Thus, we have proved that the expression gain of the chimeric
protein was due to the alteration of the mRNA structure of bR near ribosome binding site. With two
point mutations in the bR gene, which do not change the amino acid sequence, we have achieved
the expression level 50 times higher than for the native gene.
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The optimization of mRNA has also significantly increased the bR expression rate in previous
study with the use of pJP plasmid with T5 promoter under control or without control of lac operator
[20]. However,  the authors found in the mRNA 5' untranslated region the hairpin structure that
encloses  lac operator  and  hence  impairs  mRNA translation  initiation,  while  uncontrolled  T5
promoter led to the deleterious growth of  E. coli cells. In case of pSCodon plasmid we have not
observed any adverse influence of  lac operator on the protein yield. This discrepancy could be
explained by the insufficient spacing between  lac operator and ribosome binding site in the pJP
plasmid. To prevent translation suppression lac operator the authors of those study used PL promoter
repressed by temperature sensitive repressor. Transcription was induced by temperature shift from
30 to 42°C resulting in the rapid degradation of the newly synthesized protein under the chosen
expression conditions. Therefore, the total yield of unfolded bR was approximately 2 times lower
than achieved in the present study. 
In general, a combination of the complementary protein approach with rational considerations
allowed us to determine the reason of the low level of bR expression in E. coli. We have attributed
the problem to the unfavorable mRNA structure of bR downstream the ribosome binding site. The
improved  expression  system and more  optimal  conditions  of  protein  expression  allowed  us  to
achieve additional gain in protein yield comparing to the previous studies. The yield achieved was
50 times higher than for the native gene being comparable with the yield of native  H. salinarum
system [11].
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Figure  25: Expression  of  the  mRNA optimized  bR  and  its  purification  under  denaturing
conditions.  A. SDS-PAGE  illustrating  the  progress  of  protein  purification.  1  -  cell  lysate;  2  -
cytoplasm; 3 - membrane suspension; 4 - solubilized fraction; 5 - nonsoluble material; 6 - Ni-NTA
column flowthrough; 7 - Ni-NTA column wash; 8 - Ni-NTA column eluate; 9 - Protein Ladder.  B.
Corresponding  anti-His-tag  immunoblot.  The  lanes  1-8  are  the  same  as  on  SDS-PAGE.  C.
Comparison of protein yields of the optimized bR, point mutants, and reference proteins SR 1-10bR
and bR. 1 - SR1-10bR; 2 - bR; 3 - optimized bR; 4 - R7Q; 5 - R7E. The protein yields were quantified
using SDS-PAGE densitometry and BCA protein assay kit, the results are presented as histogram.
 3.6  Expression in E. coli and functional purification under non-
denaturing conditions of bR and its mutants.
3.6.1. Purification of bR in non-denaturing conditions.
When we expressed  mRNA optimized wild-type  bR in  E.  coli with  retinal  added into  cell
culture and used mild detergent DDM for the solubilization of the protein after membrane isolation,
the  protein  retained  its  functionality  during  the  purification  process  under  non-denaturing
conditions. The progress of purification is illustrated by SDS-PAGE in  Fig. 26. The first step of
affinity chromatography led to the mixed preparations of functional bR as well as not properly
folded bacterioopsin and E. coli MPs impurities. The protein yield was estimated to be 7.0±2.8 mg
per litre of culture, as measured by BCA protein assay. Sample homogeneity was confirmed by
coomassie-stained SDS-PAGE (Fig. 26, A). 
As  solubilized  bR is  unstable  at  alkaline  pH and  imidazole  is  harmful  for  the  protein,  we
removed imidazole and adjusted pH to 6.0 by dialysis. During the pH exchange the protein heavily
precipitated. The pellet was not colored and constituted of bR according to SDS-PAGE analysis
suggesting  aggregation  of  the  misfolded  protein.  After  discarding  the  pellet  the  most  of  the
functional  bR still  remained in  the  supernatant,  but  UV-Vis  spectroscopy have  shown that  the
sample was not yet free of aggregates and protein contaminations.
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Figure  26: Expression of  the mRNA optimized bR and its purification under non-denaturing
conditions.  A. SDS-PAGE  illustrating  the  progress  of  protein  purification.  1  -  cytoplasm;  2  -
membrane  suspension;  3  -  solubilized  fraction;  4  -  nonsoluble  material;  5  -  Ni-NTA column
flowthrough; 6 - Protein Ladder; 7 - Ni-NTA column eluate (protein solubilized in Sarkozyl); 8 - Ni-
NTA column eluate (protein solubilized in DDM).  B. Corresponding anti-His-tag immunoblot. The
lanes 1-8 are the same as on SDS-PAGE. C. Comparison of protein yields of the bR using different
purification protocols. 1 - under denaturing conditions; 2 - under non-denaturing conditions, total
yield; 3 - under non-denaturing conditions, functional protein. The protein yields were quantified
using SDS-PAGE densitometry and BCA protein assay kit, the results are presented as histogram.
For further purification of bR we have used size-exclusion chromatography (Fig. 27). Protein
elution profile had two distinct peaks at 69.7 ml and 86.5 ml corresponding to bR aggregates and
functional bR. The colored fractions from the latter peak were pooled, mixed and concentrated. The
UV-Vis absorbance spectrum exhibited the retinal absorption peak at 555.5±1.0 nm (Fig. 27, C)
matching absorption maximum of the dark-adapted bR from purple membranes of  H. salinarum
solubilized in DDM  [129]. The peak ratio A280/Aλmax of 1.5 was achieved demonstrating that the
purity of the protein is consistent with that of bR solubilized from native purple membranes of H.
salinarum and, thus, satisfies the requirements for the use of this protein in different applications in
science and industry. Storage stability of the protein was analyzed 5 days after purification by gel-
filtration on the same column. Bacteriorhodopsin eluted as single and symmetric (asymmetry index
1.05) peak indicating size homogeneity of the final product (Fig. 27). Thereby we have shown that
the aggregates were removed completely from the samples and the purified protein had no tendency
to denature or form aggregates upon storage. The final yield of the purified functional wild type bR
expressed in E. coli was 2.4±1.3 mg of the protein per liter of culture corresponding to 15-35% of
total synthesized bR (Fig. 26).
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Figure  27: Characteization of  bR expressed in  E. coli.  A. Elution profile  of wild type bR on
Sephacryl S200HR. The first run is shown in blue and the second in red. Peak at 68.68 ml in the
first run corresponds to aggregated colorless protein. Second peak at 85.54 ml is the target protein.
The fractions are indicated and those that were pooled are shown by pale yellow color. After 5 days
the purified protein was subjected to the second round of gel-filtration, but it  did not show any
significant  amount of  aggregates.  B. SDS-PAGE analysis  of  fractions obtained from Sephacryl
S200HR column. 1 - eluate from Ni-NTA column; 2 - pellet after dialysis; 3 - sample before gel-
filtration; 4 - fraction 23; 5 - fraction 28; 6 - fraction 34; 7 - Protein Ladder; 8 - fraction 39; 9 -
fraction - 45. C. UV-Vis absorption spectra of the samples of wild type bR expressed in E. coli (after
first and second run of gel-filtration) and of protein from native purple membranes solubilized in
OG. The spectra were normalized by absorbance at 280 nm. Proteins were solubilized in DDM and
purified using non-denaturing protocol.  The spectrum of  wild  type bR has exhibited the retinal
absorption peak at 555.5±1.0 nm matching absorption maximum of the delipidated dark-adapted
bR from purple membranes. The peak ratio A280/Aλmax of 1.5 was achieved demonstrating the high
purity of the protein.
3.6.2.Factors influencing the expression of wild type bR in E. coli. 
Karnik et al. [104] have shown that only 1-2% of bR synthesized in E. coli bound retinal, when
cells were incubated at 37°C after induction. We suppose that the cultivation temperature shows
significant influence on the yield of the functional bR in case of  E. coli expression. Indeed, it is
recommended  [130] to express MPs at lowered temperatures (20-30°C) to reduce the rate of the
protein  synthesis,  facilitate  its  membrane  insertion  and  proper  folding.  As  shown  in  vitro bR
insertion  into  membrane  occurs  co-translationally  in  Sec-dependent  manner  [123].  Its
overexpression  can  overload  the  cell  translocation  system  resulting  in  misfolded  protein  and
increased rate of protein degradation. Using similar mutations to optimize mRNA structure (-16.2
vs. -12.3 kcal/mol) we have obtained the doubled translational yield of bR comparing to previous
study  [20].  However,  the authors  of this  work employed denaturing protocol  involving organic
solvents, therefore, they had to renaturate the protein using DMPC/CHAPS vesicles, whereas our
protocol takes advantage of non-denaturing conditions, thus allowing to produce functional protein
straightforward.
It is also worth noting that high rate of bR misfolding can be attributed to unfavorable lipid
composition of  E. coli membrane. The PE lipids, a major component of  E. coli membrane, were
shown to decrease bR regeneration yield  in vitro [131]. At the same time, the folding of bR was
shown to follow a two-stage model with at least one transition state [132]. Therefore, E. coli lipids
might influence the transition state and favor bR misfolding.
The described protocol allows one to avoid in expression and purification strategy steps of
protein extraction with organic solvents, use of fusion proteins as expression drivers, solubilization
of  protein  in  denaturing  detergents  and  protein  renaturation  from SDS,  which  inherent  to  the
existing protocols  [20-24]. We have achieved expression in  E. coli and purification of functional
wild type bR under non-denaturing conditions in quantities sufficient for structural biology studies
and other purposes. The protein is stable, homogeneous and resembles the native bR from purple
membranes.
3.6.3. Purification of V49A, D85N, and D96N mutants of bR in non-denaturing
conditions.
One of the main advantages of E. coli expression system over H. salinarum is the considerably
reduced time required to produce the mutants of interest facilitating the intense study of the target
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protein. Using mRNA-optimized bR gene we have introduced mutations V49A, D85N, and D96N
and  utilizing  the  non-denaturing  purification  protocol  we  readily  obtained  functional  mutant
proteins with yields of 0.3, 3.8, and 8.8 mg per liter of culture, respectively. The mutant proteins
had essentially the same gel-filtration elution profile as wild-type bR (Fig. 28). V49A and D96N
UV-Vis  spectra  were  simular  to  the  wild-type  bR,  while  D85N mutant  exhibited  characteristic
maximum retinal absorbance at 598.0 nm and showed higher peak ratio A280/Aλmax comparing to the
wild type protein and D96N mutant (Fig. 28). Thus, we have proven that the suggested approach is
also efficient for fast production of bR mutants.
It is worth emphasizing the higher expression level of D85N and D96N mutants of bR. It is not
surprising.  The  mutation  D94N  in  the  bacteriorhodopsin  from  Haloarcula  marismortui
(corresponding to D96N mutation in bR) have increased 10-fold the yield of the functional protein
[133]. It was also shown [134] that insertion of bR helix C into membrane in vitro is impeded by
two aspartic  acid residues within transmembrane region.  In the present  work D85N and D96N
mutations led to the 1.5 to 4-fold increase in the yield of functional protein relative to wild type bR,
the fraction of properly folded protein increased as well from 25±10% to 35% and 60% of the total
yield  of  D85N and D96N mutants,  respectively.  This  increase  may be  explained by improved
incorporation  of  the  newly  synthesized  protein  into  E.  coli membrane  that  reduces  protein
degradation and facilitates the correct folding of the bR mutants.
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Figure 28: Characterization of bR mutants expressed in E. coli. A. Elution profile of bR mutants
on Sephacryl S200HR. The elution profile for D85N mutant is shown in blue, for D96N in red, for
V49A (second run) in yellow. Peak at 68 ml corresponds to aggregated colorless protein. Second
peak at 85 ml is the target protein. The fractions are indicated and those that were pooled are
shown  by  yellow color.  B. Comparison  of  yields  of  the  bR mutants.  The  protein  yields  were
quantified using BCA protein assay kit  and UV-Vis  spectroscopy,  the results are presented as
histogram. C. UV-Vis spectra of wild type bR and its mutants. The spectrum for wild type protein is
shown in red, for D85N mutant in yellow, for D96N in green, for V49A in blue.
3.6.4.Expression and functional purification of bR-Lys fusion protein 
under non-denaturing conditions.
The further development of the project in line with the objectives of this study supposed the
adaptation  of  the  developed  expression  system for  production  of  the  functional  bR-Lys  fusion
proteins. To achieve the goal we have constructed again three variants of bR-Lys fusion protein
gene in pSCodon plasmid: pSCodonbRL, pSCodonbRLE, and pSCodonbRLEs as it is described in
Materials and methods. The proteins were expressed in  E. coli and purified under non-denaturing
conditions similar to the bR and its mutants. The probes of the cytoplasm fractions, solubilization
pellets,  column  flowthroughs  and  washes  were  analyzed  on  SDS-PAGE  and  Western  blotting
showed that only solubilization pellets contained considerable part of the target protein. However,
the part of the protein in the pellet was only 20-30% of total expression yield, and, as pellet was not
colored, consisted mostly from not properly folded protein. The total yields (translational yield) of
the bR-Lys fusion proteins were estimated by BCA assay to be 5.6 mg, 4.0 mg, and 4.1 mg per liter
of culture for bRL, bRLE, and bRLEs, respectively. The purity of the preparations was estimated to
be more then 90% using SDS-PAGE.
The bRL fusion protein was not colored and, thus, functional, whereas the eluates corresponding
to the bRLE and bRLEs exhibited a faint purple color. This proteins (bRLE and bRLEs) initially
purified with Ni-NTA affinity chromatography were further purified using gel-filtration according
to the procedure described for the wild type bR. The proteins were loaded on SephacrylS200HR
column with bed volume of ~160 ml and eluted in 50 mM Na/Na-Pi pH 6.0, 0.1% DDM. Protein
elution  profiles  exhibited  two  distinct  peaks  at  60.5  ml  and  84.9  ml.  The  colored  fractions
corresponded  to  the  peak  at  84.9  ml,  were  pooled,  concentrated  and  analyzed  using  UV-Vis
spectroscopy. The spectra exhibited two characteristic peaks at 280 and 560 nm corresponding to
the  absorption  of  protein  amino  acids  and  retinal.  Using  Protein  Calculator  (available  at
http://www.scripps.edu/~cdputnam/protcalc.html) the reliable peak ratio that similar to 1.5 for bR
for the bR-Lys chimeric proteins was calculated to be 2.13. After purification on SephacrylS200HR
we were able  to  obtain the proteins  with the peak ratios  2.34 and 2.63 for  bRLE and bRLEs,
respectively, that corresponds to 91% and 81% of functional protein in the preparations. The yields
of the functional proteins were 0.83 mg and 0.41 mg what means that only 20% of bRLE and 10%
of bRLEs total protein is properly folded. The lower fractions of folded protein comparing to the
wild  type  bR may be  explained by complexity of  the  3D structure  of  the  fusion  proteins  that
decreases the probability of the proper folding. However, we were able to purify the functional
protein  to  the  purity  sufficient  for  crystallization  and  started  crystallization.  Before  starting
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crystallization  trials  we launched the  experiments  to  investigate  the  influence  of  detergent  and
native lipids on crystallization of bR.
 3.7  The influence of detergent on in meso crystallization of bR.
3.7.1.Crystallization of bR from purple membranes in the mixtures of 
detergents.
As it was stated before, to develop an effective approach for the crystallization of bR-Lys fusion
protein  and,  thus,  to  have  more  chances  to  crystallize  the  fusion protein  spending less  protein
material we need first to investigate the influence of lipid/detergent environment on the process of
in  meso crystallization.  My  task  was  to  explore  the  in  meso crystallization  of  homologously
expressed bR from purple membranes in mixtures of different detergents to establish the influence
of detergent on crystallization of MPs. This study was carried out as a part of the work under the
project  devoted  to  the  investigation  of  the  role  of  lipid/detergent  environment  in  in  meso
crystallization in our group in collaboration with my colleagues. 
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Table  1: Crystallization  conditions  of  homologously  expressed  wild  type  bR  (from  purple
membranes)  in  mixtures  of  detergents.  The  concentrations  of  the  detergents  are  indicated  in
arbitrary units. The three mixtures of detergents were used: OG-MEGA10, OG-CYMAL5, and OG-
DDM.
The crystallization was done according the modified protocol of Landau and Rosenbuch [6], as
described  in  Materials  and  Methods.  We  chose  mixtures  OG-MEGA10,  OG-DDM,  and  OG-
CYMAL5 as this detergents have shown the best results for bR crystallization in single detergent
(the data were obtained in our laboratory). The the concentrations of the detergents that were used
- 62 -
Figure 30: Crystals of wild type bR from H. salinarum purple membranes. A. Crystals of wild
type bR were obtained using in cubo crystallization approach in the mixtures of detergents. The
crystals  we up to 350 μm. B.  The datasets from single crystals  were obtained at  synchrotron
radiation. The highest resolution seen is 1.45 Å (inset).
Figure  29: The  crystallization  diagrams  showing  the  maximal  size  of  the  crystals  obtained
depending on the concentrations of the detergents in arbitrary units. The diagrams for the OG-
DDM (left) and OG-MEGA10 (right) are presented. The size of the crystals indicated by color: the
biggest crystals correspond to the red color, the blue color corresponds to the absence of crystals.
The biggest crystals reached 300-350 μm.
for screening are summarized in the Tab. 1. One of the most important data obtained from this
experiments is the maximal size of crystals that could be grown under certain conditions. For the
mixtures OG-MEGA10 and OG-DDM the crystallization diagrams are presented in  Fig. 29. The
mixture OG-CYMAL5 did not give such a big crystals, but, however, there was a plenty of crystals
with the size up to 100 μm. The OG-MEGA10 mixture gave the highly ordered crystals with size up
to 250-300 μm. In OG-DDM mixture the crystals grew up to 300-350 μm in size, however most of
the big crystals had a shape of several thin plates stuck together.
3.7.2.Data collection and model building.
The biggest highly ordered crystals were tested on the in-house X-ray radiation source. The X-
ray diffraction data sets at synchrotron radiation (ID 14-1, Grenoble, France) were taken from the 5
best  crystals  according  to  the  results  of  the  tests.  One  crystal  from  OG-MEGA10  mixture
(345OME) diffracted up to 1.45 Å resolution. It was grown in the mixture containing 3.5 a.u. OG
and 10.5 a.u. MEGA10. Two crystals grown in OG-DDM mixture (365ODM and 385ODM) gave
the diffraction up to 1.7 Å resolution. Both crystals were obtained at 7 a.u. OG and 2.4 a.u. DDM. 
The diffraction patterns were processed with MOSFILM [135] and SCALA [136]. For crystals
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Table  2: Data  collection  and  refinement  statistics.  The  data  are  presented  for  the  datasets
(models) 345OME, 365ODM, and 385ODM. The data for the highest resolution shell are shown in
parentheses.
with relatively low (less than 35%) twinning ratio the detwinning procedure was used, while for the
cases of perfect twinning the build-in algorithms of CCP4 package  [137] were used. The initial
phasing was done using molecular replacement method realized in program MOLREP [138] with
poly-Ala model of high resolution bR structure (derived from 1C3W structure  [14] in PDB Data
Bank  [2]). Protein auto-building was accomplished by ARP/wARP [139]. The initial model was
refined using Refmac [140].
All three crystals of bR belonged to the P63 space group with the cell dimensions 61×61×110
Å3.  The crystals  exhibited twinning characteristic for the most bR crystals  grown  in meso.  The
365ODM and 385ODM crystals had a relatively low twinning ratio 38.6% and 32.6%, respectively,
while 345OME crystal had a perfect twinning of 49.4%. The diffraction patterns of crystals grown
in OG-DDM mixture had intensive rings from powder diffraction on ice and remains of the cubic
phase that deteriorated the quality of diffraction data. As the 365ODM crystal had higher twinning
ratio the corresponding structure had the noisier electron densities and higher temperature factors of
the atoms comparing to the 385ODM. The models built  using 365ODM and 385ODM had the
Rwork/Rfree factors  13.60%/14.48%  and  15.56%/18.71%,  respectively.  The  statistics  of  the  data
collection and model building is presented in the Tab. 2.
Since the main objective of the study was the lipid/detergent environment of the protein, we will
mostly concentrate on the aspects related to this matter. In general, the models built do not have
significant  differences  from  the  other  high  resolution  models,  so  the  aspects  considering  the
functionally important  amino acids  as  well  as  water  molecules  network  inside  bR will  not  be
described.
3.7.3.The general overview of the model of ground state of bR. 
As there was no considerable differences between the models corresponding to the crystals of
bR grown in the OG-MEGA10 and OG-DDM mixtures, we will describe the model based on the
diffraction data with highest resolution, namely 345OME. In case there is significant difference
between the structures, it will be specially specified.
Amino  acid  sequence  of  bR  consists  of  248  amino  acids,  227  of  them were  observed  in
crystallographic structures. In accordance to previous data, bR contains 7 transmembrane helices.
The loop B-C include 20 amino acids, 14 of them form β-sheet, while the rest of the loops are short
consisting of 7-10 amino acids. N- and C-termini are disordered, thus, amino acids from 1 to 4 and
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from 235 to 248 are not included to the model. The E-F loop is flexible as well and was not built
due  to  the  insufficient  quality  of  electron  densities  in  the  corresponding  region.  Besides  the
molecules of bR the model have also the water (54 for 345OME, 62 for 365ODM, 44 for 385ODM)
and lipid molecules. The location of the secondary structure elements agrees with the previously
published. The dependance of the B-factors of the amino acid backbone is presented on the Fig. 31,
the mean B-factors of protein, waters and lipids are summarized in Table. 2. 
Molecules of the protein form trimers packed into the layers parallel to the crystallographic
plane a/b. The arrangement of the bR molecules in such layers is similar to that in native purple
membranes.  The organization  of  bR trimers  is  shown in  Fig. 32.  The trimers  are  stabilized by
hydrophobic contacts between α-helices, intermolecular salt bridge between Lys40 and Asp104, and
specific contacts with MO, which will be described later.
3.7.4.Lipid/detergent environment of bR molecules in the crystal.
One of the main objective of this study and, particularly, the model building was to investigate
whether detergents and lipids participate in the formation of the bR crystals grown  in meso. We
have solved three structures of bR from crystals grown in different mixtures of detergents as well as
in different single detergents. The lipid/detergent environment was carefully modeled and all the
structures as well as electron densities were compared.
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Figure 31: The plot illustrating the distribution of average amino acid B-factor for the models
built. The dependence of average B-factor on the amino acid number for model 345OME is shown
in blue, for model 365OME in red, and for 385OME in yellow. The  α-helices of the protein are
indicated by gray.
On the 2Fo-Fc electron density maps we have found a lot of elongated blobs around hydrophobic
core of the protein along crystallographic axis c, which were interpreted as the aliphatic chains of
the lipid molecules. Unfortunately, the lipid headgroups were disordered that did not allow us to
identify the lipids precisely. In structure 345OME we have identified 7 aliphatic chains (total 59
atoms, average B-factor is 42.10 Å2), in 365ODM - 7 chains (total 59 atoms, average B-factor is
53.11 Å2), and in 385ODM - 5 chains (total 40 atoms, average B-factor is 50.17 Å2). In the last
structure it  was possible  to  model  one molecule of  archaeol  (B-factor  is  55.44 Å2)  as well.  In
Fig. 32 the molecules of lipids are shown in yellow, blue, and red. All the parts of the molecules
- 66 -
Figure  32: Organization of  bR trimers in crystals and lipid environment of  bR molecules.  A.
Cytoplasmic view.  B. Membrane plane view. The bR molecule is shown in green, the symmetry
related bR molecules within the trimer as well as molecules of the neighbouring trimer are shown in
gray.  The MO molecules are red,  squalene molecules are blue,  and other aliphatic chains are
yellow.
match well the molecules of the archaeol modeled in the published structure. Unfortunately, the
headgroups  were  not  resolved  in  our  structures.  Possible  explanations  are  either  that  the  lipid
headgroups  are  not  ordered  properly  or  that  the  symmetry  related  positions  are  occupied  by
different types of the lipid molecules. In addition, in all the structures the molecule of squalene
(shown in blue in Fig. 32) was resolved in the crevasse formed by bR amino acids on the surface of
the  protein  near  π-bulge.  Its  location  coincides  with  the  location  of  squalene  in  the  published
structures, but the B-factors are considerably higher than for the other lipids being ~65 Å2. 
Besides native lipids we have observed the molecule of MO (Fig. 33). It stabilizes the trimer
formed by bR molecules by hydrogen bonds with Tyr147 of one bR molecule and Phe27 of the
other. Therefore, the successful use of the MO as a crystallization matrix for in meso crystallization
may be not coincidence, as this lipid specifically bound to the bR molecules. 
From the other hand, in the structures of bR obtained using the crystals grown from the different
detergent mixtures (as well as single detergents) the molecules of the detergent were not found.
What is more, the electron densities corresponding to the different models (obtained using different
detergents) looks similar indicating that detergent molecules are not included into the crystal. This
finding confirm the previous results:  the clear detergent molecules were not found in the other
published models  of  bR up to  date.  Mass-spectrometry also  did  not  observed  detergent  in  the
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Figure 33: The molecule of MO stabilizes the trimer of bR in crystals. A. The position of the MO
molecule between two molecules of bR in trimer. One molecule of bR is green and represented by
cartoon, while the symmetry related molecule is gray and presented as a surface. B. The specific
interactions with bR molecules that allow to the MO molecule to stabilize the trimer. The distances
between atoms are indicated in angstroms, prime indicates the symmetry related bR molecule. The
MO is colored magenta.
crystals of bR [109]. 
Thus, we have confirmed that detergents do not participate in the formation of the bR crystal in
cubo.  The  presence  of  the  optimal  concentrations  of  detergent  for  bR  crystallization  can  be
explained by possible influence of detergent on the physical properties of the crystallization matrix.
The native lipids from  H. salinarum were shown to play important role in the formation of the
crystals [109, 111], however, the fact that the headgroups are not ordered may indicate that it is non-
specific hydrophobic interactions that are important, but not the type of the lipid. The crystallization
of the bR expressed in E. coli could help to investigate this problem. The ability of this protein to
produce highly ordered 3D crystals will show that only hydrophobic interactions are important in
this case.
 3.8  Crystallization of bR expressed in E. coli.
Having obtained the data that detergent do not influence significantly the crystallization of bR
from H. salinarum we started the crystallization trials of bR expressed in E. coli and solubilized in
DDM. This samples do not have native lipids from H. salinarum bound to bR and crystallization
experiments should help to reveal the role that native lipids play in the crystallization process.
We  set  up  crystallization  trials  using  nanovolume  in  meso high  throughput  membrane
crystallization platform in IBS,  Grenoble.  The conditions  used  included different  detergent  and
protein concentrations for wild type bR and D85N and D96N mutants, we have used Qigen Cubic
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Figure 34: Crystals of bR D96N mutant expressed in  E. coli.  A. Crystals of bR D96N mutant
expressed  in  E.  coli were  obtained  using  in  meso nanovolume  crystallization  approach.  The
crystals  we up to  120 μm.  B. The single  crystal  (without  further  optimization of  crystallization
conditions) was tested at synchrotron radiation. The highest resolution seen is 2.5 Å (inset).
Phase I and Cubic Phase II precipitation solutions kits. The crystals were obtained for all three
proteins. The crystals of wild type bR and D96N mutants had a shape of thin hexagonal plates up to
120  μm in longest direction. We have observed a thin needles up to 250  μm as well as star-like
clusters of short thin needles. The best crystals (Fig. 34) were obtained using 0.1M Tris pH 8.8,
2.6M ammonium sulfate  precipitation solution with protein concentration being 39 mg/ml.  The
D85N mutant  gave  only  needles  up  to  200  μm in  size.  The  obtained  crystals  were  tested  on
synchrotron radiation (ID 14-1,  ESRF, Grenoble)  without  further  optimization of crystallization
parameters. The crystals of D96N mutant diffracted up to 2.4 Å resolution, while D85N crystals up
to 3.5 Å. The photos of the crystals and corresponding diffraction patterns are presented in Fig. 34.
The grow of the well ordered crystals of bR expressed in E. coli proved the highest quality of
the produced protein,  which is comparable to the quality of the protein solubilized from native
purple membranes.  Successful  crystallization of  the protein shows the aptness  of the presented
approach for expression of bR and its mutants suitable for all scientific and industrial applications.
We suppose that this result may be explained by avoiding of denaturation of the protein throughout
purification that is inherent to the other existing protocols  [20-24]. Such approach allowed us to
obtain the first reported 3D crystals of bR expressed in E. coli.
However, the most valuable finding is about the role of the native lipids from H. salinarum.
Previously the archea lipids were found to be very specific stabilizing bR molecules in trimers
inside  the  3D crystal  [109,  111].  Bacteriorhodopsin  expressed  in  E.  coli does  not  contain  the
specific lipids from  H. salinarum. Moreover, the lipid compositions of  E. coli and  H. salinarum
differ dramatically. The ability to grow the crystals of bR without involvement of  H. salinarum
native lipids indicate that stabilization of the trimers in the bR crystals is not based on specific
interactions, but on nonspecific interactions of amphifilic nature. Thus, we showed that molecules
of native lipids and detergents do not participate in specific interactions required for the formation
of  3D  crystals  of  bR.  Apparently,  native  lipids  are  bound  to  bR  by  nonspecific  amphifilic
interactions forming a belt that masks the hydrophobic areas of the protein. Also, it seems that both
detergents and native lipids influence the physical properties of  in meso crystallization matrix in
such a way affecting the process of crystallization.
Having obtained this  information we started the crystallization trials with bRLE and bRLEs
proteins using nanovolume in meso high throughout crystallization system. The crystallization trials
are ongoing.
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 4  Materials and methods
 4.1  Materials.
All the salts  and media components were either from  AppliChem (Darmstadt,  Germany) or
Sigma-Aldrich (St.  Louis,  USA) of analysis  quality or  higher.  All  enzymes were from  Thermo
Fisher Scientific (Rockford, USA). DM, DDM, MEGA10, CYMAL5 was from Affymetrix (Santa
Clara, USA), Sarcosyl from AppliChem, retinal, DMPC, and CHAPS from Sigma-Aldrich.
 4.2  DNA manipulation
Polymerase chain reactions were carried out using Phusion Hot Start II DNA Polymerase from
Fermentas,  Thermo  Scientific  (Rockford,  USA).  All  the  primers  were  synthesized  by MWG
Operon, Eurofins (Ebersberg, Germany).  Commonly, to 37.5  μl of sterile water we added 1 μl of
matrix,  5x  Phusion  High  Fidelity  Reaction  buffer,  20  pM  of  each  primer,  5  nM  of  each
deoxyribonucleotide, and 1 unit of polymerase. Total volume was 50 μl. Reactions were carried out
using Arktik Thermal Cycler from Thermo Scientific (Rockford, USA). Program used was usually
as follows: 120 s at 98°C  to activate enzyme, then 40 cycles of reaction and final elongation at
72°C for 300 seconds. The body of the cycle consisted of denaturation step at 98°C for 20 seconds,
annealing step at 66-70°C for 20 seconds and elongation step at 72°C for 40-80 seconds depending
on the length of the amplified region. 
Restriction enzymes used were of mostly Fast Digest line from Fermentas, Thermo Scientific
(Rockford, USA). Typically,  reaction mixture was composed from DNA solution, sterilized mQ
water, 10x Fast Digest buffer and 1 μl of enzyme. Total volume was generally 20 μl for plasmid and
40 μl for PCR product. Reaction mixture was incubated at 37°C from 0.5 to 2 h depending on the
amount of DNA to be cut.
Ligation of the DNA fragments was achieved using T7 DNA Ligase from Fermentas, Thermo
Scientific (Rockford, USA). Typically, DNA fragments in water or low salt buffer were mixed in
appropriate ratios, T7 Ligase buffer was added according to final volume of the sample and then 1
μl of ligase was added. Reaction mixture was incubated at 20-22°C at least 2 hours. Generally,
DNA insert was in 3-5 excess in respect to the vector DNA.
A horizontal agarose gels were used for visual analysis of DNA. Agarose was from Bio-Rad
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(Hercules, USA). Gels were prepared from TAE buffer (40mM Tris, 20mM acetic acid and 1mM
EDTA, pH 8.5) with 1% agarose and 1:20000 of GelRed solution from Biotium (Hayward, USA)
for in-gel staining. The DNA fragments were separated applying 10 V/cm voltage to the gel. When
needed DNA fragments were cut and eluted from gel using NucleoSpin Gel and PCR clean-up Kit
from  Macherey-Nagel  (Dueren,  Germany).  The  signal  was  visualized  using  manual  gel
documentation system InGenius from Syngene (Cambridge, UK).
Top10  E.  coli strain (Invitrogen,  Carlsbad,  USA) was used as  a  cloning strain.  Chemically
competent cells we prepared in-house according to a standard protocol [141]. For transformation 1
μl of plasmid solution or 2-5 μl of ligation mixture were added to frozen cells. They were incubated
on ice for 30-60 minutes and after a heat-shock at 42°C for 90 seconds the cells were incubated for
an additional 5 minutes. Then 800 μl of SOC media was added and cells were let to recover at 37°C
for 30 minutes with gentle shaking. Then cells were pelleted and resuspended in 50 μl SOC media
and applied on LB-agar plates with suitable antibiotic.
SE1  E.  coli strain  (Delphi  Genetics,  Charleroi,  Belgium)  was  used  as  expression  strain  in
combination with pSCodon plasmid (Delphi Genetics, Charleroi, Belgium). Competent cells were
prepared  by supplier  and  used  according  to  supplier  recommendations.  Shortly,  transformation
protocol was essentially the same as with Top 10 strain except 350 ml of the supplied recovery
media was added to the cells for recovery and cells were not pelleted before applying on agar plate.
BL21 E. coli strain were used for expression of SRII protein and its derivative. The competent
cells were prepared in-house by TSS-procedure [142] and transformation protocol was the same as
for Top 10 strain.
 4.3  Cloning of genetic constructs
Plasmid  pEF191  containing  wild  type  bR nucleotide  sequence  was  kindly  provided  by D.
Oesterhelt [99]. Plasmid pET27bmod_SOPII containing wild type SRII with His-tag appended to its
C-terminus was kindly provided by M. Engelhard [27]. Stabilized lysozyme gene [143] optimized
for expression in Halobium Salinarum and MISTIC (M110 from [115]) were synthesized by MWG
Operon, Eurofins (Ebersberg, Germany). All the DNA manipulations were accomplished as it was
described above and the accuracy of all constructs was proved by sequencing of the modified parts
of the plasmids by MWG company. The nucleotide sequences of the major constructs (only open
reading frames) are presented in Appendix.
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4.3.1. pEF191 constructs for homologous expression of bR in H. 
salinarum.
To obtain the pEF191-bRL plasmid the synthesized Lys was inserted into pEF191 plasmid at
NsiI and  ClaI restriction sites. We introduced these sites into the plasmid by PCR using primers
containing these sites. The gene that was synthesized by MWG company already contained these
sites and was cut out directly by restriction enzymes. Three insertions containing bRI and bRII parts
and Lys gene were ligated at BamHI and HindIII sites.
The pEF191-bRLE plasmid was obtained using  His-taged Lys (not described here). The PCR
was carried out using primers complementary to the bR gene before BsrGI restriction site and His-
tag with  XhoI site.  The  XhoI restriction site  was added to the  3'-NTR using PCR with  primer
containing this site. Two insertions containing Lys gene and 3'-NTR were ligated into pEF191-
bRLE plasmid at BsrGI and HindIII sites.
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Figure 35: Cloning of pEF191 based plasmids bearing the gene of bR-Lys fusion proteins. In
bRL fusion protein Lys is put into bR between  Met163 and Arg164, while in bRLE construct it is
appended to the bR gene. The 5'-NTR and 3'-NTR of the bR gene from H. salinarum are shown in
purple hollow rectangles, Lys is pink, bR is purple,  His-tag is yellow. The restriction enzymes are
indicated by vertical lines, while PCR primers indicated by arrows.
4.3.2.Constructs containing MISTIC-bR-Lys fusion protein.
The MISTIC gene was synthesized by MWG company, cloned into pSCodon vector containing
His-tag and was routinely used in our laboratory for expression of different fusion proteins. This
construct contains Factor Xa protease sites (IEGR) separated from MISTIC by 9 amino acid linker
GPGGSSGAS and from the target protein and  His-tag by GSS and SGAP linkers, respectively.
Thus,  after  proteolys  with  Factor  Xa  the  N-terminus  of  target  protein  would  not  contain  any
additional amino acids, while  C-terminus would contain GSSIEGR amino acids. The MbR fusion
protein gene inserted into pSCodon vector. Using this plasmid we carried out cloning to obtain
MISTIC-bR-Lys fusion protein genes according to the strategy presented in Fig. 36. 
The MbRL construct was obtained from pEF191-bRL construct using two PCR. First reaction
amplified bRI part of bR including NheI restriction site and Lys introducing HindIII restriction site
appended to the  Lys  gene, while second reaction introduced  HindIII and  BamHI restriction sites
flanking bRII part of bR. The pSCodon-MbR plasmid was cut at NheI and BamHI restriction sites
and two insertions containing bRI and Lys and bRII genes were ligated into pSCodon vector giving
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Figure  36: Cloning of  pSCodon based plasmids bearing the gene of  MISTIC-bR-Lys  fusion
proteins. In MbRL fusion protein Lys is put into bR between Met163 and Arg164, while in MbRLE
and MbRLEs construct it is appended to the native and truncated at Glu232 bR gene, respectively.
MbRLEsE11F construct contains E11F mutation in Lys gene that abolishes activity of  Lys. The
MISTIC gene is light blue, Lys is pink, bR is purple, His-tag is yellow. The restriction enzymes are
indicated by vertical lines, while PCR primers are indicated by arrows. The E11F mutation in Lys is
shown by red arrow.
pSCodon-MbRL plasmid. 
The MbRLE construct was obtained using pEF191-bRLE construct. The PCR amplified the bR
gene including NheI restriction site and Lys gene introducing BamHI restriction site (Fig. 36). The
NheI/BamHI-cut PCR product was ligated into pSCodon vector using these sites. The MbRLEs
construct was obtained from MbRLE by PCR with the same forward but different reverse primer
that appended  NsiI restriction site to the Glu232 of bR. The  NheI/NsiI insertion was ligated into
pSCodon vector obtained from pSCodon-MbRLE cut at NheI and NsiI restriction sites.
To introduce E11F mutation we used PCR. The closest suitable restriction site was BglII located
just 13 bp downstream. We amplified bR gene including NheI restriction site and the beginning of
Lys gene up to BglII restriction site using reverse primer containing E11F mutation. The NheI/BglII-
cut PCR product was ligated to the same sites of pSCodon-bRLEs plasmid. The BglII restriction site
is present in pSCodon plasmid as well. The  NheI/BglII-cut plasmid had three fragments: 6162, 710,
and 512 bp. We mixed 6162 and 512 bp fragments and PCR products for ligation.
4.3.3.Construction of chimeric proteins.
The realization of the complementary protein approach required the construction of the chimeric
proteins between SRII and bR. We have costructed chimeric proteins SR1-44bR, SR1-10bR, SR1-10, 28-
44bR, SR28-44bR, and bR1-8SR according to the strategies presented in Fig. 37.
The wild type bR gene was used as a negative control of bR expression. The construct was
produced from MbR construct by PCR using positive primer introducing NdeI restriction site to the
5'-terminus of bR gene and reverse primer complementary to the DNA downstream of the  BsrGI
restriction site. The NdeI/BsrGI-cut PCR product was ligated to the pSCodon-MbR plasmid cut by
the same enzymes.
The chimeric protein SR1-44bR was constructed by PCR. By silent mutations G144A and C147A
of bR we introduced  SpeI restriction site into bR gene: the first PCR added the  NdeI and  SpeI
restriction site flanking SRII gene region coding amino acids from 1 to 44, while the second PCR
introduce  SpeI site into bR gene. Two inserts were ligated into pSCodon-bR plasmid at  NdeI and
BsrGI sites.
First ten amino acids of SRII were introduced into bR gene by PCR using 50 bp long forward
primer containing NdeI restriction site and first 30 nucleotides of SRII. The pSCodon-bR plasmid
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was cut by  NdeI and  BsrGI restriction enzymes and PCR product cut by the same enzymes was
ligated into it.
The cloning of the SR1-10, 28-44bR chimeric protein was accomplished by two PCRs. Fortunately,
the junction of bR and SRII genes contained EagII restriction site. We carried out first PCR using
pSCodon- SR1-10bR plasmid as a matrix, thus amplifying the amino acids from 1 to 10 of SRII
inside bR gene. The second PCR was carried out using pSCodon- SR1-44bR plasmid as a matrix, thus
amplifying the amino acids from 28 to 44 of SRII inside bR gene. These two inserts were ligated at
XbaI and  BsrGI sites into pSCodon-bR plasmid. The SR28-44bR chimeric protein gene was easily
obtained from SR1-10, 28-44bR gene replacing its BglII/NheI fragment by counterpart from pSCodon-
bR plasmid that do not contain amino acids from SRII on the N-terminus of the protein.
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Figure 37: Cloning of the chimeric proteins between SRII and bR. The subscripts indicate which
amino acids of SRII were introduced to bR and  vice versa. The  Fig.  17 shows the amino acid
sequence of the N-terminus of the constructed chimeric proteins. The SRII gene is orange, bR is
purple, His-tag is yellow. The restriction enzymes are indicated by vertical lines, while PCR primers
indicated by arrows. 
To  investigate  the  influence  of  bR  N-terminus  on  expression  of  SRII  in  E.  coli we  have
constructed also the chimeric protein bR1-8SR. The amino acids from 1 to 8 were introduced to SRII
by PCR using 60 bp long reverse primer containing required nucleotide sequence from bR and
AatII restriction  site.  Two PCR fragments  were  ligated  into  pET27bmod  plasmid  at  MluI and
HindIII restriction sites.
4.3.4.Cloning of R8E and R8Q mutants, optimization of bR mRNA, and 
mutation of mRNA optimized bR.
The  cloning  of  the  R8Q  and  R8E  point  mutants  of  bR  was  accomplished  similar  to  the
construction of pSCodon-bR plasmid (Fig. 37). We used two different forward primers containing
CAA and GAA nucleotides (instead of CGT in bR) for R8Q and R8E mutants, respectively. The
inserts were ligated into pSCodon-bR plasmid at NdeI and BsrGI restriction sites. 
The optimization  of  mRNA was  carried  out  using  mRNAshapes [128] software.  Previously
[127],  it  was shown that stabilization of the (-4,  37) region of mRNA can significantly reduce
expression of the protein. Using mRNAshapes we have found that 5'-terminus of bR contains stem
structure  that  extended  further  than  (-4,  37)  region.  Thus,  we had  to  extend  the  region  under
investigation from (-4, 37) to (-4, 47) to include the observed stem. To compare the stabilization of
the N-terminus of the different proteins we calculated the mRNA folding free energies of the (-4,
47) region. Silent mutations C9A and G12A were shown to disrupt the stem structure destabilizing
the 5'-terminus of bR mRNA.
To introduce C9A and G12A mutations to the bR gene the two oligonucleotides (for sense and
antisense strands) were synthesized to fill the gap between  NdeI and  NheI restriction sites. The
oligos were mixed and ligated into pSCodon-bR plasmid cut by these enzymes.
Having obtained functional  expression  of  bR in  E.  coli we started  to  produce  the  mutants
required for the project devoted to the intermediate states of bR. We obtained V49A, D85N, and
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Figure 38: Cloning of the bR mutants using D96N mutant as example. The gene bR is purple,
His-tag  is  yellow.  The  restriction  enzymes  are  indicated  by  vertical  lines,  while  PCR primers
indicated by arrows.
D96N mutants.
The D96N mutant was constructed using PCR in two steps as there was no suitable restriction
site nearby. At first, two PCR were carried out as illustrated on Fig. 38. First reaction introduced the
D96N  mutation  with  reverse  primer  amplifying  nucleotide  sequence  from  NheI site  to  D96N
mutation  site.  Second  reaction  introduced  the  D96N mutation  with  forward  primer  amplifying
nucleotide sequence from D96N mutation site to BsrGI restriction site. The reverse primer of first
reaction  and  forward  primer  of  second  reaction  were  designed  to  contain  18  nucleotides
overlapping. After in-gel purification of the PCR products we mixed them to use these products as a
matrix  for  PCR, added primers  (forward of  first  reaction  and reverse  of  second reaction),  and
carried out new PCR. The resulting elongated PCR product was cut at  NheI and  BsrGI sites and
ligated into pSCodon-bR plasmid using these sites. The V49A mutation was introduced similarly.
The D85N mutant of bR was already present in our laboratory so we have just cut it at  NheI and
BsrGI sites and ligated this insertion to pSCodon-bR plasmid at the same sites.
4.3.5.Cloning of the bR-Lys fusion proteins.
As we already had all the required parts to accomplish the construction of the bR-Lys fusion
proteins  genes  we utilized only restriction reaction to produce these genes.  Also we wanted to
introduce the E11F mutation into Lys to abolish the enzymatic activity of this protein. The strategy
of the cloning is presented on Fig. 39.
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The bRL, bRLE, and bRLEs fusion protein genes were constructed using constructs MbRL,
MbRLE, MbRLEs, and MbRLEsE11F constructs presented in Fig. 36. All three new fusion proteins
contained E11F mutation in Lys gene and RNA optimized bR gene. We constructed first the bRLEs
construct just exchanging the  BsrGI/XhoI fragments of pSCodon-bRRNA plasmid containing RNA
optimized bR gene and pSCodon-MbRLEsE11F plasmid. 
To construct the bRLE construct we took the  NheI/NsiI fragment from MbRLE construct and
NsiI/XhoI fragment from bRLEs construct and ligated them into pSCodon-bR_RNA vector at the
NheI and  XhoI sites.  The  bRL construct  was  assembled  from three  insertions  and  pSCodon-
bR_RNA vector.  The  inserts  were:  1)  NheI/NsiI fragment  of  MbRL construct;  2)  AgeI/XhoI
fragment of MbRL construct; 3)  NsiI/AgeI fragment of bRLE construct. The first two fragments
introduced  NsiI and  HindIII restriction sites into bR gene as well as the 3'-terminus of Lys gene,
while third fragment contained E11F mutation that was absent in MbRL construct. Three inserts
were mixed and ligated into pSCodon-bR_RNA vector at the NheI and XhoI sites.
 4.4  Transformation of H. salinarum and screening of clones.
The transformation of H. salinarum L33 strain with pEF191 plasmid bearing genes of bR-Lys
fusion proteins was carried out according to [144] with slight modifications. In brief, the cells were
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Figure 39: Cloning of the bR-Lys fusion proteins with RNA optimized bR. Mutation E11F was
introduced into all three variations of fusion proteins. The Lys gene is pink, bR is purple, His-tag is
yellow. The restriction enzymes are indicated by vertical  lines, while PCR primers indicated by
arrows. Location of E11F mutation in Lys gene is indicated by red arrow.
grown in 1% pepton L37 from Oxoid, Thermo Fisher Scientific (Rockford, USA), 4.3 M NaCl, 80
mM MgSO4, 27 mM KCl, 10 mM Na3C6H5O7 pH 6.5 until the OD560 of 0.8. The 2 ml of cells were
harvested by centrifugation and resuspended in 150 μl of 2M NaCl, 27mM KCl, 15% (w/v) sucrose
buffer. Then 15 μl of EDTA was added, then after 10 minutes 5 μg of plasmid DNA was added in 10
μl of 1M NaCl, 13.5 mM KCl, 7.5% (w/v) sucrose solution. After 5 minutes 175 μl of 60% PEG600
was added, cells were shaked vigorously and incubated for 30 minutes. The cells were recovered
overnight at 37°C in 10 ml of growth media with 15% sucrose. Then the cells were collected by
centrifugation and plated on the agar plates containing 3 μg/ml mevinolin from Sigma-Aldrich (St.
Louis, USA). The first colonies were seen after 14 days at 37°C.
The screening of clones was accomplished using PCR amplification of genomic DNA. First, the
genomic DNA was isolated from cells lysated by osmotic shock and purified by sodium acetate
precipitation.  Then the genomic DNA was cut  to  smaller  pieces  by  HindIII restriction enzyme
which is not present in bR and Lys gene. The restriction mixture was taken as a matrix for PCR with
(5'-GGTTTGGAATCCGCGTGTCGGCTC-3')  forward  primer  and  either  (5'-
GCTGTCCTGCGTGTGCGATCAGTC-3')  or  (5'-GTGTCGTTGAAAAGCCGCGCCGGTT-3')
reverse primers for bRL and bRLE constructs, respectively. To differentiate correct clones the PCR
product was cut by BglII restriction enzyme. According to the amount and size of the bands from
cut  PCR product  on agarose gel  we could distinguish if  the  genetic  recombination took place.
Finally, the PCR product was sequenced by MWG company using the same primers as were used
for PCR to prove accuracy of genetic recombination.
 4.5  Growth media and cultivation of E. coli cells.
During DNA manipulations we mostly used LB and SOC media. The LB media contains 1%
w/v bactotryptone, 1% w/v yeast extract, 1% w/v NaCl. The pH of the LB media is adjusted to 7.0
with NaOH. Generally, to suppress the expression of the target protein in culture we added to the
media  also 2% w/v glucose.  The SOC media  contains  2% w/v bactotryptone,  0.5% w/v yeast
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4. The pH of the SOC media is
adjusted to 7.0 with NaOH. 
The cells were plated on LB agar plates made from the described LB media with addition of
1.5% w/v agar and proper antibiotic. The pSCodon vector contains gene providing the resistivity to
ampicillin, we used ampicillin concentrations between 100 and 250 μg/ml. The pET vector contains
gene providing the resistivity to kanamycin, we used kanamycin concentration of 50 μg/ml.
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For protein expression we used the ZYP-5052 autoinduction media according to  [145].  The
media was composed from ZY media (1% w/v bactotryptone, 1% w/v yeast extract) with stock
solutions 20×P (1 M Na2HPO4, 1 M KH2PO4, 0.5 M (NH4)2SO4) and 50×5052 (25% glycerol, 2.5%
glucose, 10% α-lactose monohydrate) and supplied with suitable antibiotics. The expression of the
membrane proteins in preparative scales was carried out in 2L baffled flasks with 400 ml ZY media
using Infors HT Minitron shaker (Bottmingen/Basel, Switzerland) at 120 rpm.
Several colonies of cell culture from a fresh plate (either fresh transformation of the cells with a
plasmid or cells freshly grown from stock at -80°C) were used to inoculate 20 ml of the fresh media
for overnight preculture that was grown ~16 h at 37°C and vigorous shaking in baffled flasks. Next
morning the cell culture was diluted 20-40 fold with a fresh media and grown at 37°C and vigorous
shaking until reached the OD600 of 2.0. Then the culture was diluted again 20 fold with a fresh
media without glucose (maximal residual concentration of glucose is 0.05% w/v) and grown at
37°C and  vigorous  shaking  until  reached  the  OD600 of  1.5.  At  this  moment  we decreased  the
temperature to 20°C, added retinal (50 mM of retinal  in ethanol solution,  400 μL per flask)  if
needed, and let the cells to grow overnight. The cells were harvested by centrifugation at 5 000 rpm
for 30 min in JLA-8000 rotor for Avanti J-26 XP preparative centrifuge (Beckman, Brea, USA).
 4.6  Protein purification.
4.6.1.Protein handling.
The protein  probes  were  taken  at  different  stages  of  protein  purification.  During  protein
solubilization and affinity chromatography we took the amount of the sample normalized to the
amount of total cell lysate. Generally, we take 40  μl of the total lysate (cell pellets from liter of
culture were resuspended in 50 ml of buffer) and prepare from it SDS-PAGE probe with the total
volume of 200 μl. All the following samples are made to contain the same amount of total lysate.
Probes  of  eluates  from  Ni-NTA  column  (Qigen,  Hilden,  Germany)  are  generally  highly
concentrated to estimate the amount of impurities and, thus, not normalized to the lysate probes.
The probes of total lysate, cytoplasm, solubilized and nonsolubilized fractions were precipitated
using trichloroacetic acid. For this we added 2.25×V of acetone and 0.35×V of trichloroacetic acid
to  a  protein  probe.  The  samples  were  incubated  at  -80°C  for  at  least  2  h,  then  protein  was
precipitated by centrifugation at 14 000 rpm in a bench centrifuge. The pellets were washed with
ice-cold acetone twice and then resuspended in 200 μl 1×SDS-PAGE loading buffer. 
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For  SDS-PAGE  analysis  we  used  in-house  made  8-16%  discontinuous  gradient  SDS
polyacrylamide gels. From 5 to 20 μl of protein probe was loaded per lane and the ~10 V/cm
voltage was applied. The gels were stained with coomassie brilliand blue from Sigma-Aldrich (St.
Louis, USA) and destained with 3% acetic acid.
For Western blotting we used a liquid transfer from gel to nitrocellulose membrane. The voltage
applied was ~1.8 V/cm2.  The transfer solution contained 47.9 mM Tris-base, 38.6 mM glycine,
0.0385% SDS, 20% methanol. After transfer nitrocellulose membrane was incubated with the 5%
solution of non-fat dry milk (Bio-Rad Laboratories, Hercules, USA) in TBST buffer (20 mM Tris-
HCl  pH  8.0,  100  mM  NaCl,  0.05%  Tween  20,  5%  glycerol).  The  primary  antibodies  were
monoclonal  His-probe  antibodies  produced  in  mouse  from Santa  Cruz  Biotechnology  (Dallas,
USA), while the secondary antibodies  were anti-mouse IgG- horseradish peroxidase conjugated
antibodies produced in goat from Sigma-Aldrich  (St. Louis, USA). The membranes were stained
with NBT/BCIP Substrate Solution from Thermo Scientific (Rockford, USA).
Size exclusion chromatography was carried out using  Superose 6pg column with 180 ml bed
volume  (preparative  scale),  Superose6HR  column  with  24  ml  bed  volume  (analytical  scale),
Sephacryl S200HR column with 165 ml bed volume (preparative scale), all from GE Healthcare
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Figure  40: Calibration  of  Superose6HR  column.  The  proteins  used:  RNAseA (13.7  kDa),
carbonic anhydrase (29 kDa), ovalbumin (44 kDa), albumin (66 kDa), alcohol dehydrogenase (150
kDa), amylase (200 kDa), ferretin (440 kDa), and thyroglobulin (660 kDa).
(Little Chalfont, UK). The column run and fraction collection was automated using ÄKTAprime
plus system from GE Healthcare (Little Chalfont, UK). For ion-exchange chromatography we used
prepacked HiTrap Sp Hp column with 1 ml bed volume from GE Healthcare (Little Chalfont, UK).
The analytical column Superose6HR was calibrated with Gel Filtration Markers Kit for Protein
Molecular Weights 12-200 kDa as well as RNAseA (~14 kDa), ovalbumin (44 kDa), ferretin (440
kDa),  and  thyroglobulin  (660  kDa)  all  from  Sigma-Aldrich  (St.  Louis,  USA)  as  presented  on
Fig. 40. The preparative scale columns were not calibrated.
To estimate the protein concentration we used SDS-PAGE densitometry, UV-Vis spectroscopy,
and BCA Protein  Assay Kit.  To estimate  the  purity  and concentration  of  the  Ni-NTA purified
samples we scanned the gel using Epson Perfection V750 Pro scanner (Suwa, Japan). The images
were transferred to grayscale and inverted, then the protein band densities were calculated using
ImageJ  software.  Total  protein  concentration  was  measured  by  BCA Protein  Assay  Kit  from
Thermo  Fisher  Scientific(Rockford,  USA)  following  supplier  protocol.  UV-Vis  absorbance
spectrum was measured on Shimadzu UV-2450 spectrophotometer (Kyoto, Japan). The fraction of
the  functional  protein  was  accessed  as  absorbance ratio  A280/Aλmax,  where  Aλmax is  maximum
absorbance of retinal [146]. Extinction coefficient for retinal in H.salinarum purple membranes was
assumed to  be  42 000  cm-1M-1 [11],  for  solubilized  bR 63 000 cm-1M-1 [147],  while  for  bR in
DMPC/CHAPS bicelles 55 300 cm-1M-1 [125].
4.6.2.Screening of detergents for solubilization of membrane proteins.
To  establish  the  purification  protocol  for  particular  MP we  should  first  select  the  proper
detergent for its solubilization. As the yield of MPs is generally rather low in order to visualize the
efficiency of solubilization by different detergents we employed the additional purification step of
Ni-NTA affinity chromatography before loading the samples on SDS-PAGE.
The cell pellets from 100 ml of cell culture were resuspended in 20 mM Tris-HCl pH 8.0, 5%
glycerol buffer adjusting the volume of cell suspension to 50 ml per each liter of cell culture. The
cells were homogenized by vigorous stirring, then 1 mg of DNAse I and 10 mg of lysozyme, both
from Sigma-Aldrich (St. Louis, USA), were added for each liter of cell culture. The cell suspension
was incubated for 2 h at 4°C with stirring and then lysated by three passes through either French
Press from SLM-Aminco (Irvine, USA) or micro-fluidizer M-110P from Microfluidics (Newton,
USA). The cell suspension was divided to equal parts and the detergents were added directly to the
suspension. Generally we used 1% DM, 1% DDM, 1% FOS-10, 1% FOS-12, 1% LDAO, 1% OG,
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2% Sarkosyl,  and 1% SDS. After  detergents dissolved in suspension we incubated the samples
overnight  at  4°C  (except  SDS  sample  which  was  kept  at  room  temperature)  for  complete
solubilization. 
Insoluble material was removed by ultracentrifugation in Ti-70 (Beckman, Brea, USA) rotor at
35 000 rpm for 1h. Supernatant was 5 times diluted with 20 mM Tris-HCl pH 8.0, 100 mM NaCl
buffer.  Suspension was loaded in batch mode on the 0.5 ml of Ni-NTA resin (Qiagen,  Hilden,
Germany) equilibrated with the same buffer. The column was first washed with 3 CV of 20 mM
Tris-HCl pH 8.0, 100 mM NaCl buffer supplied with the required detergent. We used concentrations
0.1% DM, 0.1% DDM, 0.1% FOS-10, 0.1% FOS-12, 0.1% LDAO, 0.8% OG, 0.25% Sarkosyl, and
0.1% SDS. The protein was eluted with 3 CV of 20 mM Tris-HCl pH 8.0, 300 mM imidazole buffer
supplied with the required detergent. The eluate samples were loaded on SDS-PAGE. The gels were
stained with coomassie, the Western blotting with anti-His antibodies was carried out as well.
4.6.3.Protein purification under denaturing conditions.
When it was established that Sarkosyl is the best detergent for solubilization of different bR
constructs we optimized purification protocol to obtain better purity of the protein on preparative
scale. For this purpose we isolated membranes from total lysate, washed the Ni-NTA column with
imidazole containing buffer and used larger volumes of cell culture. When the in-column detergent
exchange from Sarkosyl to SDS was required we used another sequence of washing buffers.
The cell pellets from 1 to 5 liters of cell culture were resuspended in 20 mM Tris-HCl pH 8.0,
5% glycerol buffer adjusting the volume of cell suspension to 50 ml per each liter of cell culture.
The cells were homogenized by vigorous stirring, then 1 mg of DNAse I and 10 mg of lysozyme
were added for each liter of cell culture. The cell suspension was incubated for 2 h at 4°C with
stirring and then lysated by three passes through either  french press or micro-fluidizer M-110P
(Microfluidics, Newton, USA). Then 5M NaCl was added to a final concentration of 200 mM and
suspension was layered over a glycerol cushion (1 ml - 90%, 1 ml - 80%, 1ml - 60%) in two 32 ml
tubes. The total membranes were isolated by ultracentrifugation in SW-32Ti rotor (Beckman, Brea,
USA)  at  28  000  rpm for  1h.  The  supernatant  was  discarded  and  glycerol  cushion  containing
membranes was resuspended in 50 ml of 20 mM Tris-HCl pH 8.0, 100 mM NaCl. Sarkosyl was
added to the final concentration of 2% and membranes were solubilized overnight with stirring at
4˚C.
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Insoluble material was removed by ultracentrifugation in Ti-70 (Beckman, Brea, USA) rotor at
35 000 rpm for 1h. Supernatant was 5 times diluted with 20 mM Tris-HCl pH 8.0, 100 mM NaCl,
10 mM imidazole buffer.  Suspension was loaded in batch mode on the 5 ml of  Ni-NTA resin
(Qiagen, Hilden, Germany) equilibrated with the same buffer. The column was first washed with 3
CV of 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 mM imidazole, 0.25% Sarkosyl. The protein was
eluted with 3 CV of 100 mM Na2HPO4 pH 8.0, 100 mM NaCl, 300 mM imidazole, 0.25% Sarkosyl.
When the detergent exchange was required, the sequence of washing buffers was as follows: 3
CV of 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.25% Sarkosyl, 20 mM imidazole buffer, then 5
CV of 100 mM Na2HPO4 pH 8.0, 100 mM NaCl, 0.2% SDS, and 3 CV of 100 mM Na2HPO4 pH
8.0, 0.2% SDS buffer. The protein was eluted with 3 CV of 100 mM Na 2HPO4 pH 8.0, 0.2% SDS,
300 mM imidazole.  To remove imidazole  the  samples  were dialysed  against  0.8 L of  50  mM
NaH2PO4 pH 6.0, 0.2% SDS. 
4.6.4.The cleavage of MISTIC fusion tag, renaturation of the protein in 
DMPC/CHAPS bicelles, delipidation of the protein.
The  MISTIC  fusion  protein  was  cleaved  with  Factor  Xa  protease  from  Qigen  (Hilden,
Germany). The analytical scale preparations were concentrated to 0.25 mg/ml and dialyzed against
20 mM Tris-HCl pH 8.0, 50 mM NaCl buffer supplied with 0.2% DDM. Afterwards, 1 mM of
CaCl2 was added to the reaction mixture. After dialysis 5 μg of protein was incubated 24 h at 20°C
with 1.0, 0.2, 0.04, 0.008 and 0.0016 μl of protease with concentration 2 units/μl. During prolonged
incubation with protease were used 0.4 units/μl  protease concentration  in  the sample  and took
probes every 24 hours during 4 days.
When needed the proteins were renaturated in DMPC/CHAPS bicelles according to modified
protocol of  [119]. Mixed DMPC/CHAPS bicelles were prepared by stirring DMPC from Sigma-
Aldrich (St. Louis, USA) in 50 mM sodium phosphate buffer pH 6.0 for 1 h followed by sonication.
Then CHAPS was added and the resulting clear micellar solution was stored at room temperature
and used within 24 h. Briefly, 0.5 mg/ml of the protein in 0.2% SDS (w/v) was mixed with an equal
volume of mixed DMPC/CHAPS micelles, containing all-trans-retinal. Final concentrations were
0.5 mg/ml protein,  0.1% SDS, 1% DMPC and 0.75% CHAPS, 50 mM phosphate,  and 25 μM
retinal. The samples were protected from light. Absorption and fluorescence spectra of regenerated
bR were measured after overnight incubation.
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For delipidation of the protein we used Superose6HR and Ni-NTA column. For gel-filtration the
sample was 9-fold concentrated, loaded on the column, and then eluted with 50 mM phosphate
buffer with 0.2% DDM. Before loading to Ni-NTA column the sample was 5-fold diluted. The
loading  of  the  sample  on  the  column  was  accomplished  in  a  batch-mode  overnight  at  room
temperature. Then the column was intensively washed with 50 mM phosphate buffer pH 6.0, 0.2%
DDM buffer. Then the protein was eluted with 50 mM phosphate buffer pH 6.0, 100 mM NaCl,
0.2% DDM, 300 mM imidazole buffer. After elution the samples were dialyzed against 50 mM
phosphate buffer pH 6.0, 100 mM NaCl, 0.2% DDM buffer to remove imidazole.
4.6.5.Protein purification under non-denaturing conditions and 
characterization of the protein.
DDM was added to the final concentration of 1% to the membranes isolated as described in
chapter  4.6.3 and  then  membranes  were  solubilized  overnight  with  stirring  at  4˚C.  Insoluble
material was removed by ultracentrifugation in Ti-70 rotor at 35 000 rpm for 1h. Supernatant was 5
times diluted with 20 mM Tris-HCl pH 8.0, 100 mM NaCl buffer and 10 mM imidazole was added.
Suspension was loaded on the 5 ml of Ni-NTA resin equilibrated with the same buffer. The column
was  washed  with  10  CV of  50  mM  NaH2PO4 pH  6.0,  100  mM  NaCl,  0.2% DDM,  30  mM
imidazole. The protein was eluted with 3 CV of 50 mM NaH2PO4 pH 7.4, 100mM NaCl, 0.2%
DDM, 300 mM imidazole. Only coloured fractions were pooled. To remove imidazole the samples
were immediately dialysed against 0.6 L of 50 mM NaH2PO4 pH 6.0, 100 mM NaCl for 2 hours and
removed from dialysis buffer, then after 10 hours dialysis was continued for additional 2 hours
against fresh buffer.
After  the  dialysis  the  protein  heavily  precipitated.  The  white  pellet  was  separated  by
centrifugation at 5000 rpm from colored solution and discarded. Protein was concentrated to the
volume of 2 ml by ultrafiltration and applied to 165 ml Sephacryl S200HR (GE Healthcare, UK)
column equilibrated with 50 mM NaH2PO4 pH 6.0, 100 mM NaCl, 0.1% DDM. Peak of colored
functional protein could be easily separated from the peak of the aggregated protein. 
The samples were protected from the light. Total protein concentration was measured by BCA
Protein  Assay  Kit  following  supplier  protocol.  To  access  the  protein  purity  the  samples  were
analyzed on 8-16% gradient SDS-PAGE. The fraction of the functional protein was accessed from
UV-Vis spectra as absorbance ratio A280/Aλmax, where Aλmax is maximum absorbance of retinal. The
concentration of functional protein was accessed by retinal absorbance using extinction coefficient
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63 000 cm-1M-1 [147].
 4.7  Crystallization of wild type bR from purple membranes, data 
collection and model building.
Purple membranes were produced from H. salinarum S9 bR overexpressing strain according to
[11]. The solubilization and crystallization were carried out according to the protocols routinely
used in our laboratory and described in [147]. 
The concentration of the detergent in solubilized protein was determined by weighting. First,
thin glass plate was weighted and then 10 μL of the solubilized protein was dropped on the plate.
The  liquid  was  evaporated  during  2  h  in  desiccator,  then  the  glass  plate  was  weighted  again.
Subtracting from the final mass of the plate its initial mass as well as calculated mass of the protein
and salt  we can estimate  the amount  of  detergent  in  the sample.  Comparison with the  Fourier
transformed infrared spectroscopy showed that this method gives acceptable results.
The crystallization probes were inspected in light microscope. The crystals reached the size up
to 350 μm. The selected probes transferred to the 3M sodium phosphate buffer pH 5.6 supplied with
0.1% OG where the cubic phase was dissolved. The crystals were fished out from mother liquor
with cryoloop (Hampton Research,  Aliso Viejo,  USA) and flash cooled in liquid nitrogen. The
frozen  crystals  were  tested  using  in-house  rotating  anode  X-ray  generator  (Nonius  FR  591,
Rotterdam, Netherlands),  then X-ray diffraction data  (wavelengths  0.934 Å and 0.976 Å) were
collected  at  the  beamlines  ID14-1  and ID23-1 of  the  European Synchrotron  Radiation  Facility
(ESRF, Grenoble, France) using a PILATUS 6M detector.
The diffraction patterns were processed with MOSFILM [135] and SCALA [136]. For crystals
with relatively low (less than 35%) twinning ratio the detwinning procedure was used, while for the
cases of perfect twinning the build-in algorithms of CCP4 package  [137] were used. The initial
phasing was done using molecular replacement method realized in program MOLREP [138] with
poly-Ala model of high resolution bR structure (derived from 1C3W structure  [14] in PDB Data
Bank  [2]). Protein auto-building was accomplished by ARP/wARP [139]. The initial model was
refined using Refmac [140]. The model was visualized using Coot [148]. The pictures were created
using Pymol [149].
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 4.8  Crystallization of wild type bR and its mutants expressed in E. coli,
data collection.
The crystals of wild type bR and its D85N and D96N mutants expressed in E. coli were grown
using in meso approach using nanovolume robotic system Formulatrix NT8 (Waltham, USA). The
purified protein in crystallization buffer was added to the MO-based lipid mesophase. The best
crystals were obtained using the protein concentration of 39 mg/ml and 0.1M Tris pH 8.8, 2.6M
ammonium sulfate precipitation solution. The crystals were grown at 22°C.
X-ray diffraction data  (wavelengths  0.934 Å and 0.976 Å) were collected at  the  beamlines
ID14-1 and ID23-1 of the European Synchrotron Radiation Facility (ESRF, Grenoble, France) using
a PILATUS 6M detector. Diffraction patterns were investigated using the MOSFLM software [135]
from the CCP4 program suite [137].
- 87 -
 5  Summary.
Energy production in living cells is among the most important questions in biology and for the
modern  technology.  Bacteriorhodopsin  (bR)  being  a  simplest  tool  to  produce  electrochemical
gradient of protons across membrane, a key and universal step of energy production in living cells,
have received a lot of attention. It became one of the model membrane proteins (MPs), also because
of  its  relative  abundance  in  nature  and  relative  ease  of  purification  from  natural  source,  H.
salinarum.  But homologous production of bR and its mutants in halobacteria is laborious, time-,
and resource-consuming, thus restraining the research studies. Unique properties of bR photocycle
make it useful and promising in a wide variety of technical and medical applications, thus giving
rise to growing need of this protein in basic and applied science. Despite the availability of the
atomic  structures  there  are  still  controversies  on  the  structures  of  bR photocycle  intermediates
obtained by different groups and the mechanism of the  vectorial proton transfer by bR is not yet
clear and requires new structural studies. For the investigation of the bR photocycle and obtaining
of the atomic structures of photocycle intermediates availability of different bR mutants is essential.
Archaea  is  not  very suitable  for  fast  production  of  the  required  mutants  or  large-scale  protein
production for industry, therefore the heterogeneous expression would be a desirable option as a
source  of  wild  type  and mutant  bR.  An  Escherichia coli based expression  system is  the  most
preferable because of its facility and robustness. The functional expression of bR in  E. coli was
intensively  tried  over  the  period  of  last  30  years  but  unsuccessfully.  This  is  quite  surprising
considering the fact that there are several examples (SRII, hR and bR homologs from other archaea)
of functional expression of retinal proteins in E. coli. The work presented addressed the problem of
bR functional expression in E. coli. 
At first, the hypothesis that the low yield of bR expression can be attributed to the low rate of
protein  insertion  into  bacterial  membrane  was  verified.  We  introduced  complementary  protein
approach that allowed us to localize the problem in MP expression using finite number of steps. It is
based  on  constructing  chimeric  proteins  between  a  protein  of  interest  and  complementary
homologous protein expressed in chosen system with high yield. To investigate the role of the first
transmembrane  helix  in  insertion  of  bR into  membrane  the  chimeric  proteins,  where  different
regions on the  N-terminus of bR were replaced by the corresponding parts  of SRII,  have been
expressed in  E. coli. The substitution of first ten amino acids of bR for the corresponding eight
amino acids  from SRII  was shown to  increase  the  protein  expression  yield  more  than  50-fold
making it comparable with the yields of reference retinal proteins known to express at high level in
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E. coli. We suppose also that complementary protein approach may have a general application and
can be used for MPs that are difficult to express.
Initially, we examined one of the possible reasons of such a dramatic effect – the presence of
positively charged Arg7 on the N-terminus of bR that deviates from “positive inside” rule. This rule
is based on idea that it is energetically unfavorable process to translocate the positive charge across
lipid membrane. The exchange of N-terminus removes the positive charge on the N-terminus of the
protein.  According  to  the  “positive  inside”  rule  this  could  result  in  better  incorporation  of  the
protein to the membrane and thus increase the protein yield. To verify this idea we expressed bR
point mutants R7Q and R7E where the only positive charge in the extracellular  N-terminus was
changed to neutral and negative charges, respectively. Although the yield of the point mutants were
visibly higher  than  of  wild type  gene,  it  was  considerably lower  than  that  of  chimeric  protein
indicating that presence of positive charge on the  N-terminus of bR is not the main reason of its
poor expression in E. coli.
Using RNA modeling software a putative stem structure in the  N-terminus of bR mRNA was
found revealing another possible reason of low bR expression in  E. coli. The expression yield of
optimized wild type bR gene was on the same level as yield of the chimera between bR and SRII, in
contrast to the expression of native gene. Thus, the low yield of bacteriorhodopsin native gene in E.
coli is mainly attributed to the unfavorable mRNA structure of native gene close to the ribosome
binding site.
When we used non-denaturing conditions,  the protein have retained its  functionality during
purification process. Using affinity and size-exclusion chromatography we were able to purify the
functional wild type bR expressed in  E. coli to homogeneity. The purity and functionality of the
protein obtained were confirmed spectroscopically. The yield of functional protein was 2.4±1.3 mg
of protein per liter of culture what is sufficient for a large-scale crystallization and industrial use. 
One  of  the  main  advantages  of  E.  coli expression  system is  the  considerably  shorter  time
required to produce the mutants of interest facilitating the intense study of the target protein. Using
mRNA-optimized bR gene we introduced mutations V49A, D85N, and D96N of the key amino
acids for proton pumping in bR and utilizing the non-denaturing purification protocol we have
readily obtained functional mutant proteins in short time with yields of 0.3, 3.8, and 8.8 mg per liter
of  culture,  respectively.  We suppose  that  increased  yield  of  D85N and  D96N mutants  can  be
explained by better incorporation of positively charged C-helix of bR into  E. coli membrane. As
- 89 -
translocation  of  positive  charge  across  membrane  is  energetically  unfavorable  process,  the
substitution of either Asp85 or Asp 96 with neutral Asn may favor insertion of bR into membrane.
One more task of the present work was to obtain the bR-Lys fusion protein that might help
resolving the controversies in bR structural studies. Throughout the years over almost a hundred of
bR  structures  were  deposited  in  Protein  Data  Bank  solved  by  both  electron  and  X-ray
crystallography. But still there are inconsistencies in details of proton translocation by bR. In 2007
the first  structure of GPCR was obtained using GPCR-Lys fusion protein.  We suppose that  bR
would  be  a  good  starting  model  for  investigation  of  versatility  of  the  utilization  of  Lys  as
crystallization tag. As most of the crystal contacts were formed by Lys and GPCRs have topology
similar to bR, we expect that bR-Lys can readily form crystals. As in meso grown crystals of wild
type bR are prone to twinning we hope that crystallization of bR-Lys fusion protein will provide the
twinning-free crystals in another space group allowing to determine precise structures of bR ground
state as well as its intermediates during photocycle.
Realization of such project requires a crystallization of the fusion protein between membrane
bR  and  water  soluble  Lys,  thus  demanding  high  yield  expression  system  and  effective
crystallization approaches. Here, bR can serve as a guiding reference. The previously reported X-
ray  structures  of  bR  were  solved  using  protein  preparations  from  purple  membranes.  High
resolution structures show that bR trimers are surrounded by the native lipid belt  shielding the
hydrophobic area of the protein. Despite multiple protocols of  E. coli expression there have not
been  reports  about  successful  3D  crystallization  of  the  heterologously  expressed  bR.  The  2D
crystals  of  bR  expressed  in  E.  coli were  obtained  from  protein  reconstituted  into  native  H.
salinarum lipids. Since bR-Lys fusion protein expressed in  E. coli would not have  H. salinarum
lipids bound and purification strategy of bR expressed in E. coli is based on the application of DDM
instead of usual OG, the careful investigation of the influence of lipid/detergent environment on in
meso crystallization would significantly benefit to the crystallization trials with  E. coli expressed
bR, its mutants and fusion proteins.
To study influence of detergent on the in meso crystallization we set large-scale crystallization
trials with homologously expressed bR from purple membranes using the following mixtures of
detergents: OG-DDM, OG-MEGA10, OG-CYMAL5. The crystals of different size (up to 300 μm
in OG-DDM mixture) and quality were obtained in all  three mixtures.  Crystallization diagrams
presenting the dependence of the size of the grown crystals on the crystallization conditions showed
that not the type of the detergent influences the in meso crystallization, but the normalized amount
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of  detergent  in  the  sample  indicating  that  detergent  alters  the  physical  properties  of  the
crystallization matrix.
The X-ray diffraction data sets at synchrotron radiation (ID 14-1, Grenoble, France) were taken
from the best crystals according to the results of the in-house tests. Three crystals (one from OG-
MEGA10 and two from OG-DDM mixtures) gave a diffraction 1.45 and 1.70 Å, respectively. The
full datasets were collected and three structures of bR were solved. The structures obtained did not
show  significant  differences  in  electron  densities  and  no  electron  densities  were  modeled  as
detergent molecules. These structures (along with the structures solved by my colleagues using the
crystals grown from different detergents) proved that detergent molecules do not participate in the
formation of the crystal lattice of bR crystals. Moreover, there is no need to exchange the detergent
from  DDM,  which  is  used  for  purification,  to  OG,  which  is  generally  used  for  in  meso
crystallization of bR from purple membranes.
Then, using the protein obtained by expression of RNA optimized gene in E. coli the crystals of
wild type bR and D85N and D96N bR mutants were grown. Crystals were tested under synchrotron
radiation and gave a diffraction up to 2.5Å resolution for D96N crystals and 3.7Å for D85N without
optimization of crystal growth. These are the first 3D crystals of bR which expressed in E. coli that
demonstrate the aptness of the presented approach for expression of bR and its mutants suitable for
many scientific  and industrial  applications.  In  addition,  the successful  crystallization  of  protein
isolated from E. coli demonstrated that H. salinarum native lipids are not required for the formation
of well ordered bR crystals.
 Using the mRNA optimized wild type bR gene we have expressed two bR-Lys fusion proteins
in E. coli with yield up to 0.9 mg of functional protein per liter of culture. Using metal affinity and
size-exclusion chromatography under non-denaturing conditions the functional protein was purified
to homogeneity and in meso crystallization trials are ongoing.
To summarize in brief:
• We introduced and verified complementary protein approach that is based on constructing
chimeric  proteins  between  a  target  protein  and  complementary  homologous  protein  expressed
functionally in chosen system with high yield. We suppose that such approach can be used for MPs
in general allowing to localize the underlying issues in the expression of target protein using a
limited number of steps.
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• Using  complementary  protein  modular  approach  we  found  that  replacement  of  first  10
amino acids of bR dramatically improves the yield of bR. The yield of chimeric protein is 50 times
higher and was attributed mainly to the optimization of mRNA structure.
• The point mutations R8Q and R8E also lead to the increase in bR expression yield in 6.8 and
2.7 times, respectively. Thus, the “positive inside” rule considerably influences the expression level
of bR in E. coli.
• Wild-type bR expressed in E. coli using RNA optimized gene retained its functional activity
during purification under non-denaturing conditions. We purified the protein to homogeneity using
metal affinity and size exclusion chromatography. Thus, our study established for the first time the
protocol of wild type bR expression in  E. coli  and its functional purification in non-denaturing
conditions to homogeneity in amounts sufficient for a large-scale crystallization.
• The potency of the presented approach was proved by expression in E. coli and functional
purification under non-denaturing conditions of V49A, D85N, D96N mutants of bR.
• Bacteriorhodopsin from purple membranes was crystallized in OG-MEGA10, OG-DDM,
and OG-CYMAL5 detergent mixtures giving the crystals diffracted up to 1.45 Å resolution. Three
solved  structures  of  bR  in  the  ground  state  have  not  reveal  the  detergent  in  crystal  lattice.
Crystallization diagrams, however, indicate that detergent do influence the crystallization process
altering the physical properties of amphiphilic crystallization matrix.
• The first 3D crystals of wild-type bR and its D85N and D96N mutants expressed in E. coli
were grown from the obtained protein material. First crystals were tested on synchrotron beam line
and gave a diffraction up to 2.5Å resolution for D96N and 3.7Å for D85N mutants even without
optimization  of  crystallization  parameters.  We have  demonstrated  the  aptness  of  the  presented
approach  for  expression  of  bR  and  its  mutants  suitable  for  many  scientific  and  industrial
applications. Successful crystallization of protein material expressed in E. coli demonstrated that H.
salinarum native lipids are not required for the formation of well ordered bR crystals.
• Employing the described system for bR expression in E. coli we expressed and functionally
purified  under  non-denaturing  conditions  the  bR-Lys  fusion  proteins  with  a  yield  enough  for
crystallographic studies. The crystallization trials are ongoing.
The development of the  E. coli based system for functional expression of bR and its mutants
- 92 -
opens new perspectives for the studies of this MP. Particularly, a readily available mutants of bR
will  facilitate  structural  studies  helping  to  understand  fundamentally  the  mechanism of  proton
transfer  in  the  cells.  Bacteriorhodopsin  mutants  may find  their  applications  in  multiple  studies
arising  in  bioelectronics,  biophotonics,  etc.  The  E.  coli expression  system  provides  many
opportunities  to investigate  the influence of the lipid/detergent  environment  on the folding and
crystallization of bR in vivo and in vitro. Also, we suggest that introduced here the complimentary
protein approach may find a general application for MP expression. Very valuable seems to be the
production of the functional bR-Lys fusion protein. The crystallization of this fusion protein can
give an important information concerning the generality of the crystallization tag strategy and can
allow to determine the atomic structures of bR and its intermediate states using twinning-free data.
Thus, the results presented in this thesis are of great relevancy and, we hope, will facilitate the
progress in the field.
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Appendix
Nucleotide sequences of important genetic constructs (only open reading frames).
MbRL
atgttttgtacattttttgaaaaacatcaccggaagtgggacatactgttagaaaaaagcacgggtgtgatggaagctatgaaagtgacgagtgaggaaaaggaacagctgagc
acagcaatcgaccgaatgaatgaaggactggacgcgtttatccagctgtataatgaatcggaaattgatgaaccgcttattcagcttgatgatgatacagccgagttaatgaagc
aggcccgagatatgtacggccaggaaaagctaaatgagaaattaaatacaattattaaacagattttatccatctcagtatctgaagaaggagaaaaagaaggcccgggtggc
agcagcggtgcatcgattgaaggtcgtcaggcccagatcaccggacgtccggagtggatctggctagcgctcggtacggcgctaatgggactcgggacgctctatttcctcg
tgaaagggatgggcgtctcggacccagatgcaaagaaattctacgccatcacgacgctcgtcccagccatcgcgttcacgatgtacctctcgatgctgctggggtatggcctc
acaatggtaccgttcggtggggagcagaaccccatctactgggcgcggtacgctgactggctgttcaccacgccgctgttgttgttagacctcgcgttgctcgttgacgcggat
cagggaacgatccttgcgctcgtcggtgccgacggcatcatgatcgggaccggcctggtcggcgcactgacgaaggtctactcgtaccgcttcgtgtggtgggcgatcagc
accgcagcgatgctgtacatcctgtacgtgctgttcttcgggttcacctcgaaggccgaaagcatgatgcataacatcttcgagatgctccgcatcgacgaggggctccgcctg
aagatctacaaggacacggaggggtactacaccatcggcatcgggcacctcctgaccaagagcccgtccctcaacgccgcgaaaagcgagctggacaaggcgattggcc
gcaacaccaacggcgtcatcaccaaggacgaggccgagaagctcttcaaccaggacgtggatgcggcggtgcgcggcatcctccgcaacgccaagctgaaaccggtcta
tgactcgctcgacgccgtccgacgtgccgccctcatcaacatggtgttccagatgggcgaaacgggtgtcgcgggcttcacgaactcgctgcggatgctccagcagaaacg
ctgggacgaagcggccgtcaacctcgcgaaatcgcggtggtacaaccaaacgcccaaccgcgccaaacgggtcatcaccaccttccgaaccggcacgtgggacgcctac
aagaacctgaagcttcgccccgaggtcgcatccacgttcaaagtactgcgtaacgttaccgttgtgttgtggtccgcgtatcccgtcgtgtggctgatcggcagcgaaggtgcg
ggaatcgtgccgctgaacatcgagacgctgctgttcatggtgcttgacgtgagcgcgaaggtcggcttcgggctcatcctcctgcgcagtcgtgcgatcttcggcgaagccga
agcgccggagccgtccgccggcgacggcgcggccgcgaccagcgacggatccggcattgaaggtcgtagcggtgctccgcatcaccatcaccatcaccatcactaa
MbRLE
atgttttgtacattttttgaaaaacatcaccggaagtgggacatactgttagaaaaaagcacgggtgtgatggaagctatgaaagtgacgagtgaggaaaaggaacagctgagc
acagcaatcgaccgaatgaatgaaggactggacgcgtttatccagctgtataatgaatcggaaattgatgaaccgcttattcagcttgatgatgatacagccgagttaatgaagc
aggcccgagatatgtacggccaggaaaagctaaatgagaaattaaatacaattattaaacagattttatccatctcagtatctgaagaaggagaaaaagaaggcccgggtggc
agcagcggtgcatcgattgaaggtcgtcaggcccagatcaccggacgtccggagtggatctggctagcgctcggtacggcgctaatgggactcgggacgctctatttcctcg
tgaaagggatgggcgtctcggacccagatgcaaagaaattctacgccatcacgacgctcgtcccagccatcgcgttcacgatgtacctctcgatgctgctggggtatggcctc
acaatggtaccgttcggtggggagcagaaccccatctactgggcgcggtacgctgactggctgttcaccacgccgctgttgttgttagacctcgcgttgctcgttgacgcggat
cagggaacgatccttgcgctcgtcggtgccgacggcatcatgatcgggaccggcctggtcggcgcactgacgaaggtctactcgtaccgcttcgtgtggtgggcgatcagc
accgcagcgatgctgtacatcctgtacgtgctgttcttcgggttcacctcgaaggccgaaagcatgcgccccgaggtcgcatccacgttcaaagtactgcgtaacgttaccgtt
gtgttgtggtccgcgtatcccgtcgtgtggctgatcggcagcgaaggtgcgggaatcgtgccgctgaacatcgagacgctgctgttcatggtgcttgacgtgagcgcgaaggt
cggcttcgggctcatcctcctgcgcagtcgtgcgatcttcggcgaagccgaagcgccggagccgtccgccggcgacggcgcggccgcgaccacccggatgcataacatc
ttcgagatgctccgcatcgacgaggggctccgcctgaagatctacaaggacacggaggggtactacaccatcggcatcgggcacctcctgaccaagagcccgtccctcaac
gccgcgaaaagcgagctggacaaggcgattggccgcaacaccaacggcgtcatcaccaaggacgaggccgagaagctcttcaaccaggacgtggatgcggcggtgcg
cggcatcctccgcaacgccaagctgaaaccggtctatgactcgctcgacgccgtccgacgtgccgccctcatcaacatggtgttccagatgggcgaaacgggtgtcgcggg
cttcacgaactcgctgcggatgctccagcagaaacgctgggacgaagcggccgtcaacctcgcgaaatcgcggtggtacaaccaaacgcccaaccgcgccaaacgggtc
atcaccaccttccgaaccggcacgtgggacgcctacaagaacctgggatccggcattgaaggtcgtagcggtgctccgcatcaccatcaccatcaccatcactaa
MbRLEs
atgttttgtacattttttgaaaaacatcaccggaagtgggacatactgttagaaaaaagcacgggtgtgatggaagctatgaaagtgacgagtgaggaaaaggaacagctgagc
acagcaatcgaccgaatgaatgaaggactggacgcgtttatccagctgtataatgaatcggaaattgatgaaccgcttattcagcttgatgatgatacagccgagttaatgaagc
aggcccgagatatgtacggccaggaaaagctaaatgagaaattaaatacaattattaaacagattttatccatctcagtatctgaagaaggagaaaaagaaggcccgggtggc
agcagcggtgcatcgattgaaggtcgtcaggcccagatcaccggacgtccggagtggatctggctagcgctcggtacggcgctaatgggactcgggacgctctatttcctcg
tgaaagggatgggcgtctcggacccagatgcaaagaaattctacgccatcacgacgctcgtcccagccatcgcgttcacgatgtacctctcgatgctgctggggtatggcctc
acaatggtaccgttcggtggggagcagaaccccatctactgggcgcggtacgctgactggctgttcaccacgccgctgttgttgttagacctcgcgttgctcgttgacgcggat
cagggaacgatccttgcgctcgtcggtgccgacggcatcatgatcgggaccggcctggtcggcgcactgacgaaggtctactcgtaccgcttcgtgtggtgggcgatcagc
accgcagcgatgctgtacatcctgtacgtgctgttcttcgggttcacctcgaaggccgaaagcatgcgccccgaggtcgcatccacgttcaaagtactgcgtaacgttaccgtt
gtgttgtggtccgcgtatcccgtcgtgtggctgatcggcagcgaaggtgcgggaatcgtgccgctgaacatcgagacgctgctgttcatggtgcttgacgtgagcgcgaaggt
cggcttcgggctcatcctcctgcgcagtcgtgcgatcttcggcgaaatgcataacatcttcgagatgctccgcatcgacgaggggctccgcctgaagatctacaaggacacgg
aggggtactacaccatcggcatcgggcacctcctgaccaagagcccgtccctcaacgccgcgaaaagcgagctggacaaggcgattggccgcaacaccaacggcgtcat
caccaaggacgaggccgagaagctcttcaaccaggacgtggatgcggcggtgcgcggcatcctccgcaacgccaagctgaaaccggtctatgactcgctcgacgccgtc
cgacgtgccgccctcatcaacatggtgttccagatgggcgaaacgggtgtcgcgggcttcacgaactcgctgcggatgctccagcagaaacgctgggacgaagcggccgt
caacctcgcgaaatcgcggtggtacaaccaaacgcccaaccgcgccaaacgggtcatcaccaccttccgaaccggcacgtgggacgcctacaagaacctgggatccggc
attgaaggtcgtagcggtgctccgcatcaccatcaccatcaccatcactaa
bR
atgcaggcccagatcaccggacgtccggagtggatctggctagcgctcggtacggcgctaatgggactcgggacgctctatttcctcgtgaaagggatgggcgtctcggac
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ccagatgcaaagaaattctacgccatcacgacgctcgtcccagccatcgcgttcacgatgtacctctcgatgctgctggggtatggcctcacaatggtaccgttcggtgggga
gcagaaccccatctactgggcgcggtacgctgactggctgttcaccacgccgctgttgttgttagacctcgcgttgctcgttgacgcggatcagggaacgatccttgcgctcgt
cggtgccgacggcatcatgatcgggaccggcctggtcggcgcactgacgaaggtctactcgtaccgcttcgtgtggtgggcgatcagcaccgcagcgatgctgtacatcct
gtacgtgctgttcttcgggttcacctcgaaggccgaaagcatgcgccccgaggtcgcatccacgttcaaagtactgcgtaacgttaccgttgtgttgtggtccgcgtatcccgtc
gtgtggctgatcggcagcgaaggtgcgggaatcgtgccgctgaacatcgagacgctgctgttcatggtgcttgacgtgagcgcgaaggtcggcttcgggctcatcctcctgc
gcagtcgtgcgatcttcggcgaagccgaagcgccggagccgtccgccggcgacggcgcggccgcgaccagcgacggatccggcattgaaggtcgtagcggtgctccgc
atcaccatcaccatcaccatcactaa
SR1-10, 28-44bR
atggtgggacttacgaccctcttttggatctggctagcgctcggtacggcgctaatgggactcgggacgctctatttcggccgtgacgccggaagcggcgagcgacggtact
acgccatcacgacactagtcccagccatcgcgttcacgatgtacctctcgatgctgctggggtatggcctcacaatggtaccgttcggtggggagcagaaccccatctactgg
gcgcggtacgctgactggctgttcaccacgccgctgttgttgttagacctcgcgttgctcgttgacgcggatcagggaacgatccttgcgctcgtcggtgccgacggcatcatg
atcgggaccggcctggtcggcgcactgacgaaggtctactcgtaccgcttcgtgtggtgggcgatcagcaccgcagcgatgctgtacatcctgtacgtgctgttcttcgggttc
acctcgaaggccgaaagcatgcgccccgaggtcgcatccacgttcaaagtactgcgtaacgttaccgttgtgttgtggtccgcgtatcccgtcgtgtggctgatcggcagcga
aggtgcgggaatcgtgccgctgaacatcgagacgctgctgttcatggtgcttgacgtgagcgcgaaggtcggcttcgggctcatcctcctgcgcagtcgtgcgatcttcggcg
aagccgaagcgccggagccgtccgccggcgacggcgcggccgcgaccagcgacggatccggcattgaaggtcgtagcggtgctccgcatcaccatcaccatcaccatc
actaa
bR1-8SR
atgcaggcccagatcaccggacgtccggagtggctcggcgcaatcggcatgctcgtcggcacgctcgcgttcgcgtgggccggccgtgacgccggaagcggcgagcga
cggtactacgtgacgcttgtcggcatcagtggtatcgcagcagtcgcctacgtcgtcatggcgctgggcgtcggctgggttcccgtggccgaacggactgtttttgccccccg
gtacattgactggattctcacaaccccgctcatcgtctacttcctcgggctgcttgcggggcttgatagtcgggagttcggcatcgtcatcacgctcaacaccgtggtcatgctcg
ccggcttcgccggggcgatggtgcccggtatcgagcgctacgcgctgttcggcatgggggcggtcgcattcctcggactggtctactacctcgtcgggccgatgaccgaaa
gtgccagccagcggtcctccggaatcaagtcgctgtacgtccgcctccgaaacctgacggtcatcctctgggcgatttatccgttcatctggctgcttggaccgccgggcgtg
gcgctgctgacaccgactgtcgacgtggcgcttatcgtctaccttgacctcgtcacgaaggtcggattcggcttcatcgcactcgatgctgcggcgacacttcgggccgaaca
cggcgaatcgctcgctggcgtcgatactgacgcgcctgcggtcgccgacgagaattcgcaccaccaccaccaccaccactaa
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Abstract.
Energy production in a living cells is among the most important questions in biology and for the
modern  technology.  Bacteriorhodopsin  (bR)  being  a  simplest  tool  to  produce  electric  potential
across membrane have received a lot of attention. It became one of the model membrane proteins,
also because of its relative abundance in nature and relative ease of purification from natural source,
H. salinarum. Unique properties of bR photocycle make it useful and promising in a wide variety of
technical applications, thus giving rise to growing need of this protein. Despite the availability of
the  atomic  structures  there  are  still  controversies  in  mechanism  of  proton  pumping  by  bR.
Homologous production of bR and its mutants in halobacteria is laborious, time-, and resource-
consuming,  therefore  facile  and  robust  E. coli expression  system  would  be  of  wide  interest.
Recently several  structures of GPCRs were obtained using GPCR-lysozyme fusion protein where
lysozyme  served  as  a  crystallization  tag.  We  suppose  that  bR  would  be  a  good  model  for
investigation of versatility of lysozyme as crystallization tags. As in meso grown crystals of bR are
prone  to  twinning  crystallization  of  bR-lysozyme  fusion  protein  could  provide  twinning-free
crystals allowing to clarify the details of bR photocycle.
In this work, it was suggested that the low yield of bR expression in E. coli can be attributed to
the  poor  insertion  of  the  protein  into  membrane.  We  have  introduced  protein  complementary
approach  that  may allow to  localize  the  problem in  membrane  protein  expression  using  finite
number of steps. It is based on constructing of chimeric proteins between a protein of interest and
complementary homologous protein expressed with high yield. Applying this approach we showed
that the substitution of first ten amino acids of bR for the corresponding eight amino acids from
SRII  increase  the  expression  yield  of  bR more  than  50-fold.  The reason for  high  yield  of  the
chimera could be the positively charged Arg7 on the N-terminus of bR that deviates from “positive
inside” rule and absent in the chimera. We expressed bR mutants R7Q and R7E where this positive
charge was substituted for neutral and negative charges, respectively. Although the yields of the
mutants  were  higher  than  of  wild  type  gene,  they  were  still  considerably lower  than  yield  of
chimera. Thus, the positive charge on the N-terminus of bR is not the reason of its poor expression
in E. coli. A putative stem structure 5'-end of bR mRNA was proposed to be another reason of low
bR expression in  E. coli. The expression yield of optimized wild type bR gene was on the same
level as yield of the chimera. Therefore, the low yield of bacteriorhodopsin native gene in E. coli
was attributed to the unfavorable mRNA structure of native gene close to the ribosome binding site.
When purified under  non-denaturing conditions,  the protein have retained its  functionality.  The
yield of functional homogenious protein was 2.4±1.3 mg per liter of culture what is sufficient for a
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large-scale crystallization and industrial use.  Using this approach we produced as well functional
V49A, D85N, and D96N mutants of bR in short time with yields of 0.3, 3.8, and 8.8 mg per liter of
culture, respectively. We suppose that increased yield of D85N and D96N mutants can be explained
by better incorporation of positively charged C-helix of bR into E. coli membrane.
The  second  goal,  crystallization  of  the  bR-lysozyme  fusion  protein,  demands  a  high  yield
expression system and effective crystallization approaches. Here, bR can serve as a reference. High
resolution  structures  show that  bR trimers  are  surrounded  by the  belt  of  native  lipid.  Despite
multiple protocols of E. coli expression, 3D crystallization of this protein was not reported. Since
expressed in  E. coli bR-lysozyme fusion protein would not have  H. salinarum lipids bound and
purification  of  this  protein is  based  on  the  application  of  DDM instead  of  usual  OG,  careful
investigation of the influence of lipid/detergent environment on in meso crystallization is important.
To study the influence of detergent on the in meso crystallization we set large-scale crystallization
trials with homologously expressed bR in mixtures of detergents. The crystals of different size (up
to  300  μm)  were  obtained.  Three  crystals  grown  in  mixtures  of  detergents  radiation  gave  at
synchrotron a diffraction up to 1.45 Å. The full datasets were collected and three structures of bR
were solved. We have not observed detergent molecules on the electron densities corresponding to
the  structures.  These  experiments  showed  that  detergent  molecules  do  not  participate  in  the
formation of the crystal lattice of bR. Moreover, there is no need to exchange the detergent from
DDM used for purification to OG that is generally used for in meso crystallization of homologously
expressed bR. Then, using the protein expressed E. coli the crystals of wild type bR and D85N and
D96N  bR  mutants  were  grown.  Crystals  were  tested  under  synchrotron  radiation  and  gave  a
diffraction up to 2.5Å resolution. The first 3D crystals of bR expressed in E. coli demonstrate that
expression of bR and its mutants in E. coli is suitable for scientific and industrial applications. In
addition,  the  successful  crystallization  of  protein  isolated  from  E.  coli demonstrated  that  H.
salinarum lipids are not strictly required for grow of well ordered bR crystals.
 Using the optimized bR gene we have expressed bR-lysozyme fusion proteins in E. coli with yield
up  to  0.9  mg  of  functional  protein  per  liter  of  culture.  This  protein  was  purified  under  non-
denaturing conditions to homogeneity and in meso crystallization trials are ongoing.
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Zusammenfassung
Die Energieproduktion in lebenden Zellen ist  eine der wichtigsten Fragen der modernen Biotechnologie.
Bacteriorhodopsin (bR) als eines der einfachsten Mittel zur Erzeugung eines elektrischen Potenzials an einer
Membran  hat  in  diesem  Zusammenhang  große  Beachtung  gefunden.  Auch  aufgrund  seines  häufigen
Vorkommens in der Natur in H. salinarum und der relativ unproblematischen Aufreinigung gilt es heute als
Modellmembranprotein.  Dank seines  einzigartigen Photozyklus  ist  bR ein nützliches,  vielversprechendes
Protein für eine große Bandbreite technischer Anwendungen, was zu einem steigenden Bedarf geführt hat.
Obwohl die Struktur des Proteins aufgeklärt ist, sind Details des Protonenpumpmechanismus von bR noch
immer  umstritten.  Die  homologe  Produktion  von  bR  und  seiner  Varianten  in  Halobakterien  ist
arbeitsaufwändig, langwierig und ressourcenintensiv. Ein einfaches und robustes E.-coli-Expressionssystem
würde daher auf großes Interesse stoßen. In der letzten Zeit wurden verschiedene GPCR-Strukturen mit Hilfe
von GPCR-Lysozym-Fusionsproteinen mit Lysozym als Kristallisations-Tag hergestellt. Es ist anzunehmen,
dass  bR  ein  geeignetes  Modell  für  die  Untersuchung  der  Verwendungsmöglichkeiten  von  Lysozym als
Kristallisations-Tag  sein  kann.  In  meso gewachsene  bR-Kristalle  neigen  zur  Zwillingsbildung.  Durch
Kristallisation des bR-Lysozym-Fusionsproteins können zwillingsfreie Kristalle gewonnen werden, um die
Details des Photozyklus von bR näher zu untersuchen.
In dieser Arbeit wurde die Vermutung aufgestellt, dass die geringe Ausbeute bei der bR-Expression in E. coli
auf den unzureichenden Einbau des Proteins in die Membran zurückzuführen ist. Es wurde ein Ansatz mit
komplementären  Proteinen  eingeführt,  um  das  Problem  bei  der  Membranproteinexpression  mit  einer
endlichen  Anzahl  von  Schritten  zu  lokalisieren.  Dieser  Ansatz  basiert  auf  der  Herstellung  von
Fusionsproteinen, die aus dem untersuchten Protein und einem geeigneten komplementären und homologen
Protein  bestehen,  das  mit  hoher  Ausbeute  exprimiert  wird.  Mithilfe  dieses  Verfahrens  konnte  mittels
Substitution  der  ersten  zehn  Aminosäuren  von  bR  durch  die  ersten  acht  Aminosäuren  von  SRII  die
Expressionsausbeute  von  bR  um  das  Fünfzigfache  erhöht  werden.  Grund  für  die  hohe  Ausbeute  an
Fusionsprotein ist möglicherweise, dass das positiv geladene Arg7 am N-Terminus von bR (eine Abweichung
von der ‚Innen-positiv-Regel‘) in diesem Protein nicht vorliegt. Es wurden die bR-Varianten R7Q und R7E
exprimiert, bei denen die positive Ladung jeweils durch eine neutrale bzw. negative Ladung ersetzt wurde.
Obwohl die Ausbeute beider Varianten die des Wildtyps überstieg, lag sie doch deutlich niedriger als bei dem
Fusionsprotein. Die positive Ladung am N-Terminus von bR ist daher nicht der Grund für seine schwache
Expression  in  E.  coli.  Eine  vermeintliche  Stielstruktur  am  5'-Ende der  bR-mRNA wurde  als  weiterer
möglicher Grund für die niedrige bR-Expression in E. coli vermutet. Die Expressionsausbeute lag bei dem
optimierten bR-Wildtypgen auf dem gleichen Niveau wie bei dem Fusionsprotein. Die geringe Ausbeute bei
dem natürlich vorkommenden Bacteriorhodopsin-Gen in E. coli wurde auf seine ungünstige mRNA-Struktur
im Bereich der Ribosom-Bindungsstelle zurückgeführt.  Bei der Aufreinigung unter nicht denaturierenden
Bedingungen bleibt die Funktionalität des Proteins erhalten. Die Ausbeute an funktional homogenem Protein
lag bei 2,4 ± 1,3 mg pro Liter Kultur, was für eine Kristallisation im Großmaßstab und industrielle Nutzung
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ausreichend ist. Mit diesem Ansatz konnten innerhalb kurzer Zeit funktionelle V49A-, D85N- und D96N-
Varianten von bR mit einer Ausbeute von 0,3 mg, 3,8 mg bzw. 8,8 mg pro Liter Kultur hergestellt werden. Es
ist  anzunehmen, dass die erhöhte Ausbeute der D85N- und D96N-Varianten durch einen erfolgreicheren
Einbau der positiv geladenen C-Helix von bR in die E.-coli-Membran zurückzuführen ist.
Das  zweite  Ziel,  die  Kristallisation  des  bR-Lysozym-Fusionsproteins,  erfordert  ein  hochproduktives
Expressionssystem und effektive Kristallisationsansätze. Hier kann bR als Referenz dienen. Hochauflösende
Strukturanalysen zeigen, dass bR-Trimere von einem Gürtel aus nativen Lipiden umgeben sind. Obwohl eine
Reihe von Expressionsprotokollen für  E. coli vorliegen, wurde bisher nicht von einer 3-D-Kristallisation
dieses  Proteins  berichtet.  Da  das  bR-Lysozym-Fusionsprotein  bei  einer  Expression  in  E.  coli keine  H.-
salinarum-Lipide binden würde und bei  der  Aufreinigung dieses  Proteins  DDM statt  des  üblichen OGs
verwendet  würde,  muss  hier  sorgfältig  untersucht  werden,  wie  sich  eine  eine  solche  Lipid/Detergens-
Umgebung auf die In-meso-Kristallisation auswirkt.
Um  den  Einfluss  des  Detergens  auf  die  In-meso-Kristallisation  zu  untersuchen,  wurden  großangelegte
Kristallisationsversuche mit  homolog exprimiertem bR in Detergenziengemischen durchgeführt.  Ergebnis
waren Kristalle verschiedener Größe (bis zu 300 μm). Bei drei in Gemischen von Detergenzien gewachsenen
Kristallen wurde bei der Beugungsanalyse im Synchrotron eine Auflösung von bis zu 1.45 Å gemessen. Die
vollständigen Datensätze wurden gesammelt und die drei bR-Strukturen aufgeklärt. Die Elektronendichten,
die diesen Strukturen entsprechen, zeigen keine Detergenzienmoleküle. Diese Versuche belegen, dass die
Detergenzienmoleküle bei der Entstehung des bR-Kristallgitters keine Rolle spielen. Darüber hinaus besteht
keine Notwendigkeit, das für die Aufreinigung verwendete Detergens DDM durch OG zu ersetzen, das im
Allgemeinen für die  In-meso-Kristallisation von homolog exprimiertem bR verwendet wird. Im Anschluss
wurden Kristalle des bR-Wildtyps und der Varianten D85N und D96N unter Verwendung des in  E. coli
exprimierten  Proteins  gezüchtet.  Die  Untersuchung  der  Beugung  mit  Synchrotronstrahlung  zeigte  eine
Auflösung von bis  zu  2.5Å.  Die  ersten  3-D-Kristalle  des  in  E.  coli exprimierten  bR belegen,  dass  die
Expression von bR und seinen Varianten in  E. coli für  wissenschaftliche und industrielle Anwendungen
geeignet ist. Darüber hinaus zeigt die erfolgreiche Kristallisation von aus E. coli isoliertem Protein, dass H.-
salinarum-Lipide für das Wachstum regelmäßiger Kristalle nicht unbedingt erforderlich sind.
Mit dem optimierten bR-Gen konnten die bR-Lysozym-Fusionsproteine in E. coli mit einer Ausbeute von bis
zu  0,9 mg  funktionellem Protein  pro  Liter  Kultur  exprimiert  werden.  Dieses  Protein  wurde  unter  nicht
denaturierenden Bedingungen bis zur Homogenität aufgereinigt. Die In-meso-Kristallisationsversuche laufen
derzeit noch.
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